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REPROGRAMMING DURING MOUSE PREIMPLANTATION DEVELOPMENT.
Sarayu Ratnam, PhD
University of Pittsburgh, 2004
Inheritance of DNA methylation on imprinted genes depends on the Dnmt1 (cytosine-5-)
methyltransferase protein.  Methylation patterns on imprinted genes are maintained by oocyte-
specific Dnmt1o isoform at the 8-cell stage of preimplantation development.  Methylation
patterns in postimplantation embryos are maintained by the Dnmt1s isoform.  To determine if
Dnmt1s can functionally replace Dnmt1o, we expressed Dnmt1s in oocytes and discovered that
Dnmt1s can maintain genomic imprints in the absence of Dnmt1o.  However, the ability of
Dnmt1s to maintain imprinting is dependant on the level of oocyte Dnmt1s.  Though Dnmt1s and
Dnmt1o have equivalent maintenance methyltransferase functions in oocytes, the unstable nature
of oocyte Dnmt1s, in comparison to oocyte Dnmt1o, leads to levels lower than what are required
to maintain methylation at the 8-cell stage.  We also determined that in cloned embryos, Dnmt1o
undergoes none of its expected trafficking to 8-cell stage nuclei.  Instead, these embryos exhibit
a mosaic pattern of Dnmt1s expression.  Defects in intracellular trafficking of Dnmt1o and
misexpression of Dnmt1s, along with the intrinsic instability of Dnmt1s, might contribute to
iv
aberrant DNA methylation in cloned embryos, thus raising concerns about the use of current
cloning technologies for therapeutic cloning.
Molecular mechanisms involved in the formation of ovarian teratomas were also analyzed.
Unfertilized oocytes arrest at the MII stage of meiotic maturation.  After fertilization, oocytes
continue into cell division.  Premature activation of MII oocytes without fertilization, can lead to
ovarian teratoma formation.  To better understand mechanisms governing the prevention of
spontaneous oocyte activation, we investigated the molecular defects leading to formation of
ovarian teratomas in the Tgkd mouse model.  Tgkd is a transgene insertional mutation that leads
to reduced levels of the Inpp4b protein in MII oocytes of hemizygous Tgkd females.  Wildtype
GV oocytes have less Inpp4b protein than MII oocytes, and a significant decrease in Inpp4b is
also seen after fertilization.  Also, the dependence of ovarian teratoma formation on the mouse
strain, emphasizes the role of a strain-specific modifier on chromosome 6, possibly IP31.  Thus,
it is possible that oocyte Inpp4b normally suppresses spontaneous MII oocyte activation,
possibly by reducing levels of IP3, an intermediate in the oocyte activation mechanism, that
occurs following fertilization.
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11. Role of Dnmt1 cytosine methyltransferases in genomic imprinting during mouse
preimplantation development
1.1. Introduction
In the classical Mendelian pattern of inheritance, each parent contributes a complete set of
chromosomes to its offspring and in most cases the genetic contribution of each parent is
equivalent.  However, a subset of mammalian genes is controlled by genomic imprinting, a
process that causes a gene to be expressed from only one chromosome homologue depending on
whether it originally came from the egg or the sperm (Cattanach and Beechey 1997) and this
subset of genes are called imprinted genes.
1.1.1. Genomic imprinting in humans
The importance of genomic imprinting for mammalian development was first shown by the
occurrence of a human tumor called the hydatidiform mole.  These tumors are caused due to the
fertilization of an egg, without a pronucleus, by a haploid sperm.  The sperm chromosome
content then replicates to form an androgenetic diploid genome (Kajii and Ohama 1977; Jacobs
et al. 1980).  Instead of proceeding with normal development, this egg develops into a mass of
extra-embryonic tissue, suggesting that normal mammalian development cannot occur with
genetic information solely derived from the male parent.
2 Normal mammalian development also does not occur with genetic information obtained
only from the female parent.  This has been shown by the formation of ovarian teratomas which
develop from the activation of an egg in the absence of fertilization (parthenogenesis).  These
ovarian teratomas consist of differentiated tissues and include endoderm, mesoderm and
ectoderm but there is no evidence of placental tissues in these tumors (Linder et al. 1975).
It has been shown that genomic imprinting is also involved in a number of genetic
disorders in humans like the Prader-Willi syndrome and Angelman syndrome (Table 1).  Prader-
Willi syndrome is caused due to the lack of expression of paternally expressed imprinted genes
in region q11-q13 of human chromosome 15 while Angelman syndrome is caused due to loss of
expression of maternally expressed imprinted genes within the same region (Nicholls et al.
1989).  Thus, understanding the inheritance of imprinted genes is critical to our understanding of
the occurrence of various diseases and disorders in humans.  But the extent of analysis possible
through the study of families with imprinting disorders is very limited.
 The mouse can be used as an excellent model system to study genomic imprinting.  There
are a number of reasons for this.  Mice have a relatively short gestation period, a large litter size
and are easy to handle and maintain.  The process of genomic imprinting is conserved between
humans and mice, and many human imprinted genes have mouse homologues that are also
imprinted (Table 2; Morison and Reeve 1998).  The genetics of inbred mouse strains has been
well characterized and the large amount of sequence information available, including single
nucleotide polymorphisms (SNPs), for various laboratory mouse strains helps us analyze the
inheritance of imprinted genes.  Also, the ability to generate transgenic or knockout mice using
3Table 1. Mapped parent-of-origin gene effects in humans
The table describes the imprinted loci identified in humans and has been modified from Morison
and Reeve 1998.  Specific regions of chromosomes or uniparental disomy (UPD) of
chromosomes that give rise to imprinting disorders in humans have been listed.
4Table 1. Mapped parent-of-origin gene effects in humans
Chromosome
Location
Parent-of-origin effect
         1p36 p73 is maternally expressed and located in the region showing preferential maternal loss of heterozygosity in
neuroblastoma.
UPD of
chromosome 1 One case of maternal heterodisomy including partial isodisomy of 1q has been reported.
2p24 N-Myc is amplified preferentially from the paternal allele in neuroblastoma.
UPD of
chromoosme 2 Maternal UPD is possibly associated with an abnormal phenotype.
4q21-q22 Anomalous imprinting has been hypothesized as the reason for the central nervous system overgrowth in the4q21/4q23 syndrome.
5q22-q31 U2AFBPL the human homologue of U2afbp-rs is imprinted in mice but not in human placenta.
6q25.3-q26 MAS1 (a tyrosine kinase protooncogene) shows monoallelic expression in human breast
6q25.3
IGF2R (insulin-like growth factor II receptor; mannose 6-phosphate receptor, cation independent) is
maternally expressed in mouse. It may be imprinted polymorphically in humans. Allele-specific methylation
(methylation of the active maternal allele) is maintained in humans.
6q22-23
Neonatal diabetes mellitus. Two cases of neonatal diabetes had paternal UPD 6. Additionally, paternal UPD
was associated with agenesis of pancreatic beta cells and neonatal diabetes although paternal UPD has also
occurred in a normal child.
7q11.23 Williams syndrome was associated with significantly more severe growth retardation and microcephaly if the
associated deletion of 7q11.23 was maternally derived.
7q32
PEG1/MEST (paternally expressed gene 1/mesoderm-specific transcript, member of the [alpha]/[beta]-
hydroxylase fold family) is paternally expressed in human fetal tissues, but biallelically expressed in adult
blood. Peg1 is imprinted in mice.
UPD of
chromosome 7
Several cases of maternal iso- and heterodisomy in Russell-Silver syndrome indicate the presence of
imprinted growth gene(s).
UPD of
chromosome 8 Paternal UPD is associated with normal development.
9q34 Loss of maternal ABO antigens has been reported in acute myeloid leukaemia cases.
11p15
The 11p15 region (involved in the Beckwith-Wiedemann syndrome) contains a number of imprinted genes,
which are listed in order.
H19 is maternally expressed in mouse and humans. The gene product is an abundant untranslated RNA of
unknown function.
IGF2 (insulin-like growth factor 2, a fetal growth factor) is paternally expressed in humans and rodents.
Expression is not imprinted in the choroid plexus, leptomeninges, brain, adult human liver and chondrocytes.
It is probably imprinted secondarily under the control of the H19 locus.
INS (insulin) is paternally expressed in mouse yolk sac, but not imprinted in human or mouse pancreas.
Insulin is suspected to be imprinted in humans since the susceptibility to type 1 diabetes is significantly
influenced by the parent-of-origin of insulin alleles, but the mechanism of this effect is unclear.
ASCL2/HASH2 (achaete-scute complex like 2/human achaete-scute homologue 2, human homologue of
murine Mash2, a helix-loop-helix transcription factor) is maternally expressed. It is expressed in human
extravillous trophoblasts and in the spongiotrophoblast cells of mouse placenta.
KCNA9 (KvLQT1, potassium channel involved in long QT syndrome) is maternally expressed. Its expression
is imprinted in several tissues but not in the heart.
CDKN1C (p57KIP2, a cyclin-dependent kinase inhibitor) was maternally expressed in humans and mouse. It
is completely imprinted in mouse but only partially in humans.
2G3-8 is under study, but may show allelic expression bias in some tissues.
IMPT1/BWR1A.ORCTL2 (imprinted multi-membrane-spanning polyspecific transporter-like gene-1) is
relatively repressed on the paternal allele.
IPL/TSSC3/BWR1C (imprinted in placenta and liver, tumor-suppressing STF cDNA 3) shows maternal
expression with relative repression of the paternal allele. It is expressed in placenta and most fetal tissues and
is homologous to mouse apoptosis-promoting gene TDAG51.
11p13
WT1 (Wilms tumor 1, a zinc finger protein): there are conflicting data. It was reported to be partially or
completely imprinted and maternally expressed in some tissues (placenta and brain) but was paternally
expressed in fibroblasts and lymphocytes from some individuals.
511q13 FCERIB ([beta] subunit of the high-affinity IgE receptor): in allergic asthmatics, the Leu181 allele was
always maternally inherited.
11q13.1, 11q22.3-
q23.3
Familial glomus tumors (non-chromaffin paragangliomas): linkage studies suggest two distinct loci, but the
tumor susceptibility is always inherited from carrier fathers.
13q14
RB locus: the retinoblastoma gene itself does not appear to be imprinted, but there may be parent-of-origin
effects on the transmission of retinoblastoma susceptibility in humans and in mice (earlier onset of tumors
when mutant Rb is paternally inherited).
13q14
HTR2a [serotonin (hydroxytryptamine) receptor type 2a] was expressed biallelically in normal tissues, but in
fibroblasts of retinoblastoma patients with germline deletions or translocations it was only expressed in those
with a paternally derived deletion or translocation, but not in those with a maternal deletion. Promoter region
methylation (partial) corresponded positively with expression. It is imprinted in mouse.
14q24.3-q31 A case report of dup(14q24.3-31), inherited from a phenotypically normal father, suggests that this region
may be imprinted.
UPD of
chromosome 14
Both paternal and maternal UPD suggest parent-of-origin effects on this chromosome. Maternal uniparental
heterodisomy and isodisomy is associated with a characteristic phenotype [hypotonia, motor developmental
delay, mild dysmorphic facial features, low birth weight, growth abnormalities (precocious puberty)].
Paternal UPD is associated with a severe mental and musculoskeletal phenotype.
15q11-q13
The 15q11-q13 region contains a cluster of imprinted genes that may be involved in the pathogenesis of the
Prader-Willi and Angelman syndromes; they are listed in order from the centromeric end:
ZNF127 and FNZ127 are two overlapping paternally expressed transcripts. ZNF127 putatively encodes a 505
amino acid polypeptide-containing zinc finger motif.
NDN (necdin) is paternally expressed in brain (human and mouse) and fibroblasts. It is expressed in
differentiated neurones.
BD exons of SNRPN. This region may constitute the 15q imprinting centre and is comprised of alternate
5[prime] exons (the BD exons, BD1B, BD1B*, BD1A, BD2, BD3) of SNRPN. Mutations of these exons
cause Angelman syndrome perhaps through failure to erase the imprint from the previous generation.
SNRPN (small nuclear ribonucleoprotein-associated polypeptide N) is paternally expressed and may be
involved in the pathogenesis of Prader-Willi syndrome. It may be imprinted secondarily, under the control of
an imprinting centre.
PAR-SN (an RNA transcript between SNRPN and PAR5) is paternally expressed in lymphoblasts.
PAR5 (D15S226E) (Prader-Willi/Angelman region) is paternally expressed but contains no open reading
frames.
IPW (imprinted in Prader-Willi) is paternally expressed but probably untranslated.
PAR1 (D15S227E) (Prader-Willi/Angelman region) is paternally expressed but probably contains no open
reading frames.
UBE3A/E6-AP (ubiquitin protein ligase 3A) is maternally expressed in human and mouse brain, but is
biallelically expressed in other tissues. This gene is mutated in some cases of Angelman syndrome, deleted
in others (60-70%), and affected by paternal UPD in others.
GABAA receptor subunit genes (GABRB3, GABRA5, GABRG3) are paternally expressed. There is paternal
methylation of the 5’ end of GABRB3.
15q11-q13 Autism in a family was associated with a 15q11-q13 duplication only when maternally transmitted
19q13.4 PEG3, the human homologue of imprinted mouse gene Peg3 (see mouse 7) is located here, but its imprinting
status has not been reported.
20q13.11
GNAS (Gs alpha, a G protein) is assumed to have specific paternal expression in some tissues based on in
situ hybridization in mice with PatDp2 and MatDp2 and in humans because of the transmittance pattern of
Albright hereditary osteodystrophy (33/36 transmitting parents were maternal). All 60 maternal offspring had
full expression of the phenotype (pseudo-hypoparathyroidism type Ia) whereas all six paternal offspring had
partial expression (pseudopseudo-hypoparathyroidism). However, transcription in human fetal tissues was
not imprinted.
Xq13.2
XIST shows preferential paternal expression with associated silencing of the paternal X chromosome in the
extraembryonic tissues of mouse and in trophoblastic cells in humans. XIST is an untranslated RNA. Most
genes on the X chromosome could be described as secondarily imprinted, in response to XIST expression.
Xp11.23-Xqter
Turner syndrome patients with a maternally retained X (45,Xm) showed significantly poorer verbal and
higher-order executive function skills than those with 45,Xp. A higher prevalence of cardiovascular
abnormalities and neck webbing was noted when the retained X was maternal.
UPD of
chromosome X
Maternal UPD had no obvious clinical stigmata. Paternal UPD was associated with impaired gonadal
function and shortness of stature.
6Table 2. Mouse imprinted regions and genes
The table describes the imprinted loci identified in mice and has been modified from Morison
and Reeve 1998.  Specific regions of chromosomes containing single or clusters of imprinted
genes have been listed.
7Table 2. Mouse imprinted regions and genes
Chromosome Region Comments
Proximal Maternal disomy causes early embryonic lethality.
2 Distal
There may be two imprinted regions. Neuronatin (Nnat, Peg5) is paternally
expressed, maternally methylated, and expressed in pituitary, central and
peripheral nervous systems. In a more distal region which contains Gnas (see
human 20q13), both maternal and paternal disomy cause neonatal lethality.
6 Proximal Maternal disomy of this region, which includes Peg1/Mest (see human 7q), is
associated with early embryonic lethality.
Proximal
Peg3/Apoc2 is a paternally expressed, zinc finger protein. Asp3 (audiogenic
seizure prone gene 3) is an as yet unidentified gene linked to proximal
chromosome 7. The susceptibility of epilepsy-prone mice to audiogenic seizures
was dependent on parental origin. Maternal disomy shows late fetal lethality
with fetal and placental growth retardation.
Central This region is syntenic with human 15q11-q13 and includes Ndn, Snrpn, Ipw,Ube3a and Znf127.
7
Distal
This region is syntenic with human 11p15.5 and includes H19, Igf2, Ins2,
Mash2, Tapa1, Kvlqt1, p57Kip2, Impt and Ipl. Preliminary data indicate that
Tapa1 shows relative repression of the paternal allele in extra-embryonic
tissues.
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Grf1 (Irlgs2/Cdc25Mm, a guanine nucleotide exchange factor) is paternally
expressed, but the maternal allele is expressed at low levels (<10% of paternal
levels) in brain.
U2afbp-rs/U2af1-rs1/D11Ncvs75 (U2 small nuclear ribonucleoprotein
auxiliary factor-binding protein-related sequence) is paternally expressed.
Proximal Grb10/Meg1 (growth factor receptor-bound protein 10/maternally expressedgene 1) is maternally expressed. The GRB10 protein binds to the insulin
receptor and the IGF1 receptor, and is a candidate for the growth retardation of
Russell-Silver syndrome in humans.
11
UPD Maternal disomy resulted in small size whereas paternal disomy resulted inlarge size . The mice were otherwise normal and fertile.
Gtl2lacZ: a dwarfism phenotype resulting from an insertional mutation of a
LacZ-containing transgene. Although expression from the transgene was not
affected by its parent-of-origin, the mutant dwarfism phenotype was expressed
most strongly when paternally inherited.
12
Distal Early embryonic lethality occurs when both alleles are inherited paternally.
14 Band D3 Htr2 (serotonin receptor 2a) shows maternal expression in mouse cerebrum,
ovary and embryonic eye.
Proximal
This includes the Tme locus (T-maternal effect) which is related to the Hairpin
tail mutation locus. This phenotype is attributable to disruption of the imprinted
gene Igf2r (insulin-like growth factor 2 receptor). Igf2r is maternally expressed
in mouse but there are conflicting data in humans.
17
Distal Paternal disomy causes small body size evident from day 7 after birth.
Proximal Impact (imprinted and ancient, belongs to the YCR59c/yigZ protein family with
unknown function) is paternally expressed.18
UPD Maternal and paternal disomy are possibly associated with growth retardation.
19 Distal
Ins1 (insulin 1) is paternally expressed. It was reported to be imprinted in yolk
sac at day 16, but not in the pancreas. In contrast, others found no evidence of
imprinting at days 12.5, 13.5 and 14.5. It has no human homologue.
Xist: there is preferential inactivation of the paternal X chromosome in extra-
embryonic tissues, corresponding to preferential expression of the paternal Xist.
Mdx (dystrophin) expression: parent-of-origin effects on the proportion of
muscle cells expressing dystrophin in mice inheriting a heterozygous null
mutation of dystrophin have been reported.
X
Ovarian granulosa cell carcinoma: an X-linked imprinted gene modifies the
predisposition to tumorigenesis in SWR and SWRXJ mice.
8numerous techniques, is an added advantage to study the phenomenon of genomic imprinting.
1.1.2.  Genomic imprinting in mice
Maternal and paternal genome non-equivalence in the mouse was first demonstrated in
1984 by pronuclear transfer experiments (McGrath and Solter 1984; Surani et al. 1984).
Zygotes in which both pronuclei were derived from the female parent were termed as
gynogenotes, and those zygotes containing two paternal pronuclei were referred to as
androgenotes.  Neither diploid gynogenetic nor androgenetic embryos developed normally.
Gynogenotes were characterized by fair embryonic tissue development and poor extraembryonic
tissue development.  In contrast, androgenotes were characterized by poor embryonic
development and fair extraembryonic tissue development.  These experiments clearly illustrated
that an embryo must contain information from both parents in order to be viable.
Experiments later showed that inheriting two copies of certain subchromosomal regions
from only one parent resulted in abnormal phenotypes in the embryo including embryonic
lethality (Cattanach and Kirk 1985).  This narrowed the focus from entire chromosomes to sub-
chromosomal regions.  These chromosomal regions were later shown to contain imprinted genes
(Kaneko-Ishino 1995; Cattanach et al. 1992; Bartolomei et al. 1991).  Approximately 50
mammalian imprinted genes have been identified which map to around 15 genomic locations in
the mouse (www.mgu.har.mrc.ac.uk/imprinting).  Many are located in clusters containing
maternally expressed genes alongside the paternally expressed genes.  Imprinted domains can
therefore contain closely linked but reciprocally imprinted genes.  This organization is also seen
in humans.  For instance, the maternal uniparental disomic inheritance of human chromosome 15
9leads to the Prader-Willi syndrome due to the absence of a number of paternally expressed
imprinted genes found in a cluster in region q11-q13 (Nicholls and Knepper 2001).
1.1.2.1. Imprinted gene loci in the mouse
The first imprinted locus identified in the mouse was the RSVIgmyc transgene (Swain et
al. 1987, Chaillet et al. 1991; Chaillet et al. 1991).  When the transgene was inherited from a
female parent, it was not expressed in the mouse, but when the transgene was inherited from a
male parent, it was expressed in the heart.  The imprinting of the transgene was not dependant on
its position of integration in the mouse genome.
The first endogenous imprinted gene that was identified was the Insulin-like growth factor2
gene (Igf2) (DeChiara et al. 1991).  A targeted mutation of this gene resulted in a dwarfing
phenotype when inherited paternally but not when inherited maternally.  This phenotype was
seen in both heterozygous and homozygous mice that inherited the mutation from their male
parent.
1.1.3. The imprinting mark
As has been observed, for normal mammalian development to occur certain information
present exclusively in the male or female germlines is required.  Therefore the male and female
germlines must be marked or “imprinted” to distinguish each from the other.  This mark is
termed an “epigenetic mark” as it is distinct from the information contained in the sequence of
the genome.
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 An epigenetic mark can include modifications like DNA cytosine methylation, and
histone modifications such as phosphorylation, acetylation, methylation, ubiquitination, and
ADP-ribosylation.  Atleast four characteristics must be exhibited by an epigenetic mark capable
of distinguishing the alleles of an imprinted gene.  It must be associated with the DNA but does
not alter the DNA sequence itself; it must be heritable through cell divisions; it must be
removable during gametogenesis; and ultimately it must have an effect on gene expression.
DNA methylation makes an excellent candidate for such a mark as it fulfils all of the above
criteria (as will be described in detail in the following paragraphs).
1.1.4.  DNA Methylation
DNA methylation is associated with transcriptional repression and occurs mainly at the
cytosine in the dinucleotide CpG (Bird 2002).  Over 70% CpGs are methylated in vertebrate
DNA but distinct patterns can be observed between different somatic and germline tissues
(Sanford et al. 1987).  These inherited patterns of methylation were hypothesized early on to
have functional consequences, and early studies indicated that there was a correlation between
the methylation status of a gene and its expression status (Groudine et al. 1987; Weintrub H
1985).
DNA methylation occurs mainly by the enzymatic transfer of a methyl group from S-
adenosylmethionine (SAM) to the fifth position of cytosine in a CpG (Bird, 2002; Bestor 2000).
The mammalian genome contains ~3 x 107 residues of methylcytosine, most at the dinucleotide
5’-CpG-3’ (Roy and Weissbach 1975).  DNA cytosine methylation is established on both strands
of the DNA duplex through a process called de novo methylation.  There are three possible states
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of DNA methylation in the mammalian genome (Figure 1).  A DNA duplex containing
methylation of the CpG dinucleotide on both strands of the DNA is referred to as fully
methylated. Following semi-conservative DNA replication the parent strand of each duplex is
methylated and the corresponding daughter strand is unmethylated.  This state is referred to as
hemimethylated.  The pattern of methylation on the parent DNA strand is copied to the
corresponding unmethylated daughter strand through a process termed maintenance methylation
(Wigler 1981).  The third state is the unmethylated state when both strands of DNA at the
dinucleotide contain unmethylated cytosines.
DNA methylation can be erased by two possible mechanisms.  Active DNA
demethylation describes the removal of the methyl group from cytosine by the action of an
enzyme termed a demethylase.  However, there is currently no known DNA demethylase.
Passive demethylation of DNA occurs by lack of maintenance methylation over successive cell
divisions.
In mammals, DNA methylation is involved in a number of cellular processes like genomic
imprinting (Chaillet et al. 1991; Chaillet et al. 1995), genome stabilization (Xu et al. 1997), X-
chromosome inactivation (Lyon et al. 1992) and silencing of transposons and endogenous
retroviruses (Yoder et al. 1997; Walsh et al. 1998).  All of these processes are tightly regulated
during development and this regulation involves the changes in DNA methylation states during
development.
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Figure 1. States of DNA methylation in the mammalian genome
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Figure 1. States of DNA methylation in the mammalian genome
In the mammalian genome, there are three possible states of DNA methylation.  When both
strands of DNA at the CpG dinucleotide contain unmethylated cytosines, it is called the
unmethylated state.  Due to de novo methyltransferases, CpG dinucleotides on both strands of the
DNA get methylated and this state is referred to as fully methylated.  Following semi-
conservative DNA replication the parent strand of each duplex is methylated and the
corresponding daughter strand is unmethylated.  This state is referred to as hemimethylated state.
The pattern of methylation on the parent DNA strand is copied to the corresponding
unmethylated daughter strand through a process termed maintenance methylation by the action
of maintenance methyltransferases (Wigler 1981).  The DNA strands can lose their methylation
either by active or passive demethylation.
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1.1.4.1. DNA methylation during mammalian development
DNA methylation patterns are dynamic during mammalian development.  Mouse
development is accomplished by two major waves of genome-wide demethylation and
remethylation, one during germ cell development and another after fertilization (Meehan et al.
2003).  Male primordial germ cells (PGCs) enter mitotic arrest and female PGCs enter meiotic
arrest when genome-wide demethylation occurs.  The de novo methylation takes place at the
prespermatogonia stage in the male germ line, whereas in the female germ line it occurs after
birth during the growth of the oocyte.  Thus, remethylation during gametogenesis results in
highly methylated genomes of mature sperm and oocyte with the establishment of differential
methylation marks on paternal and maternal alleles of the imprinted genes that are essential for
embryo growth (Sanford et al. 1987)
After fertilization, it has been observed that the male pronucleus is rapidly demethylated
in a replication independent mechanism (Monk et al. 1987; Oswald et al. 2000).  In contrast, the
maternal genome initially maintains its methylation but this progressively drops until the 8-cell
stage and the methylation content appears to be equivalent between the maternal and paternal
genomes (Figure 2).  The level of methylation drops to about 15% at the blastocyst stage. What
determines the susceptibility of the maternal and paternal genomes to the replication-independent
demethylase is unknown.  Genome-wide de novo methylation occurs at the blastocyst stage after
implantation resulting in higher levels and uniform pattern of methylation on the homologous
chromosomes (Reik et al. 2001).
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Figure 2. Dynamics of DNA methylation patterns during mouse development.
Imprinted genes 
Genomic
Relative DNA 
Methylation
PGC Gametes Zygote Blastocyst
Maternal
Paternal
Dnmt1o
Dnmt1sDnmt1s
Adult
16
Figure 2. Dynamics of DNA methylation patterns during mouse development.
The black line represents the genomic methylation patterns where you see a loss of methylation
during preimplantation development and then once again, an increase in methylation after the
blastocyst stage.  The blue line represents the methylation of the paternal allele of the imprinted
gene, which shows a similar pattern to genomic methylation.  The purple line represents the
maternal allele, which maintains its methylation even during pre-implantation development.
Dnmt1o protein is the only isoform that is expressed in the oocytes and during preimplantation
development while Dnmt1s is expressed during postimplantation development and in the adult
cells.
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At imprinted genes, one of the alleles (either maternal or paternal) follows the similar
pattern of demethylation and remethylation as the rest of the genome during early development.
In contrast, the other (imprinted) allele maintains its methylation level during that critical period
of preimplantation development when there is a decrease in the genome wide methylation level
(Figure 2; Stoger et al. 1993; Tremblay et al. 1995).  Genome-wide reprogramming of DNA
methylation patterns has also been observed, although to differing extents with different timing,
in bovine, pig and rat zygotes (Dean et al. 2001).
1.1.4.2. DNA methylation and imprinting
The first gene shown to contain parental specific methylation imprints was the RSVIgmyc
transgene (Chaillet et al. 1995).  This transgene is heavily methylated on the maternal allele
while showing lower levels of methylation on the paternal allele.  This difference in methylation
is maintained throughout embryogenesis and in adult cells.
Differential methylation patterns between parental alleles have also been seen in all the
endogenous imprinted genes identified so far.  These differences in methylation have been
restricted to specific regions of these genes termed the differentially methylated domains
(DMDs).  This differential methylation on the two chromosome homologues affects the
interactions between the genomic template and regulatory molecules, and causes some genes to
be active on one parental allele and inactive on the other (Reik et al. 2002).  DMD's of imprinted
genes can act over both, short distances, influencing gene-specific regulatory elements such as
promoters, and over long distances affecting the activity of several imprinted genes within a
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cluster. As has been mentioned before, many imprinted genes in mouse are located in clusters
containing maternally expressed genes alongside the paternally expressed genes. It now appears
that this organization has implications for their control as can be seen from the ability of the
DMD’s of specific imprinted genes to act over long distances and affect the activity of other
imprinted genes in their cluster.
1.1.5. DNA Methyltransferases
The generation of genomic patterns of methylation is likely due to the interplay between
DNA cytosine methyltransferases and chromatin remodelling machinery (Dennis et al. 2001;
Meehan et al. 2001).  To date, five mammalian cytosine DNA methyltransferases (Dnmt) have
been identified, Dnmt1, Dnmt2, Dnmt3a, Dnmt3b and DnmtL (Figure 3).  All of them contain a
highly conserved C-terminal catalytic domain and a variable N-terminal extension (Bestor 2000).
Splice sites and promoter specific variants have also been identified which generate functional
diversity for the different DNA methyltransferases (Mertineit et al. 1998; Okano et al. 1998).
1.1.5.1. Dnmt1 methyltransferase
The predominant DNA (cytosine-5)-methyltransferase in mammals is the Dnmt1 protein,
(Mr 190,000) composed of an 1100 residue amino-terminal regulatory domain and a 500 residue,
carboxy-terminal catalytic domain that is closely related to bacterial methyltransferases (Bestor
2000).  Dnmt1 homologues have been identified in many species including sea-urchin,
amphibians, fish, birds and mammals (Meehan 2003).  Sequences within the N-terminal domain
are required for the localization of Dnmt1 to the nucleus and to replication foci during S-phase
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Figure 3.  Structure of the known DNA Methyltransferases (Dnmt's)
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Figure 3.  Structure of the known DNA Methyltransferases (Dnmt's)
Dnmt1, Dnmt3a and Dnmt3b can be divided into two domains, the regulatory domain (the N-
terminal domains) and the catalytic domain which contain five characteristic sequence motifs
which show strong conservation (roman numerals) (As modified from Robertson et al., 2001)
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(Leonhardt et al. 1992).  Although Dnmt1 catalyzes both de novo and maintenance methylation
in vitro, it has a 5-30 fold preference for hemimethylated DNA substrates over unmethylated
substrates (Yoder et al. 1997).  These data suggest that Dnmt1's main role, or only role, in
mammalian organisms is to maintain DNA methylation patterns on hemimethylated DNA
following DNA replication.  Homozygous mutant embryonic stem (ES) cells and embryos
derived from matings between parents heterozygous for Dnmt1 null alleles have marked
reductions in Dnmt1 and in the level of CpG methylation which results in the death of these
embryos (Lei et al. 1996; Li et al. 1992).  The residual methylation appears to be confined to
repetitive DNA sequences, whose methylation may be due to other DNA (cytosine-5)-
methyltransferases.  Dnmt1 exists as three different isoforms, Dnmt1o, Dnmt1s and Dnmt1p,
which are expressed at different periods of mouse development.  The structure and significance
of these isoforms will be discussed in detail in later paragraphs.
1.1.5.2. Dnmt3 methyltransferases
Dnmt3a and Dnmt3b methyltransferases were identified in silico by screening mouse and
human databases with sequences corresponding to the catalytic domain of Dnmt1 (Okano et al.
1998).  In addition to the catalytic domain, they contain a proline-trytophan-tryptophan-proline
[PWWP] domain and a plant homeodomain [PHD]-like Zinc finger domain.  The PWWP
domain can bind DNA and may be involved in targeting these enzymes to specific loci.  The
Dnmt3a and Dnmt3b enzymes share about 80% homology over the catalytic domains and 60%
homology over the PHD domains.  In vitro and in vivo, Dnmt3a and Dnmt3b primarily possess
de novo methyltransferase activities (Okano et al. 1998; Okano et al. 1999; Xu et al. 1999) and
are required at different periods of mouse development.  Dnmt3a-deficient mice survive to term
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but die around 4 weeks of age while Dnmt3b-deficient mice develop normally up to embryonic
day 9.5 (E9.5) but die before birth. Mice deficient in both Dnmt3a and Dnmt3b die during early
embryogenesis, and have a more severe phenotype than mice deficient in either individual
enzyme.  Loss of maternal imprints have been observed in the embryos derived from the
homozygous mutant Dnmt3a or mutant Dnmt3b oocytes (Hata et al. 2002).
In humans, mutations in DNMT3B are associated with ICF syndrome (immunodeficiency,
centromeric region instability, and facial abnormalities) (Hansen et al. 1999).  ICF syndrome is
associated with hypomethylation of specific satellite repeats leading to chromosomal instability.
This correlates well with the loss of minor satellite repeat methylation specific to Dnmt3b-/-
embryos in mice.  Null mutations in the human DNMT3B protein have never been observed in
ICF patients, suggesting that DNMT3B is essential for viability in humans as well as in mice.
Dnmt3L was also identified by database screening and has the PWWP, PHD and catalytic
domains related to those of Dnmt3a and Dnmt3b, however, it lacks the conserved PC and ENV
residues in motifs IV and VI which are known to form the catalytic center of DNA cytosine
methyltransferases (Hata et al. 2002).  Dnmt3L is expressed in E7.5-E8.5 mouse embryos in the
chorion and also in mouse oocytes and spermatocytes.  Males deficient in Dnmt3L were infertile.
Females deficient in Dnmt3L are fertile but their embryo die in utero around E9.5 with defects
seen in the methylation of maternal imprints.  Recombinant Dnmt3L cannot methylate DNA but
interacts and co-localizes with Dnmt3a and Dnmt3b in the nuclei of transfected cells (Hata et al.
2002).  These proteins probably co-operate to carry out de novo methylation of maternally
imprinted genes during oogenesis and early mouse development.
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1.1.5.3. Dnmt2 methyltransferase
Like the Dnmt3 family of methyltransferases the Dnmt2 protein was identified due to its
homology with the Dnmt1 methyltransferase (Yoder and Bestor 1998).  Though Dnmt2 contains
all 10 sequence motifs that are conserved among the methyltransferases it has no detectable
methyltransferase activity towards DNA substrates and is not required for de novo and
maintenance methylation of viral DNA in ES cells (Okano et al. 1998; Van den Wyngaert et al.
1998).  Still, recent studies suggest that Dnmt2 may possess minimal methyltransferase activity
(Tang et al. 2003; Hermann et al. 2003; Liu et al. 2003).  Therefore, the involvement of Dnmt2
in the process of genomic methylation remains a possibility, and further investigation into this
issue is required.
1.1.5.4. The isoforms of Dnmt1 protein
The Dnmt1 gene in mice contains three alternative 1st exons (exon1s, exon 1o and exon 1p)
driven by specific promoters that are differentially utilized in different cell types, thus, leading to
the expression of three specific Dnmt1 isoforms at different periods of development.  The
promoter upstream of exon 1s drives the expression of a 5.2 kb mRNA species which is
ubiquitously expressed in somatic cells (Figure 4).  This mRNA contains an in frame ATG
inititation codon in exon 1s and encodes for the Dnmt1s protein (M r 190,000) which is
abundantly expressed in nuclei of somatic cells such as adult spleen cells and kidney cells, and it
is readily detected in nuclei of all cells of the early post-implantation embryo (Trasler et al. 1996;
Yoder et al. 1997).  However, Dnmt1s has not been detected in oocytes and in cells of
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preimplantation embryos (Carlson et al. 1992; Mertineit et al. 1998; Cardoso and Leonhart
1999).  In these stages, there is an abundance of a variant Dnmt1 protein, Dnmt1o. Dnmt1o is
found in the cytoplasm of the mature metaphase II (MII) oocyte, and in the cytoplasm of all
preimplantation cleavage stages, but is found in the nuclei of the 8-cell embryo (Carlson et al.
1992; Mertineit et al. 1998; Cardoso and Leonhart, 1999; Howell et al. 2001).  The promoter
upstream of exon 1o (which, in turn, is located ~7 kb upstream of exon 1s) drives expression of
an oocyte-specific 5.1 kb mRNA species which contains an open reading frame that does not
begin until exon 4 (Figure 4; Mertineit et al. 1998).  This open reading frame translates into a
protein product that is the size of Dnmt1o (Mr 175,000).  Thus, The Dnmt1o form is identical to
the Dnmt1s form except that it lacks a 118 amino acid extension that is present at the N-terminus
of the Dnmt1s form (figure 3; Mertineit et al. 1998).  What is interesting to note is that Dnmt1o
is expressed at that critical period of development (preimplantation development) when the
methylation on one of the alleles of an imprinted gene is maintained while there is a decrease in
methylation levels in the rest of the genome (Figure 2).  The mRNA encoding the somatic form
of the protein, Dnmt1s, is expressed during the preimplantation period, but, as mentioned before,
Dnmt1s protein does not appear in normal embryos until after implantation (Carlson et al. 1992;
Mertineit et al. 1998; Ratnam et al. 2002).  Thus, either the Dnmt1s mRNA is not translated or
this protein cannot accumulate in the early embryo.  The 6.0 kb transcript generated from the
exon 1p promoter, specific to pachytene spermatocytes, is not translated into protein presumably
due to multiple ATG initiation codons in the first exon (Mertineit et al. 1998)
Studies in mice homozygous for a targeted disruption of the Dnmt1 oocyte-specific
promoter indicate that preimplantation Dnmt1o is derived from the oocyte’s cytoplasmic store of
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Figure 4.  Sex-specific exons and oocyte-specific species of Dnmt1.
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Figure 4.  Sex-specific exons and oocyte-specific species of Dnmt1.
A. Organization of sex-specific exons in the 5’ end of the Dnmt1 gene.  B. The oocyte-specific
Dnmt1o transcript initiates at exon 1o and is spliced to exon 2; Dnmt1o translation is initiated at
the ATG in exon 4.  The initiating ATG codon for Dnmt1s is located in exon 1s (also spliced to
exon 2).  C. Comparison of Dnmt1s and Dnmt1o proteins.  The Dnmt1o protein is 118 amino
acids shorter than the Dnmt1s form at the N-terminus and the difference between the two forms
of Dnmt1 is not known to extend beyond this N-terminal truncation. The somatic and oocyte
ATG codons are shown, as are, a sequence that mediates interaction of Dnmt1 with replication
foci during S phase of somatic cells (Rep. foci), a zinc-binding cysteine-rich domain (Cys-rich)
and a domain that is related to a domain in Polybromo-1 from chicken.  The epitopes specific to
the three antibodies UPT82, UTC21 and PATH52 are shown in the figure.
27
Dnmt1o (Howell et al. 2001).  The Dnmt1∆1o mutation results in loss of Dnmt1o expression from
the mutant allele.  Oocytes and preimplantation embryos from homozygous Dnmt1∆1o female
mice lack Dnmt1o protein.  Embryos derived from Dnmt1o-deficient oocytes typically die
during the last third of gestation with variable phenotypes. These embryos show a 50% reduction
in methylated alleles of imprinted genes.  This loss is most likely due to the loss of nuclear
Dnmt1o at the 8-cell stage resulting in a loss of maintenance methylation in 8-cell blastomeres.
The proteins that supply the maintenance methyltransferase activity for the other S phases of
preimplantation development are unknown.
The reason for the use of two Dnmt1 isoforms at different periods of mouse development is
not clear, particularly because they appear to have the same function in somatic cells (Ding et al.
2002).  Dnmt1o when expressed in somatic cells, instead of Dnmt1s, maintained normal patterns
of methylation.  It is still to be determined if Dnmt1s can functionally replace Dnmt1o during
oogenesis and preimplantation development, in terms of methyltransferase activity.  Also, ES
cell lines expressing both isoforms of Dnmt1 revealed that Dnmt1o is much more stable than
Dnmt1s (Ding et al. 2002).  It is still unknown if there is a difference in stability between the two
isoforms during preimplantation development and if the reason for Dnmt1o being used as a
maternal effect protein is its increased stability.
1.1.6. Cloning and methylation
Cloning is defined as the production of a group of individuals with the same genotype by
asexual reproduction.  This phenomenon occurs naturally in many plants and some lower forms
of animals such as hydra, sea anemone and annelids.  But the majority of the animal kingdom
28
solely uses bisexual reproduction for reproduction.  The reason for this could be to avoid
irreversible accumulation of detrimental mutations in the face of a constantly changing
environment and to accelerate the rate of adaptation in evolution.
Artificial animal cloning was started towards the end of the 19th century when two or four
smaller, but complete larvae were obtained from the separated blastomeres of a single 2-4-cell
sea urchin embryo (Driesch, 1892; Yanagimachi 2002).  The principle of this technique has been
applied successfully to various animals including mammals like mice, rabbits, sheep and pigs
(Willadsen 1979).  Spemann in 1938 used another cloning technique where he ligated a recently
fertilized newt egg so that cell division occurs in only one of two halves.  When the nucleated
portion cleaved to 8-16 cells, one of these nuclei was allowed to enter the enclaved portion of the
egg before it was completely separated from the rest.  This resulted in the development of two
normal larvae, thus depicting the totipotency of the nuclei of an 8-16 cell embryo. In 1962,
Gurdon obtained adult frogs by injecting enucleated oocytes with the nuclei of endothelial cells
of swimming tadpoles.
The first successful animal cloning using adult somatic cells was achieved in mammals.
In 1997, Campbell and his associates reported the birth of a sheep, Dolly, which was cloned by
injecting the nucleus of a mammary gland cell derived from an adult sheep into an enucleated
oocyte (Campbell et al. 1996; Wilmut et al. 1997).  Later Wakayama et al. (1998) and Kato et al.
(1999) confirmed that cloning using adult somatic cells was also possible in mice and cattle.
Subsequently, pigs and goats were cloned with adult somatic cells (Polajaeva et al. 2000;
Behboodi et al. 2001).
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The successful cloning of animals by transfer of embryonic or somatic nuclei into
enucleated oocytes demonstrates that the genetic and epigenetic programs can be reversed and
nuclear totipotency can be established.  However, nuclear transfer using somatic cells is, so far, a
very inefficient process. Cloned progeny often exhibit phenotypic anomalies (Eggan et al. 2001;
Tamashiro et al. 2000; Tanaka et al. 2001; Renard et al. 1999).  The reasons for these
abnormalities have not been fully elucidated.  Most cloned embryos arrest development before
implantation, indicating defects in essential, early events (Eggan et al. 2001).  A transplanted
donor cell nucleus alters the physiology or metabolism of mouse embryos during preimplantation
development, indicating that the normal activation of other genes associated with early
embryonic development, or the inactivation of somatically expressed genes, may not occur
readily in clones (Chung et al. 2002).
The frequent anomalies inherent in cloned animals in different species argue that
epigenetic, rather than genetic, changes are responsible for many of the developmental failures.
Increasing experimental evidence from diverse model organisms indicate that the abnormalities
or fatalities of cloned animals are due, at least in part, to the faulty or incomplete establishment,
maintenance, and resetting of epigenetic states during and after nuclear transfer (Young et al.
2001; Fairburn et al. 2002)
1.1.6.1. Methylation reprogramming in cloned animals
The production of cloned animals by somatic nuclear transfer reveals at least some highly
methylated and differentiated somatic nuclei can be reprogrammed to a large extent for
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embryonic development.  But the common gestational or neo-natal developmental failures
resulting from cloning suggest a possible dysregulation of epigenetic control. There are indeed
aberrant methylation patterns observed in cloned animals.  Abnormalities in DNA methylation
have been reported, including variable levels of methylation among embryos, incomplete DNA
methylation at some tissue-specific sites, and hyper-methylation at other sites (Humpherys et al.
2001; Ohgane et al. 2001; Kang et al. 2001; Bourc'his et al. 2001; Reik et al. 2001; Dean et al.
2001).  These observations indicate that incomplete or abnormal methylation occurs during
reprogramming of the donor genome in cloned embryos.
1.1.6.2. Dnmt1 methyltransferase in cloned animals
The reason for the aberrant methylation patterns found in cloned animals remains unclear.
As mentioned earlier, in normal embryos, maintenance of a correct DNA methylation pattern
requires both the expression and the correct, stage-specific post-translational regulation of
Dnmt1 proteins (Ratnam et al. 2002; Howell et al. 2001; Li et al. 1992; Li et al. 1993).  Since a
somatic nucleus introduced into an enucleated oocyte contains the Dnmt1s isoform that is
normally not present in early embryos, the incompatibility of the DNA methylation systems of
somatic nuclei and early embryos might be partially responsible for the abnormal methylation
reprogramming observed in clones.  Also, as mentioned before, post-transcriptional gene
regulatory mechanisms comprise some of the most critical mechanisms controlling early
development during normal embryogenesis.  These mechanisms require the temporally correct
production of ooplasmic proteins, including the Dnmt1 protein, and efficient interaction of these
proteins with the embryonic genome. Whether aberrant expression or localization of Dnmt1
proteins could contribute to methylation defects such as those reported previously for cloned
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embryos, and possibly to developmental arrest at subsequent stages of development, has not been
examined as yet.
1.1.7. Specific aims
1.1.7.1. Specific aim 1
As mentioned before, the reason for two specific isoforms of Dnmt1, which only differ
from each other by 118 amino acids at the N-terminus of one of the isoforms (Dnmt1s) and have
a similar function of maintaining genomic DNA methylation, is still unknown.  This study
focuses on the efforts taken to determine if Dnmt1s protein can functionally replace Dnmt1o
protein.  Dnmt1s will be expressed during preimplantation development instead of Dnmt1o and
the ability of Dnmt1s to maintain imprinted gene methylation and expression will be examined
by analyzing the methylation and expression of certain imprinted genes like H19 and Snrpn.  The
maintenance methyltransferase activity of the two isoforms in mature oocytes will be analyzed
for functional equivalency.  The relative stability of the two isoforms during preimplantation
development will also be determined as previous studies have proven that the Dnmt1s protein is
not as stable as the Dnmt1o protein in somatic cells. These experiments will thus address the
functional significance of the Dnmt1 isoforms at various stages of development.
1.1.7.2. Specific Aim 2
It has already been noted that mammalian cloning by somatic cell nuclear transfer is very
inefficient and the majority of cloned embryos arrest development before implantation.  In
normal embryos, maintenance of a correct DNA methylation pattern requires both the expression
and the correct, stage-specific post-translational regulation of the Dnmt1 proteins.  Whether
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aberrant expression or localization of Dnmt1 proteins contributes to methylation defects in
cloned embryos has not been examined. The second part of Chapter 1 discusses the studies
undertaken to determine whether cloned preimplantation embryos exhibit a normal pattern of
expression and cytoplasmic-nuclear trafficking of Dnmt1 proteins.
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1.2. Results
To determine the functional significance of the Dnmt1s and Dnmt1o isoforms, Dnmt1s
was forced to express during oogenesis and preimplantation development in mouse.  Two
approaches were used by Carina Howell and Richard Chaillet to generate mice that expressed
Dnmt1s during oogenesis.  The first approach was to produce mice that contained a targeted
mutation of the Dnmt1 locus whereby the coding region of exon1s was substituted in place of
exon1o.  These mice were designated Dnmt11s/1o, and encoded for an oocyte-specific Dnmt1s
transcript. Homozygous Dnmt11s/1o males and females were phenotypically normal and fertile.
This line was maintained on a C57/BL6/J background.
The second approach was to generate mice that contained a transgene that drove the
expression of Dnmt1s during oogenesis.  Two different lines were obtained with this transgene,
the Dnmt1s-TG1 and Dnmt1s-TG2.  Females and males from both lines were phenotypically
normal and fertile. This line was maintained on a FVB/N background.
1.2.1. Functional analysis of Dnmt1s protein in the presence of Dnmt1o protein
To determine if the expression of Dnmt1s protein during preimplantation development lead
to abnormal methylation patterns, we analyzed the Dnmt11s/1o mice, which expressed both forms
of the protein (as will be discussed in the following paragraph), and the Dnmt1s-TG1 and
Dnmt1s-TG2 mice, carrying the Dnmt1s transgene, which overexpressed the Dnmt1s protein in
their oocytes.
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Figure 5.  Dnmt11s/1o allele.
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Figure 5.  Dnmt11s/1o allele.
Targeted modification of the Dnmt1 locus by insertion of Dnmt1 exon 1s sequences into exon 1o
and Cre-mediated excision of resistance cassette placed approximately 100 bp 3’ of the modified
exon 1o.  H, HindIII; R, EcoRI; X, XbaI. B. Sequences of exon 1o, exon 1s, and hybrid exon
1s/1o.  The overlined sequences in exon 1s replace the underlined sequences in exon 1o to give
rise to the mutant exon 1s/1o. The amino acid codons for exon 1s and exon 1s/1o are shown.
The nucleotides represented in italics are the changes made in exon 1s to create SnaBI restriction
sites (TACGTA).  These sites were used to replace a portion of exon 1o with exon 1s sequences.
C. PCR primers flanking exon 1o and exon 1s/1o (shown in panel A) distinguish wildtype
Dnmt1 and mutant Dnmt11s/1o alleles following Cre-mediated excision of the resistance cassette.
D. Immunoblot probed with the UPT82 antibody shows the Mr 190,000 Dnmt1 somatic isoform
in oocytes obtained from homozygous Dnmt11s/1o  females. E. Immunoblot probed with the
UPTC21 antibody reveals the Mr 175,000 Dnmt1o variant in addition to the Mr 190,000 Dnmt1
isoform in oocytes obtained from homozygous Dnmt11s/1o females.
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Figure 6. Dnmt1s transgene
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Figure 6. Dnmt1s transgene
A. The coding region for Dnmt1s (4.5 kb) was inserted into the multiple cloning site of
pcDNA3.1/His at a unique EcoRV site. An epitope containing an ATG initiation codon,
polyhistidine region, Anti-Xpress antibody epitope, an enterokinase recognition site are
contained on the N-terminus of Dnmt1s expressed from this vector. The bovine growth hormone
polyadenylation signal is located 3’ of the Dnmt1s sequence inserted. The pcDNA3.1’His vector
sequence remains (5.5 kb) 3’ of the Dnmt1s insertion. The promoter region is from the ZP3 zona
pellucida 3 gene in mice. B. PCR analysis with the Mtase44 and Mtase 45 primers show the
presence of a 310 bp band, in addition to a 425 bp band, in the Dnmt1s-TG1 mice while the
wildtype mice show the presence of  only the  425 bp band.
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Figure 7. Dnmt1s expression in oocytes from Dnmt1s-TG1 and Dnmt1∆1o mice
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Figure 7. Dnmt1s expression in oocytes from Dnmt1s-TG1 and Dnmt1∆1o mice
A. Immunoblot probed with the UPT82 antibody shows the Mr 190,000 (Dnmt1s) isoform in
oocytes obtained from Dnmt1s-TG1 females. B. Immunoblot probed with the PATH52 antibody
reveals the presence of only the Dnmt1s isoform in oocytes obtained from Dnmt1s-
TG1/Dnmt1∆1o females. C. Immunoblot probed with the UPT82 antibody reveals the difference
in the amount of Dnmt1s protein expressed between the Dnmt1s-TG1 and Dnmt1s TG2 oocytes.
D. Immunoblot probed with the UPTC21 antibody shows the decrease in the Dnmt1o protein to
half its level in the oocytes obtained from heterozygous Dnmt1∆1o females when compared to the
wildtype oocytes, and absence of the Dnmt1o protein in the oocytes obtained from homozygous
Dnmt1∆1o females.
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1.2.1.1. Expression of  Dnmt1s protein in the Dnmt11s/1o females during oogenesis
The homozygous mutant female mice produced MII oocytes containing both the Mr
190,000 and the Mr 175,000 form of Dnmt1, as shown on immunoblots stained with UPT82 and
UPTC21 (Figure 5).  Both forms of Dnmt1 are probably expressed because of the short 5’UTR
in the Dnmt11s/1o transcript and thus frequent translation initiation from the methionine codon in
exon 4.  This codon is normally the initiation codon for Dnmt1o produced from wildtype
Dnmt1o transcripts.  Preimplantation embryos derived from these mutant oocytes also expressed
both isoforms of the Dnmt1 protein (Figures 8B and 8C).
1.2.1.2. Expression of the Dnmt1s protein in the Dnmt1s-TG1 and Dnmt1s-TG2 females
during oogenesis
The Dnmt1-TG1 and Dnmt-TG2 mice also produced Dnmt1s protein in the oocytes.  The
MII oocytes from both the lines produced full-length tagged Dnmt1s protein that was detected on
immunoblots of MII oocyte extract stained with UPT82 antibody, an antibody specific to the
Dnmt1s protein (Figure 7A).  The concentration of the Dnmt1s protein in the Dnmt1s-TG1
oocytes was comparable to the concentration of the endogenous Dnmt1o protein.  The Dnmt1s-
TG2 mice produced lesser amounts of Dnmt1s protein in their oocytes than the Dnmt1s-TG1
mice. This was determined by staining immunoblots of extracts of Dnmt1s-TG1 or Dnmt1s-TG2
oocytes with the UPT82 antibody (Figure 7C).
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1.2.1.3. Localization and trafficking of the Dnmt1s protein during oogenesis and
preimplantation development
Using the UPT82 and UPTC21 antibodies we analyzed the localization of the Dnmt1s
protein in preimplantation embryos obtained from either the homozygous Dnmt11s/1o   females or
the Dnmt1s-TG1 females.  The time course of nuclear localization of Dnmt1s in the embryos
obtained from Dnmt11s/1o females parallels that of Dnmt1o in wild type embryos, with nuclear
localization evident only at the 8-cell stage.  However, cytoplasmic localization of Dnmt1s
evident in 2-cell, 4-cell and 8-cell embryos stained with UPT82 was different than the pattern of
cytoplasmic localization of Dnmt1o seen in wild type embryos (Carlson et al. 1992; Howell et al.
2001). Cytoplasmic Dnmt1s from homozygous Dnmt11s/1o oocytes was aggregated, whereas
wild-type cytoplasmic Dnmt1o is more evenly distributed (Figure 8). The distribution of both
forms was seen after staining with the UPTC21 antibody (Figure 8). The difference in
intracytoplasmic distribution of the two Dnmt1 forms is likely to be due to differences in the way
the two proteins are stored in the oocyte’s cytoplasm and the way they traffic after fertilization.
The Dnmt1s-TG1 mice also showed a similar cytoplasmic-nuclear localization of the
Dnmt1s protein as the wild type Dnmt1o isoform. Using the UPT82 antibody it was seen that the
Dnmt1s protein localized to the cytoplasm of the MII oocytes, 2-cell embryos, 4-cell embryos
and morulae.  In 8-cell embryos Dnmt1s was found in both the nucleus and cytoplasm (Figure
8D).  What was also confirmed by this analysis is that the epitope-tagged Dnmt1s expressed
from the Dnmt1s transgene localized in a similar way to the untagged Dnmt1s protein from the
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Figure 8. Expression and localization of Dnmt1 proteins during preimplantation
development.
A.   Dnmt1s TG1  embryos stained with UPT82 
Oocyte           2-cell             4-cell            8-cell             Morula         Blastocyst
B   Embryos from Dnmt1         females 1s/1o
D   Embryos from Dnmt1s-TG1 females
Oocyte           2-cell             4-cell            8-cell             Morula         Blastocyst
Oocyte           2-cell             4-cell            8-cell             Morula         Blastocyst
C   Embryos from Dnmt1         females 1s/1o
A   Embryos from wildtype females 
Oocyte           2-cell             4-cell            8-cell             Morula         Blastocyst
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Figure 8. Expression and localization of Dnmt1 proteins during preimplantation
development.
Immunostaining with UPTC21 to show A. Dnmt1o localization in wildtype preimplantation
embryos and B. Dnmt1s and Dnmt1o proteins in Dnmt11s/1o embryos. Immunostaining with
UPT82 to localize Dnmt1s in the embryos from C. Dnmt11s/1o females and D. Dnmt1s TG1
females. Arrows indicate the nuclear localization of Dnmt1s protein.
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Figure 9. Expression and localization of Dnmt1s protein, in the absence of Dnmt1o protein,
during preimplantation development
B   Embryos from homozygous Dnmt1       females ∆1o
Oocyte           2-cell             4-cell            8-cell              Morula          Blastocyst
Oocyte           2-cell             4-cell            8-cell              Morula          Blastocyst
C   Wildtype embryos 
Oocyte           2-cell             4-cell            8-cell              Morula          Blastocyst
A   Embryos from Dnmt1s-TG1/Dnmt1       females ∆1o  
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Figure 9. Expression and localization of Dnmt1s protein, in the absence of Dnmt1o protein,
during preimplantation development
Immunostaining with UPT82 to show Dnmt1s nuclear localization in 4-cell, 8-cell and 16-cell
stages of preimplantation development in A. embryos from Dnmt1s-TG1/Dnmt1∆1o females and
B. embryos from homozygous Dnmt1∆1o females C. Immunostaining with UPT82 to show
absence of Dnmt1s expression in wildtype preimplantation embryos.  Arrows indicate the
nuclear localization of Dnmt1s protein.
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Dnmt11s/1o allele.  But in the transgenic mice, the cytoplasmic Dnmt1s was not as aggregated as
was seen in the Dnmt11s/1o mice (Figure 8D).
1.2.1.4. Methylation of imprinted genes with forced expression of Dnmt1s protein
The oocytes obtained from either the homozygous Dnmt11s/1o females or the Dnmt1s-TG1
females, expressed both the Dnmt1s and Dnmt1o proteins.  Offspring obtained from these mice
were fertile and phenotypically normal. But there was the possibility of abnormal imprinted gene
methylation due to the presence of the Dnmt1s protein in the nuclei of 8-cell stage embryos.  To
rule out this possibility, the methylation of imprinted genes H19 and Snrpn were analyzed in
offspring obtained from the mice misexpressing the Dnmt1s protein during oogenesis.  This was
done by using the bisulfite genomic sequencing technique to determine parental-allele specific
methylation patterns on these imprinted gene sequences (Figure 10).
The methylation of H19 and Snrpn genes in the E13.5 embryos obtained from Dnmt11s/1o
mice and Dnmt1s-TG1 mice was found to be similar as in the wildtype embryos (Figures 11 and
12; Tables 3 and 4).  The paternal alleles of the H19 gene showed extensive methylated CpG
dinucleotides while the maternal alleles showed very few methylated CpG dinucleotides, just
like it is seen in wildtype mice.  Similarly, the maternal Snrpn alleles showed extensive
methylation while the paternal alleles showed insignificant amount of methylation.  Thus, it
appears that the forced expression of the Dnmt1s protein during oogenesis and preimplantation
development does not cause aberrant methylation of imprinted genes.
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Figure10.  Analysis of DNA methylation using bisulfite genomic sequencing.
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Figure 10.  Analysis of DNA methylation using bisulfite genomic sequencing.
Methylated CpG dinucleotides in a specific DNA sequence of interest can be detected using the
bisulfite genomic sequencing technique.  When treated with Sodium bisulfite, cytosines are
converted to uracils while the methylcytosines are not converted.  The specific regions to be
analyzed are PCR amplified, the PCR products are cloned and sequenced.  The presence of CpGs
in the sequence indicate that they were originally methylated in the genomic sequence, while the
replacement of CpGs by CpAs indicate that they were not methylated.
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Figure 11. Analysis of imprinted gene methylation in Dnmt1s-TG1 mice
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Figure 11. Analysis of imprinted gene methylation in Dnmt1s-TG1 mice
To determine if Dnmt1s expression during preimplantation development causes abnormal
imprinted gene methylation, tail DNA from Dnmt1s-TG1 mice (hybrids for C57B6/J and CAST7
strains) were subjected to sodium bisulfite treatment and specific regions of imprinted genes
were PCR amplified. The PCR products were cloned and sequenced to detect the methylated
CpG dinucleotides.  Each horizontal line represents an allele of the imprinted gene being
analyzed. Each square represents a methylated CpG dinucleotide in the analyzed sequence.  Lack
of methylation at a CpG dinucleotide is depicted by the absence of a square.  The paternal alleles
were distinguished from the maternal alleles by a specific single nucleotide polymorphism
(SNPs) between the C57B6/J and CAST7 strains of mice in the region being analyzed. A.
Analysis of ~400 bp region of H19 gene in Dnmt1s-TG1 mice.  As is depicted at the top of panel,
the wildtype paternal alleles (the blue circle represents the paternal SNP) show methylation of
almost all the CpG dinucleotides in the H19 region while the wildtype maternal alleles (the red
circle represents the maternal SNP) show absence of CpG methylation in the same region.  In the
Dnmt1s-TG1 mice a wildtype pattern of methylation is seen in the H19 region where the paternal
alleles show methylation of almost all their CpG dinucleotides while the maternal alleles show
nearly complete absence of methylated CpG dinucleotides.  B. Analysis of ~400 bp region of
Snrpn gene in Dnmt1s-TG1 mice. As is depicted at the top of figure, the wildtype paternal alleles
show absence of methylation of almost all the CpG dinucleotides in the Snrpn region while the
wildtype maternal alleles methylation of almost all the CpG dinucleotides in the same region.  In
the Dnmt1s-TG1 mice a wildtype pattern of methylation is seen in the Snrpn region where the
maternal alleles show methylation of almost all their CpG dinucleotides while the paternal alleles
show near ly  complete  absence of  methylated CpG dinucleot ides .
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Figure 12. Analysis of imprinted gene methylation in Dnmt11s/1o mice
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Figure 12. Analysis of imprinted gene methylation in Dnmt11s/1o mice
In the Dnmt11s/1o mice, wildtype patterns of methylation are observed in the H19 and Snrpn
genes.  A. Analysis of H19 region in Dnmt11s/1o mice.  The paternal alleles show methylation of
almost all their CpG dinucleotides in the H19 region while the maternal alleles show nearly
complete absence of methylated CpG dinucleotides.  B. Analysis of Snrpn region in Dnmt11s/1o
mice. The maternal alleles show methylation of almost all their CpG dinucleotides while the
paternal alleles show nearly complete absence of methylated CpG dinucleotides.
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1.2.2. Functional analysis of Dnmt1s protein in Dnmt1o-deficient mice
As mentioned before, homozygous Dnmt1∆1o females, when mated to wildtype males very
rarely gave rise to live births due to lack of maintenance methylation in certain imprinted genes
of the embryos. There was loss of one half of methylation in the imprinted genes studied.  To
determine if Dnmt1s can functionally replace Dnmt1o during preimplantation development and
maintain normal methylation on imprinted genes, the Dnmt1s-TG1 mice and the Dnmt1s-TG2
were mated onto the Dnmt1∆1o background to get mice that produce the Dnmt1s protein in their
oocytes instead of the Dnmt1o form. These mice were called the Dnmt1s-TG1/Dnmt1∆1o and the
Dnmt1s-TG2/Dnmt1∆1o mice respectively.
1.2.2.1. Expression of the Dnmt1s protein in the Dnmt1s-TG1/ Dnmt1∆1o females during
oogenesis
 The mature oocytes from Dnmt1s-TG1/Dnmt1∆1o females expressed only the Dnmt1s
protein. This was determined by staining immunoblots of extracts of Dnmt1s-TG1/ Dnmt1∆1o
oocytes with the PATH52 antibody which recognizes both the Dnmt1s and Dnmt1o proteins
(Figure 7B).  Only the Mr 190,000 form of the Dnmt1 protein was picked up by the antibody on
the immunoblot.
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1.2.2.2. Localization and trafficking of the Dnmt1s protein in Dnmt1o-deficient mice during
oogenesis and preimplantation development
In the embryos derived from the Dnmt1s-TG1/Dnmt1∆1o females there is a somewhat
different pattern of nuclear localization of the Dnmt1s protein when compared to the endogenous
Dnmt1o protein.  The Dnmt1s protein was observed, using the UPT82 antibody, in the nuclei of
the 4-cell, 8-cell and 16-cell embryos, as opposed to the endogenous Dnmt1o protein which only
shows nuclear localization at the 8-cell stage (Figure 9A). Similar expression and nuclear
localization of the Dnmt1s protein was observed in the preimplantation embryos derived from
the homozygous Dnmt1∆1o females (Figure 9B) without the Dnmt1s transgene.  This ectopic
Dnmt1s protein is not seen in the embryos derived from the homozygous Dnmt11s/1o females
which produce both the Dnmt1s and Dnmt1o proteins.  Therefore, the absence of the maternal
Dnmt1o protein and subsequent aberrant embryonic synthesis of the Dnmt1s protein might be
the cause of the aberrant nuclear localization of the Dnmt1s protein seen in the 4-cell and 16-cell
embryos derived from Dnmt1s-TG1/Dnmt1∆1o and homozygous Dnmt1∆1o females.
1.2.2.3. Restoration of genomic imprinting in offspring derived from Dnmt1s-TG1/Dnmt1∆1o
mice
To study the ability of Dnmt1s protein to functionally rescue the Dnmt1o-deficient
oocytes, we mated the Dnmt1s-TG1/Dnmt1∆1o females to wild type males and recorded the
number of live births obtained from these matings. The number of live births (survivors)
obtained was significantly higher (6 litters out of 9 matings) than in the mutant homozygous
Dnmt1∆1o females.  But the number of mice in a litter was still lesser than in a wildtype litter.
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Figure 13. Analysis of imprinted gene methylation in survivors obtained from Dnmt1s-
TG1/Dnmt1∆1o females.
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Figure 13. Analysis of imprinted gene methylation in survivors obtained from Dnmt1s-
TG1/Dnmt1∆1o females.
Tail DNA from survivors obtained from Dnmt1s-TG1/Dnmt1∆1o females were subjected to
sodium bisulfite treatment and specific regions of imprinted genes were analyzed for CpG
dinucleotide methylation. A. Analysis of H19 region in survivor 1 from Dnmt1s-TG1/Dnmt1∆1o
female.  Wildtype patterns of methylation are observed in the H19 region in survivor 1 where the
paternal alleles show methylation of almost all their CpG dinucleotides while the maternal alleles
show nearly complete absence of methylation of all their CpGs.  B. Analysis of Snrpn region in
survivor 1 from Dnmt1s-TG1/Dnmt1∆1o female.  The maternal alleles show primarily methylated
CpG dinucleotides while the paternal alleles show mostly unmethylated CpG dinucleotides. C.
Analysis of Peg3 region in survivor 1 from Dnmt1s-TG1/Dnmt1∆1o female.  Just like in the Snrpn
gene, the maternal alleles contain predominantly methylated CpG dinucleotides and the paternal
alleles contain mostly unmethylated CpG dinucleotides.  Thus, it appears that survivor 1 from
Dnmt1s-TG1/Dnmt1∆1o female shows a wildtype pattern of methylation on the imprinted genes,
H19, Snrpn and Peg.  The other three survivors analyzed also showed similar patterns of
imprinted gene methylation as survivor 1.
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To determine if there were normal methylation patterns established in these survivors obtained
from the Dnmt1s-TG1/Dnmt1∆1o females, we studied the maintenance of methylation in the three
imprinted genes: H19, Snrpn and Peg3 using the bisulfite genomic sequencing technique.
In all 4 survivors analyzed in a litter, there was complete restoration of methylation in all
three genes (Figures 13 and 22; Table 13).  Specifically, all the paternal alleles of the H19 gene
showed extensive methylation of CpG dinucleotides, unlike in the embryos derived from the
homozygous Dnmt1∆1o females where the paternal alleles of the H19 gene showed a 50%
reduction in methylation.  The maternal alleles showed an insignificant level of CpG
dinucleotide methylation, as is normally seen in wildtype alleles.  The Snrpn and Peg3 genes
also showed normal methylation patterns. The maternal alleles of these genes showed a high
level of methylation at CpG dinucleotides, comparable to wildtype alleles while the paternal
alleles showed virtually no methylation.  It seemed like Dnmt1s had a similar function to
Dnmt1o during preimplantation development and could thus functionally rescue the Dnmt1o-
deficient phenotype.
But as mentioned before, the number of mice in a litter was significantly lower than in a
wildtype litter.  We therefore looked at E13.5 embryos from Dnmt1s-TG1/Dnmt1∆1o females and
found that the number of E13.5 embryos obtained was similar to that from a wildtype litter.  We
then analyzed the methylation of imprinted genes in these embryos obtained from Dnmt1s-
TG1/Dnmt1∆1o females to look for differences in the maintenance of methylation on imprinted
genes (namely H19, Snrpn and Peg3 genes) between the embryos.  Among the 4 embryos
studied, one of them (embryo 1 and embryo 3) showed normal methylation patterns for the H19
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gene.  The other two embryos (embryo 2 and embryo 4) exhibited patterns of maternal and
paternal methylation that were more consistent with a partial or incomplete restoration of H19
methylation (Figures 14 and 22; Table 3).  The maternal alleles in these two embryos showed no
evidence of aberrant methylation yet there was a distinct deficit of methylation on the paternal
alleles when compared to the methylation on the paternal alleles from wildtype embryos. But this
loss was not as high as a 50% loss that was seen in the embryos from Dnmt1∆1o   homozygous
females (Figure 17; Howell et al. 2001).
Similar patterns of methylation were seen for the Snrpn and Peg3 genes.  Embryo 1
showed the normal pattern of methylation as seen in wildtype embryos.  But the other three
embryos showed less than complete methylation on the maternal alleles that would normally
have been completely methylated (Figures 15 and 16; Tables 3 and 4).  But the loss of
methylation was significantly lower than a 50% loss that was seen in embryos derived from
Dnmt1∆1o   homozygous females.  Thus, a partial or nearly complete restoration of imprinted
methylation was once again evident for the Snrpn and Peg3 genes, just like in the H19 gene.
Taken together, the methylation analysis on these four embryos was consistent with oocyte-
derived Dnmt1s protein maintaining imprinted methylation patterns, either wholly or partially,
during preimplantation development.
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Figure 14. Analysis of H19 methylation in day 13.5 embryos obtained from Dnmt1s-
TG1/Dnmt1∆1o females
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Figure 14. Analysis of H19 methylation in day 13.5 embryos obtained from Dnmt1s-
TG1/Dnmt1∆1o females.
Day 13.5 embryos were obtained from Dnmt1s-TG1/Dnmt1∆1o females, ground in liquid
nitrogen, subjected to sodium bisulfite treatment and specific regions of imprinted genes were
analyzed for CpG dinucleotide methylation. A variation in H19 methylation is observed in the
four embryos (embryo1, embryo 2, embryo 3 and embryo 4) obtained from Dnmt1s-
TG1/Dnmt1∆1o females.  Embryo 1 and embryo 3 show a pattern of methylation that is similar to
the wildtype pattern of methylation where almost all the paternal alleles have their CpG
dinucleotides methylated while the maternal alleles have near or complete absence of methylated
CpG dinucleotides. On the other hand, some of the paternal alleles from embryo 2 and embryo 4
show a loss of methylation on a significant number of their CpG dinucleotides.
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Figure 15. Analysis of Snrpn methylation in day 13.5 embryos obtained from Dnmt1s-
TG1/Dnmt1∆1o females
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Figure 15. Analysis of Snrpn methylation in day 13.5 embryos obtained from Dnmt1s-
TG1/Dnmt1∆1o females
Just like in figure 14, a variation in Snrpn methylation is also observed in the four embryos
(embryo 1, embryo 2, embryo 3 and embryo 4) obtained from Dnmt1s-TG1/Dnmt1∆1o females.
Embryo 1 shows the normal pattern of methylation as seen in wildtype embryos.  But the other
three embryos show less than complete methylation on the maternal alleles that would normally
have been completely methylated.
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Figure 16. Analysis of Peg3 methylation in day 13.5 embryo obtained from Dnmt1s-
TG1/Dnmt1∆1o females
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Figure 16. Analysis of Peg3 methylation in day 13.5 embryo obtained from Dnmt1s-
TG1/Dnmt1∆1o females.
As in figures 14 and 15, a variation in Peg3 methylation is also observed in the four embryos
(embryo 1, embryo 2, embryo 3 and embryo 4) obtained from Dnmt1s-TG1/Dnmt1∆1o females.
Embryo 1 shows a wildtype pattern of methylation.  But the other three embryos show less than
complete methylation on the maternal alleles that would normally have been completely
methylated. Thus, a partial or nearly complete restoration of imprinted methylation is evident for
the H19, Snrpn and Peg3 genes in these embryos.
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1.2.2.4. Expression of imprinted genes in offspring derived from Dnmt1s-TG1/Dnmt1∆1o
females
As mentioned before, there is a strict correlation between the parental allele-specific
methylation of imprinted genes and their expression (Groudine et al. 1987; Weintrub H 1985).
This would lead to the expectation that the restoration of imprinted gene methylation in the
offspring obtained from Dnmt1s-TG1/Dnmt1∆1o females is also reflected in the parental allele-
specific expression of these imprinted genes.  To confirm this, we analyzed the expression of
maternal and paternal alleles of H19 and Snrpn genes in both the survivors and the E13.5
embryos derived from the Dnmt1s-TG1/Dnmt1∆1o female mice.  As shown in Figure 18, the
expression analysis of the H19 and Snrpn genes showed that there was monoallelic expression of
these genes (maternal allele expression in H19 and paternal allele expression in Snrpn) in all the
survivors, correlating with their methylation pattern and confirming the restoration of gene
imprinting in the survivors.
 We also looked at the expression of these imprinted genes in the E13.5 embryos.  Two of
the embryos (embryo1 and embryo 3) showed monoallelic expression of H19 and Snrpn genes
that was consistent with the restoration of methylation in these embryos (Figure 18). The other
two embryos showed biallelic expression of the H19 and Snrpn genes and this correlated with
the reduced levels of methylation observed in the paternal H19 alleles and the maternal Snrpn
alleles in these embryos.
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Thus, it appears that Dnmt1s can either completely or partially restore the function of
Dnmt1o during preimplantation development.  Only some of the embryos in the litter appeared
to show complete maintenance methylation of imprinted genes and their corresponding
monoallelic expression and presumably it is these embryos which give rise to live births.  The
other embryos that showed reduced levels of methylation in the imprinted genes analyzed are
probably the ones that do not survive to term.
1.2.2.5. Analysis of genomic imprinting in embryos obtained from Dnmt1s-TG2/Dnmt1∆1o
females
To determine if it is important to have high levels of Dnmt1s protein in the mature oocyte
to restore genomic imprinting in the Dnmt1o-deficient mice, the Dnmt1s-TG2/Dnmt1∆1o line of
mice was analyzed.  As shown in Figure 7C, the MII oocytes from the Dnmt1s-TG2 females
expressed lesser amounts of Dnmt1s protein when compared to the oocytes from the Dnmt1s-
TG1 females.  So this line of mice would be suitable to study the differences in restoration of
genomic imprinting in Dnmt1o-deficient mice due to differences in the level of oocyte-derived
Dnmt1s protein.
Dnmt1s-TG2/Dnmt1∆1o females were mated to wildtype CAST7 males to obtain embryos
and survivor offspring.  Not unexpectedly, no survivors were obtained from Dnmt1s-
TG2/Dnmt1∆1o females.  We then looked for E13.5 embryos in the Dnmt1s-TG2/Dnmt1∆1o
females. The number of embryos obtained from a single litter was lesser than that normally
derived from a wildtype female but corresponded to the number of embryos typically obtained
from a homozygous Dnmt1∆1o female (Howell et al. 2000).
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Figure 17 Analysis of imprinted gene expression using Single Nucleotide Primer Extension
(SNuPE)
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Figure 17 Analysis of imprinted gene expression using Single Nucleotide Primer
Extension (SNuPE)
The SNuPE method (Szabo and Mann 1995) uses the single nucleotide polymorphisms
(SNPs) found between the C57B6/J and CAST7 strains of mice. RNA from a hybrid
mouse tissue is obtained and subjected to RT-PCR.   The cDNA is mixed with a
radiolabeled nucleotide specific to the allele of the parent to be tested for expression and
one round of amplification is performed without the addition of other nucleotides.  The
PCR product is run on an acrylamide gel and exposed to film.
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Figure 18. Expression analysis of imprinted genes.
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Figure 18. Expression analysis of imprinted genes.
A. Analysis of H19 expression. cDNA was obtained from the various samples and the H19
region was PCR amplified.  The PCR product was digested by Cac81.The presence of a 641 bp
band indicated maternal expression and the presence of a 509 bp band indicated paternal
expression. B. Analysis of Snrpn expression using SNuPE.  cDNA was obtained from the
various samples and the Snrpn region was PCR amplified, followed by the SNuPE assay.
Presence of a band with only 32P dGTPs indicated monoallelic expression while presence of
bands with both 32P dATPs and 32P dGTPs indicated biallelic expression.  1-4 > D13.5 embryos
from Dnmt1-TG1 female on a Dnmt1∆1o   background, 5-6 > D13.5 embryos from homozygous
Dnmt1∆1o   female, 7-10 > tissue samples from survivors obtained from Dnmt1-TG1 female on a
Dnmt1∆1o   background, 11 > tissue sample from a CAST7 female, 12 > tissue sample from a
FVB/N female, 13 > tissue sample from a wildtype female.
71
We then analyzed the methylation of imprinted genes, specifically H19, Snrpn and Peg3 in one
of these E13.5 embryos obtained from Dnmt1s-TG2/Dnmt1∆1o females.  As expected, H19 and
Snrpn showed an almost 50% loss of methylation in their paternal and maternal alleles
respectively when compared to the alleles in wildtype embryos (Figure 20; Tables 3 and 4).
Peg3 showed a 30% loss of methylation from the maternal alleles.  The maternal alleles in H19
and paternal alleles in Snrpn and Peg3 showed no aberrant methylation in their CpG
dinucleotides.  The methylation pattern seen in the embryos from Dnmt1s-TG2/Dnmt1∆1o oocytes
is very similar to that seen in embryos derived from Dnmt1o-deficient oocytes (Howell et al.
2000; Figure 19; Tables 3 and 4).  Thus, it appears that the Dnmt1s-TG2/Dnmt1∆1o line cannot
rescue the Dnmt1∆1o phenotype.  As seen before, the only difference between the Dnmt1s-
TG1/Dnmt1∆1o oocytes and Dnmt1s-TG2/Dnmt1∆1o oocytes is the amount of Dnmt1s protein
expressed in the mature oocyte.  This leads to the conclusion that the Dnmt1s protein needs to be
present in high levels in the MII oocyte for the maintenance of methylation in imprinted genes
during the 8-cell preimplantation stage of development.
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Figure 19. Analysis of imprinted gene methylation in day 13.5 embryos obtained from
homozygous Dnmt1∆1o females on a FVB/N background.
Paternal
Maternal Maternal
Paternal
Paternal
Maternal
H19 Snrpn
Peg3
A B
C
73
Figure 19. Analysis of imprinted gene methylation in day 13.5 embryos obtained from
homozygous Dnmt1∆1o females on a FVB/N background.
 Day 13.5 embryo was obtained from homozygous Dnmt1∆1o females, ground in liquid nitrogen,
subjected to sodium bisulfite treatment and specific regions of imprinted genes were analyzed for
CpG dinucleotide methylation. The H19 region show a marked loss of methylation on its CpG
dinucleotides as can be seen in panel A. Specifically, about half the paternal alleles show a
complete absence of methylated CpG dinucleotides. The maternally methylated imprinted genes
Snrpn and Peg3 also show a similar 50% loss of methylation as can be seen in panels B and C
respectively.
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Figure 20. Analysis of imprinted gene methylation in day 13.5 embryo obtained from
Dnmt1s-TG2/Dnmt1∆1o females.
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Figure 20. Analysis of imprinted gene methylation in day 13.5 embryo obtained from
Dnmt1s-TG2/Dnmt1∆1o females.
Panel A demonstrates that in the embryo obtained from Dnmt1s-TG2/Dnmt1∆1o female, the H19
region did not show a restoration of methylation as seen in the embryos obtained from Dnmt1s-
TG1/Dnmt1∆1o females. Instead, the paternal alleles still showed a 50% loss of methylation on its
CpG dinucleotides as seen in the embryos obtained from homozygous Dnmt1∆1o females. The
maternally methylated imprinted genes Snrpn and Peg3 also show a similar 50% loss of
methylation as can be seen in panels B and C respectively.
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Figure 21. Analysis of imprinted gene methylation in day 13.5 embryo obtained from
heterozygous Dnmt1∆1o female on a FVB/N background.
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Figure 21. Analysis of imprinted gene methylation in day 13.5 embryo obtained from
heterozygous Dnmt1∆1o female on a FVB/N background.
Inspite of lower levels of Dnmt1o protein in the oocytes compared to wildtype oocytes, day 13.5
embryo obtained from heterozygous Dnmt1∆1o female shows wildtype patterns of imprinted gene
methylation. Specifically, all the paternal alleles of H19 gene show complete CpG dinucleotide
methylation (A) while all the maternal alleles of Snrpn and Peg3 genes contain predominantly
methylated CpG dinucleotides (B and C respectively).
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Figure 22. Methylation analysis of imprinted genes.
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Figure 22. Methylation analysis of imprinted genes.
A. Graph depicting the methylation of the H19 gene. Blue bars depict the paternal allele and red
bars depict the maternal alleles. B. Graph representing the methylation of the Snrpn gene. C.
Graph showing the methylation of the Peg3 gene. 1 > D13.5 embryo from Dnmt11s/1o female, 2
>D13.5 embryo from Dnmt1s-TG1 female, 3-6 > D13.5 embryos from Dnmt1s-TG1/Dnmt1∆1o
female, 7-10 > survivors from Dnmt1-TG1 female on a Dnmt1∆1o   background, 11 > D13.5
embryos from a wildtype female, 12 > D13.5 embryo from a homozygous Dnmt1∆1o    female, 13
> D13.5 embryo from Dnmt1s-TG2/Dnmt1∆1o   female, 14 > D13.5 embryo from Dnmt1∆1o/+
female.
80
Table 3. Percentage of CpG dinucleotide methylation in imprinted genes
Using the bisulfite genomic sequencing analysis, the number of methylated CpG dinucleotides
per allele (paternal or maternal) was calculated for each gene (H19, Snrpn and Peg3). The total
number of methylated CpG dinucleotides from all the paternal or maternal alleles of H19 was
then compared to the total number of CpG dinucleotides (methylated and unmethylated) present
in the paternal or maternal alleles of H19 and thus, the percentage of methylated CpG
dinucleotides was calculated.  Similarly the percentage of methylated CpG dinucleotides was
calculated for Snrpn and Peg3.
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Table 3. Percentage of CpG dinucleotide methylation in imprinted genes
H19 Snrpn Peg3Embryo
or
Survivor
#
Paternal
alleles
Maternal
alleles
Paternal
alleles
Maternal
alleles
Paternal
alleles
Maternal
alleles
Wildtype Embryo1 93 3 0 91 3 87
Dnmt1s-TG1 Embryo 1 92 2 4 92 NA NA
Dnmt11s/1o Embryo 1 94 1 3 92 NA NA
Embryo 1 88 9 4 89 1 68
Embryo 2 69 13 4 79 7 79
Embryo 3 87 8 1 73 5 88
Embryo 4 54 0 2 84 5 82
Survivor1 71 0 3 93 7 89
Survivor2 87 0.7 11 77 7 89
Survivor3 85 17 5 93 3 82
Dnmt1s-TG1/Dnmt1∆1o
Survivor4 82 11 0 96 0.7 91
Dnmt1s-TG2/Dnmt1∆1o Embryo 1 48.2 1 0 62 0 65
Homozygous Dnmt1∆1o Embryo 1 57 3 1 44 8 47
Heterozygous
Dnmt1∆1o Embryo 1 93 5 0 97 98 5
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Table 4. Paired Student T-test for analysis of methylation differences in imprinted genes
Using the bisulfite genomic sequencing analysis, the methylated CpG dinucleotides per allele
(paternal or maternal) were identified for each gene (H19, Snrpn and Peg3). The average number
of methylated CpGs per allele and their standard deviation was calculated for all the paternal
alleles of H19 from a specific strain of mice. The significance in difference in CpG dinucleotide
methylation in the paternal alleles of H19 between two different strains of mice was then
calculated using the standard formula for paired student T-test: t = /x1 – x2/ ÷ √A*B
where A = (n1 + n2)  ÷ n1n2
and B = [(n1 – 1) s1
2 + (n2-1)s2
2] ÷ [n1 + n2 – 2]
x1 and x2 = sample mean from the two strains
s1 and s2 = standard deviation from the two strains
n1 and n2 = total number of  methylated CpGs  in each of the two strains
Similarly the significance in difference in methylated CpG dinucleotides was calculated for the
maternal alleles of Snrpn and Peg3 between different strains of mice.
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Table 4. Paired Student T-test for analysis of methylation differences in imprinted genes
Test for significant difference with
wildtype CpG methylation
Test for significant difference with
homozygous Dnmt1∆1o CpG
methylation Mouse strain
Embryo
or
Survivor
#
H19
paternal
alleles
Snrpn
maternal
alleles
Peg3
maternal
alleles
H19
paternal
alleles
Snrpn
maternal
alleles
Peg3
maternal
alleles
Wildtype Embryo1 - - - p < 0.025 p < 0.025 p < 0.025
Dnmt1s-TG1 Embryo 1 No SD No SD NA p < 0.025 p < 0.025 p < 0.025
Dnmt11s/1o Embryo 1 No SD No SD NA p < 0.025 p < 0.025 p < 0.025
Embryo 1 No SD p < 0.05 p < 0.05 p < 0.025 P < 0.05 p < 0.05
Embryo 2 p < 0.05 No SD No SD p < 0.05 p < 0.025 p < 0.025
Embryo 3 No SD No SD No SD p < 0.025 p < 0.025 p < 0.025
Embryo 4 p < 0.05 No SD p < 0.025 No SD p < 0.025 p < 0.025
Survivor1 No SD No SD No SD p < 0.05 p < 0.025 p < 0.05
Survivor2 No SD No SD No SD p < 0.025 p < 0.025 p < 0.025
Survivor3 No SD No SD No SD p < 0.025 p < 0.05 p < 0.025
Dnmt1s-
TG1/Dnmt1∆1o
Survivor4 No SD No SD No SD p < 0.025 p < 0.025 p < 0.025
Dnmt1s-
TG2/Dnmt1∆1o Embryo 1 p < 0.025 p < 0.05 p < 0.05 No SD No SD No SD
Heterozygous
Dnmt1∆1o Embryo 1 No SD No SD No SD p < 0.025 p < 0.025 p < 0.025
Homozygous
Dnmt1∆1o Embryo 1 p < 0.025 p < 0.025 p < 0.025 - - -
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1.2.2.6. Dnmt1o versus Dnmt1s protein during preimplantation development
From our earlier analyses, it appears that the concentration of oocyte-derived Dnmt1s is
critical for its function.  In the Dnmt1s-TG1/Dnmt1∆1o females, we observed a restoration of
imprinting to a number of Dnmt1o-deficient embryos.  In contrast, there was complete lack of
restoration of imprinting in Dnmt1o-deficient embryos obtained from Dnmt1s-TG2/Dnmt1∆1o
females that produced lesser amounts of Dnmt1s protein in their oocytes.  This confirmed the
importance of the levels of Dnmt1s protein in the oocytes to maintain genomic imprinting.
Another important observation is that, even though the Dnmt1s-TG1/Dnmt1∆1o females
produced levels of oocyte-derived Dnmt1s protein that were consistent with the levels of
endogenous Dnmt1o proteins in wildtype oocytes, imprinting abnormalities were consistently
observed in E13.5 embryos from the Dnmt1s-TG1/Dnmt1∆1o females.  Only some of the embryos
showed complete restoration of imprinting and went on to survive after birth.  This suggests that
the oocyte-derived Dnmt1s protein is not as effective as the stored Dnmt1o protein in
maintaining imprinted DNA methylation patterns during preimplantation development.
There are two possible explanations as to why the stored Dnmt1s protein is less effective
than the Dnmt1o protein.  The first reason is that the maintenance methyltransferase activity of
oocyte-derived Dnmt1s protein is less than that of the oocyte-derived Dnmt1o protein.  The
second reason is that the oocyte-derived Dnmt1s protein is less stable than the Dnmt1o protein.
We examined both possibilities using the various mouse lines that had been created.
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1.2.2.7. Maintenance methyltransferase activity of oocyte-derived Dnmt1s and Dnmt1o
proteins
To compare the maintenance methyltransferase activity of the Dnmt1s and Dnmt1o
proteins, we employed an in vitro enzymatic assay that measures the transfer of methyl groups
from S-Adenosyl Methyltransferase to poly (dIdC) templates in extracts of MII oocytes.  As
shown in Table 5, an oocyte from homozygous Dnmt1∆1o female showed only a slight increase in
activity level from the background level of activity whereas a wildtype oocyte showed a 50-fold
increase in activity when compared to the background level.  This confirms that the Dnmt1o
protein is responsible for the majority of maintenance methyltransferase activity in the oocyte.
Therefore, any increase in activity seen in the Dnmt1s-TG1 or Dnmt1s-TG2 oocytes should be
due to the transgene-derived Dnmt1s protein.  The residual activity seen in the homozygous
Dnmt1∆1o oocytes may be attributed to the maintenance methyltransferase activity of the Dnmt3a
and Dnmt3b proteins.
A Dnmt1s-TG1 oocyte, which has equal levels of Dnmt1s and Dnmt1o proteins, showed
twice the activity seen in a wildtype oocyte (Table 5).  A TG1/Dnmt1∆1o oocyte, which expressed
levels of Dnmt1s protein alone that was comparable to the levels of Dnmt1o protein seen in the
wildtype oocyte, showed equal maintenance methyltransferase activity as that found in wildtype
ooctes (Table 5).  These results lead us to the conclusion that Dnmt1s and Dnmt1o have equal
maintenance methyltransferase activities.
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Table 5. Activity of Dnmt1 methyltransferase in mouse oocyte
The assay was adapted from Issa et al. 1993.  The MII stage oocytes were lysed and the oocyte
protein was incubated with 5ug of poly (dIdC) and 3uCi of 3H-S-Adenosyl methyltransferase
(SAM) at 37°C for 2 hours.  The radiolabeled methyl group was transferred from SAM to the
poly (dIdC) by the activity of the DNA methyltransferase in the oocyte. Thus, by measuring the
radioactivity in the poly (dIdC) sample, using a liquid scintillation counter, the DNA
methyltransferase activity was measured.  The values shown in the table are values obtained after
subtracting them from the background (poly (dIdC) + SAM) activity value which was 7.1
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Table 5. Activity of Dnmt1 methyltransferase in mouse oocyte
Strain of origin of the
oocyte
Maintenance
methyltransferase activity
per oocyte
Wildtype 13416.4
Dnmt1s-TG1 26391
Dnmt1s-TG1/Dnmt1∆1o 12457.6
Dnmt1s-TG2/Dnmt1∆1o 5178.8
Homozygous Dnmt1∆1o 19.7
Heterozygous Dnmt1∆1o 6722.9
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As observed earlier, heterozygous Dnmt1∆1o females are able to maintain normal
methylation patterns on imprinted genes inspite of lower levels of Dnmt1o protein in their
oocytes.  To confirm that the level of protein correlates with its enzymatic activity, the
maintenance methylation activity was measured in oocytes from heterozygous Dnmt1∆1o female.
As seen from Table 5, an oocyte from a heterozygous Dnmt1∆1o female has only half the activity
seen in a wildtype oocyte.  This confirms that, inspite of lower levels of Dnmt1o activity,
oocytes from heterozygous Dnmt1∆1o females still maintain imprinted gene methylation during
preimplantation development.
When the enzymatic activity in a Dnmt1-TG2/Dnmt1∆1o oocyte was measured, it was
found to be lesser than the activity in a Dnmt1-TG2/Dnmt1∆1o oocyte. This was expected as the
amount of Dnmt1s protein is lesser in a Dnmt1-TG2/Dnmt1∆1o oocyte.  Surprisingly, the activity
was similar to the activity found in a heterozygous Dnmt1∆1o oocyte.  But when imprinted genes,
H19, Snrpn and Peg3 were analyzed in embryos derived from heterozygous Dnmt1∆1o females,
they showed normal patterns of methylation as seen in wildtype embryos (Figure 21). Thus,
inspite of similar levels of maintenance methyltransferase activity, oocytes from heterozygous
Dnmt1∆1o females are able to maintain genomic imprinting while oocytes from Dnmt1-
TG2/Dnmt1∆1o fail to do so.  This suggests that the Dnmt1o protein is more effective than the
Dnmt1s protein inspite of similar maintenance methyltransferase activity.  This leads us to the
second explanation that there may be differences in their stability during preimplantation
development.
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1.2.2.8. Stability of oocyte-derived Dnmt1s and Dnmt1o proteins during preimplantation
development
It has already been shown that Dnmt1o protein that is misexpressed in somatic cells of
the mouse is much more stable than the normally expressed Dnmt1s protein (Ding and Chaillet
2002).  To determine if oocyte-derived Dnmt1s protein is less stable than oocyte-derived
Dnmt1o protein, we compared the level of Dnmt1o protein to the level of Dnmt1s protein during
preimplantation development in embryos expressing both proteins, specifically the Dnmt1s-TG1
and the Dnmt11s/1o embryos.  The ZP3 promoter that has been used for the Dnmt1s-TG1
transgene is only active during the growth phase of oogenesis (Philpott 1987). Similarly the
Dnmt1o promoter is also inactive after fertilization, as measured by the absence of Dnmt1o
transcripts (Ratnam et al. 2001).  Thus, the Dnmt1s and Dnmt1o proteins measured during
preimplantation development are both derived from oocyte stores and so the time course of
protein levels during preimplantation development reflects the in vivo decay of the protein.
Equal number of oocytes, 2-cell, 4-cell and 8-cell embryos were collected from Dnmt1s-TG1
females that had been mated to wildtype males and these lysed samples were run on a 5%
acrylamide gel, transferred to a PVDF membrane and probed with PATH52 antibody which
recognizes both proteins.  As shown in Figure 23, the ratio between the Dnmt1s and Dnmt1o
proteins steadily increased through preimplantation development leading us to the conclusion
that Dnmt1s protein is less stable than the Dnmt1o protein. To confirm this result, the UPT82
antibody, which only recognizes the Dnmt1s protein, was used to probe a blot containing the
oocyte and preimplantation embryo samples derived from the Dnmt1s-TG1 females.  A definite
decrease was observed in the level of Dnmt1s protein from the oocyte stage to the 8-cell stage of
development (Figure 23).
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Figure 23. Stability of the Dnmt1o protein.
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Figure 23. Stability of the Dnmt1o protein.
A. Immunoblot of protein extracts from oocytes, 2-cell, 4-cell and 8-cell embryos obtained from
Dnmt1s-TG1 females and probed with the PATH52 antibody that detects both Dnmt1o and
Dnmt1. The Dnmt1o protein is seen to be relatively constant from the oocyte stage to the 8-cell
stage of preimplantation development.  In contrast, the Dnmt1s protein shows a significant
decrease in levels at the 8-cell stage when compared to the oocyte stage. B. Immunoblot of
protein extracts from oocytes 2-cell, 4-cell and 8-cell embryos obtained from Dnmt1s-TG1
females and probed with the UPT82 antibody that detects only Dnmt1s protein.  There is a rapid
decline in the levels of Dnmt1s protein from the oocyte stage to the 8-cell stage confirming the
results from panel B. C. Immunoblot of protein extracts from oocytes and 8-cell embryos
obtained from Dnmt11s/1o females and probed with the PATH52 antibody.  The results obtained
are  similar to those shown in panels A and B where the Dnmt1s protein shows a decrease in its
level at the 8-cell stage while the Dnmt1o protein level stays constant.  The intensity of the bands
on the immunoblots was measured using the National Institutes of Health Image program
(http://rsb.info.nih.gov/nihimage/). The values obtained for the bands on each immunoblot is
t a b u l a t e d  b e s i d e  t h e  s p e c i f i c  i m m u n o b l o t .
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In the Dnmt1s-TG1 embryos, the Dnmt1s protein is expressed with an epitope tag that
was incorporated at the N-terminus during the construction of the Dnmt1s-TG1 transgene
(Materials and Methods).  To confirm that the decrease in stability of the Dnmt1s protein is not
due to the additional epitope tag, we analyzed the Dnmt11s/1o strain of mice as well.  The
Dnmt11s/1o females, as mentioned before, express roughly equal amounts of Dnmt1s and Dnmt1o
proteins from their Dnmt11s/1o allele (Figure 5) during oogenesis.  Equal number of oocytes and
8-cell embryos were collected from heterozygous Dnmt11s/1o females and analyzed by
immunoblots using the PATH52 antibody.  There was a distinct fall in the level of Dnmt1s
protein at the 8-cell stage, when compared to the Dnmt1o protein, indicating that Dnmt1s protein
is not as stable as Dnmt1o protein to last till the 8-cell stage where it is required for maintaining
methylation on imprinted genes.
Thus, our observations support the notion that, during preimplantation development, the
Dnmt1s and the epitope-tagged Dnmt1s proteins are intrinsically much less stable than the
Dnmt1o protein.
1.2.3. Dnmt1 expression in cloned preimplantation embryos
To analyze the expression and localization of Dnmt1 proteins during cloned mouse
preimplantation development, cloned preimplantation embryos were obtained from Dr. Keith
Latham  (Temple University, Philadelphia, PA) and analyzed by immunofluorescence techniques
using antibodies specific to Dnmt1 proteins.
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1.2.3.1. Aberrant expression of Dnmt1s protein in cloned preimplantation embryos
The cloned preimplantation embryos were fixed and stained with the UPT82 antibody,
which specifically recognizes epitopes present in Dnmt1s, but not in Dnmt1o (Ratnam et al.
2002).  Aberrant Dnmt1s protein expression was observed in blastomeres of 8-cell stage cloned
embryos (Figure 24B).  Dnmt1s was present in the cytoplasm of all blastomeres, but Dnmt1s was
detected in only some blastomere nuclei (Figure 25). Of 35 cloned embryos examined, all
displayed staining for the somatic form of the protein.  No nuclear staining for Dnmt1s was
observed for cloned embryos at the 1-cell, 2-cell or 4-cell stages indicating that the staining seen
at later stages was not likely the result of carryover of protein from the donor nucleus. Some
cytoplasmic staining persisted at the morula and blastocyst stages, but no nuclear staining was
seen.  In contrast, no nuclear staining for Dnmt1s was ever observed in any of the 21 control
embryos examined, all of which were derived from normally fertilized eggs (Figure 24A and
Ratnam et al. 2002), thus indicating a significant difference between cloned and fertilized
embryos (p < 1 x 10-6).  When analyzed with PATH52 antibody, which recognizes both Dnmt1s
and Dnmt1o proteins, similar mosaic nuclear expression of Dnmt1 was observed at the 8-cell
stage (Figure 26). Thus, it was obvious that at the 8-cell stage, certain nuclei lacked both the
Dnmt1s and Dnmt1o proteins.
To confirm that the aberrant expression of Dnmt1s protein was only seen in cloned
embryos, 8-cell stage tetraploid embryos and parthenogenetic embryos were also fixed and
stained with UPT82.  None of the eight 8-cell stage tetraploid embryos examined displayed
nuclear staining for Dnmt1s (Figure 24C), which thus differed significantly from diploid cloned
embryos (p < 1 x 10 –6), indicating that endogenous oocyte-derived chromosomes (which
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Figure 24. Immunostaining of normal and cloned preimplantation mouse embryos with the
UPT82 antibody
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Figure 24. Immunostaining of normal and cloned preimplantation mouse embryos with the
UPT82 antibody.
A. Dnmt1s protein expression in an eight cell-stage clone. UPT82 staining was absent in other
cleavage stages. B. Absence of Dnmt1s expression in preimplantation stage embryos derived
from normal, fertilized eggs. C. Absence of Dnmt1s expression in an eight-cell-stage tetraploid
cloned embryo. D. Absence of Dnmt1s expression in an eight-cell-stage parthenogenetic embryo.
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Figure 25. UPT82 immunostaining of cloned eight-cell embryos derived by either a
delayed- or an immediate-activation protocol.
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Figure 25. UPT82 immunostaining of cloned eight-cell embryos derived by either a
delayed- or an immediate-activation protocol.
A.  Confocal sections through a cloned eight-cell embryo (delayed activation), stained with
DAPI (upper panel) and UPT82 (lower panel). B. Confocal sections through a cloned eight-cell
embryo (immediate activation), stained with DAPI (upper panel) and UPT82 (lower panel). The
arrows in panels A and B mark the nuclei that did not stain with UPT82, thus indicating the
mosaic nuclear staining pattern seen with the UPT82 antibody.
98
Figure 26. Immunostaining of normal and cloned preimplantation mouse embryos with the
PATH52 antibody, which recognizes both Dnmt1o and Dnmt1s.
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Figure 26. Immunostaining of normal and cloned preimplantation mouse embryos with the
PATH52 antibody, which recognizes both Dnmt1o and Dnmt1s.
 A. Stage-specific nuclear staining for Dnmt1 protein in cloned embryos. B.  Stage-specific
nuclear staining for Dnmt1 protein in control (wildtype) embryos. C. Confocal sections through
an eight-cell cloned embryo (lower panel) and corresponding DAPI images (upper panel). The
arrows mark the nuclei that did not stain with PATH52, thus indicating the mosaic pattern of
nuclear staining seen with PATH52. D. Confocal sections through normal fertilized eight-cell
embryo (lower panel) and corresponding DAPI images (upper panel), revealing positive staining
in all nuclei.
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comprise part of an authentic embryonic genome) prevented the aberrant nuclear expression of
the Dnmt1s protein that was observed in diploid cloned embryos.   As expected, none of the
seven diploid parthenogenetic embryos examined showed Dnmt1s nuclear staining (Figure 24D).
The absence of Dnmt1s protein in the nuclei of tetraploid embryos also indicated that the nuclear
expression of Dnmt1s seen in cloned embryos was neither a result of protein carryover from the
donor cell, nor an artifact of the injection procedure or the culture system, as the tetraploid
embryos experienced the identical series of treatments as cloned embryos except for removal of
the oocyte spindle-chromosome complex.  The aspect of the maternal chromosomes that confers
the embryonic type of Dnmt1s regulation in the tetraploid cloned embryos is not known.  The
maternal chromosomes may express regulatory factors that are lacking in cloned embryos
containing only somatic nuclei from differentiated cells.
1.2.3.2. Lack of Dnmt1o expression in the nuclei of 8-cell cloned embryos
There are different explanations for the mosaic patterns of UPT82 and PATH52 (Figures
25 and 26) staining in 8-cell clones.  PATH52-stained nuclei may contain only Dnmt1s, only
Dnmt1o, or a mixture of Dnmt1o and Dnmt1s.  To distinguish among these possibilities, single
8-cell cloned embryos were stained simultaneously with both the UPT82 rabbit antibody which
only detects Dnmt1s, and the UPTC21 chicken antibody, which detects both Dnmt1s and
Dnmt1o. They were then simultaneously incubated in their corresponding secondary antibodies.
Because no antibody that is specific for Dnmt1o can be generated, dual immunofluorescent
labeling combined with confocal microscopic image analysis constitutes the best method for
determining which Dnmt1 proteins reside in the blastomere nuclei.  As shown in Figure 27B,
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Figure 27. Analysis of mosaic Dnmt1s and Dnmt1o protein expression in mutant and
cloned embryos using simultaneous immunostaining with UPT82 and UPTC21 antibodies.
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Figure 27. Analysis of mosaic Dnmt1s and Dnmt1o protein expression in mutant and
cloned embryos using simultaneous immunostaining with UPT82 and UPTC21
antibodies.
 A. Comparison between confocal fluorescent images of PATH52 and UPTC21 staining in
oocyte-cumulus cell complex, eight-cell fertilized embryos, and eight-cell cloned embryos. Note
the highly similar staining patterns. B. Confocal fluorescent images of an eight-cell cloned
embryo by simultaneous immunostaining with UPT82 and UPTC21 antibodies and their
secondary antibodies.  In the merged UPT82/UPTC21 images, green-stained cytoplasm
(indicated by arrows) indicates the presence of Dnmt1o and the absence of Dnmt1s. The
arrowheads mark the nuclei that stained with both UPT82 and UPTC21, indicating the
expression of the Dnmt1s protein in those nuclei. No nucleus was observed that stained with
UPTC21 but not with UPT82 thus indicating the lack of Dnmt1o protein in any of the 8-cell
stage nuclei in cloned embryos. In the corresponding DAPI images, the arrows mark the nucleus
that did not stain with either UPT82 or UPTC21, thus indicating the mosaic pattern of staining
seen with both UPT82 and UPTC21.
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there were areas of cytoplasm that stained with UPTC21, but did not stain with UPT82,
indicating that both Dnmt1o and Dnmt1s are in the cytoplasm.  All of the nuclei that stained with
UPTC21 also stained with UPT82.  This observation is consistent with the presence of only
Dnmt1s or a mixture of Dnmt1o and Dnmt1s in stained nuclei of cloned 8-cell embryos.  It is not
consistent with the presence of only Dnmt1o in any of the stained nuclei.  Because the intensity
of nuclear staining with UPTC21 or PATH52 was lesser in cloned embryos than in control
(fertilized) embryos (Figure 27A), if any Dnmt1o enters the nuclei of cloned embryos, the
amount is probably diminished compared to normal embryos.  We conclude from this analysis
that none of the blastomeres examined in cloned embryos exhibited the appropriate embryonic
pattern of nuclear Dnmt1 staining.
Because trafficking of the Dnmt1o protein from the cytoplasm to the nucleus in 8-cell-
stage blastomeres is greatly reduced, Dnmt1s expression in these nuclei may be a consequence of
the reduced nuclear abundance of Dnmt1o. As seen from earlier data, 4-cell, 8-cell, and 16-cell
embryos derived from homozygous mutant Dnmt1∆1o females, lacking Dnmt1o in their oocytes,
showed intense UPT82 staining for Dnmt1s in all their nuclei (Figure 9).  This is consistent with
the hypothesis that the absence of Dnmt1o in the nucleus leads to aberrant expression of Dnmt1.
Despite the expression of the Dnmt1s protein in these embryos, they remain non-viable and show
a loss of methylation on imprinted genes, indicating a lack of functional compensation for the
missing Dnmt1o protein (Howell et al. 2001).  Based on this observation, the Dnmt1s protein in
nuclei of 8-cell cloned embryos may also be unable to maintain methylation patterns on alleles of
imprinted genes.
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1.2.3.3. Quantitative analysis of aberrant Dnmt1s expression in nuclei of eight-cell stage
embryos
The mosaic pattern of nuclear UPT82 staining in the 8-cell cloned embryos was analyzed
further. The intensity of staining of each nucleus was measured using the National Institutes of
Health Image program (http://rsb.info.nih.gov/nihimage/).  There was a wide range of staining
intensities among nuclei of individual clones (Figure 28A). The average number of nuclei per
cloned embryo showing moderate-to-intense levels of UPT82 staining was 4.4 + 1.03 (mode 4,
median 4.0).  Similar degrees of mosaic protein expression were seen in cloned embryos stained
with PATH52 (Figure 28B), with 5.4 +/- 0.70 nuclei stained per embryo (mode 6, median 5.5).
We also made clones using an immediate oocyte activation protocol, which avoids the possibility
of chromosome loss (Wakayama et al. 2001).  Embryos from this immediate-activation protocol
also showed a mosaic pattern of Dnmt1 expression with a wide range of nuclear staining
intensities (Figures 25B and 28A).  Mosaicism appeared to be reduced slightly, with 5.3 + 0.82
nuclei showing moderate-intense staining (mode 6, median 5.5), but this reduction was not
statistically significant.  Thus, the mosaic Dnmt1s nuclear staining cannot be explained by the
loss of chromosomes, consistent with the expression of Dnmts1 protein in the cytoplasm of all
blastomeres of cloned embryos.  Also, mosaic Dnmt1s nuclear staining in cloned embryos
contrasted significantly (p < 1 x 10 –6) with the Dnmt1s staining of embryos from Dnmt1o-
deficient mothers (n = 5 examined), in which all of the nuclei were within approximately 80% of
the intensity of the most heavily stained nucleus  (Figure 28A).
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Figure 28. Quantitative analysis of nuclear staining for Dnmt1 proteins in cloned
      embryos, wildtype embryos and fertilized embryos from Dnmt1o-deficient oocytes.
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Figure 28. Quantitative analysis of nuclear staining for Dnmt1 proteins in cloned embryos,
wildtype embryos and fertilized embryos from Dnmt1o-deficient oocytes.
  A. Quantitative analysis of nuclear staining with UPT82 for Dnmt1s in 8-cell stage cloned
embryos (both immediate and delayed activation) and fertilized embryos from Dnmt1o-deficient
oocytes.  For each embryo, confocal images through the middle of each nucleus were obtained.
The intensity of staining of each nucleus was measured in these confocal sections using the NIH
Image program (http://rsb.info.nih.gov/nih-image/).  The eight intensity values for each embryo
were then plotted as a fraction of the maximum nuclear intensity value. Each filled circle
represents a nucleus and each line represents an embryo.  Note the variable nuclear intensities
among cloned embryos, but not among nuclei in embryos derived from Dnmt1∆1o homozygous
mutant females. B Quantitative analysis of nuclear staining with PATH52 for Dnmt1 proteins in
8-cell stage cloned embryos and 8-cell stage fertilized embryos. The nuclear intensity values for
t h e  e m b r y o s  w e r e  c a l c u l a t e d  a s  i n  A .
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Thus, the results reported here indicate that there is a highly consistent, early disruption in
regulation of Dnmt1 protein expression in cloned embryos.   Cloned embryos thus lack the
ability to regulate post-transcriptionally the expression and cytoplasmic-nuclear trafficking of
Dnmt1 proteins, and possibly other proteins.  The apparent uniformity of these defects among
cloned embryos indicates that these defects are likely to affect all cloned embryos and thus are
likely to be a general feature of early clonal development.
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1.3. Materials and Methods
1.3.1. Functional significance of Dnmt1s during preimplantation development
1.3.1.1. Generation of mice that exogenously expressed Dnmt1s during oogenesis
Two different approaches were used by Carina Howell and Richard Chaillet to generate
mice that expressed Dnmt1s during oogenesis. The first approach was to produce mice that
contained a targeted mutation of the Dnmt1 locus in an attempt to express Dnmt1s instead of
Dnmt1o and this was done by substituting the coding region of exon1s in place of exon1o. The
second approach was to generate mice which contained a transgene that drove the expression of
Dnmt1s during this specific time period.
1.3.1.2.  Generation of mice that contain a targeted replacement of exon 1s for exon 1o at the
Dnmt1 locus
A targeting construct was designed which contained the coding region for exon 1s instead
of exon 1o, the LTNL selectable marker and surrounding genomic DNA (Figure 5).  The 1s exon
contains an ATG start codon and the coding sequence for part of the N-terminal extension found
in exon 1s.  This exon was placed in exon 1o, leaving both the 5’ and 3’ splice sites intact.  An
LTNL selectable marker cassette was placed 3’ of the 1o exon, leaving room for accurate
splicing to occur.  This construct was electroporated into W9.5 embryonic stem (ES) cells and
clones were selected.  Southern blot analysis of DNA isolated from ES cells revealed lines which
contained a homologous recombination event at the Dnmt1 locus.  Homologous recombination
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events at this locus were high, approximately 40% of ES lines obtained contained homologously
recombined DNA.  Cre-mediated recombination allowed removal of the selectable marker
cassette in ES cells.  ES clones containing the 1s substitution were injected into blastocysts
obtained from C57BL6/J females.  Chimeric mice were obtained and bred to C57BL6/J mice.
After germ line transmission, mice were bred to obtain homozygotes for this modified allele
which is designated Dnmt11s/1o, and encodes for an oocyte-specific Dnmt1s transcript.
Homozygous Dnmt11s/1o males and females are phenotypically normal and fertile. This line is
being maintained on a C57/BL6/J background.
1.3.1.3. Generation of constructs and mice containing transgenes to exogenously express
Dnmt1s during oogenesis
Three constructs were generated to express Dnmt1s in oocytes. In this paragraph only the
design of the functional construct has been described.  The construct was assembled in the
pcDNA3.1/His expression vector (Invitrogen, SanDiego, CA). The coding region for Dnmt1s
(4.5 kb) was inserted into the multiple cloning site of pcDNA3.1/His vector at a unique EcoRV
site.  An epitope tag containing an ATG initiation codon, polyhistidine region, Anti-Xpress
antibody epitope and an enterokinase recognition site were contained on the N-terminus of
Dnmt1s expressed from this vector.  In addition, the bovine growth hormone polyadenylation
signal was located 3’ of the Dnmt1s inserted sequence.  The pcDNA3.1’His vector sequence (5.5
kb) remains 3’ of the Dnmt1s insertion.  The construct was linearized using a unique MfeI site.
The 3’ vector sequence was mostly removed by a SmaI digestion.  The promoter region was
from the mouse ZP3, zona pellucida 3 gene.  The ZP3 is specifically expressed in mouse oocytes
(Philpott et al. 1987), and the region that directs this expression was used in this study (Lira et al.
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1990; Lira et al. 1993).  ZP3 promoter has been shown to express in growing oocyte prior to
completion of first meiotic division (Wassermann and Kinloch, 1993). The transgene was
injected into the oocytes from FVB/N females and reimplanted into the oviducts of
pseudopregnant Swiss Webster female mice.  Two different lines were obtained with this
transgene, the Dnmt1s-TG1 and Dnmt1s-TG2.  Females and males from both lines were
phenotypically normal and fertile.
1.3.1.4. Collection of oocytes and preimplantation embryos
Oocytes of all stages were obtained by puncture of ovarian follicles of 7-12 week-old-
females in MII medium (Specialty Media, Phillipsburg, NJ), as previously described (Clarke et
al. 1992). Metaphase II (MII) oocytes were collected from 7-24 week-old females that were
superovulated by injection of 5 IU of pregnant mares’ serum gonadotropin, PMSG
(CalBioChem, La Jolla, CA), followed 44 to 48 hours later by 5 IU of human chorionic
gonadotropin, hCG (CalBioChem, La Jolle, CA).  These oocytes were recovered from the
oviducts 20 hours post-hCG and the cumulus cells were dispersed with 1 mg/ml hyaluronidase
(Roche Diagnostics, Mannheim, Germany), as described (Hogan et al. 1986).
Preimplantation embryos were obtained as previously described (Clarke et al. 1992).
Superovulated females were caged individually with stud males overnight, and examined for the
presence of a vaginal plug the next morning.  One-cell embryos were recovered from the
oviducts at E0.5 in Hepes-buffered CZB medium (Erbach et al. 1994) and the cumulus mass
dispersed as described above. Two-cell, four-cell embryos, eight-cell embryos, morulae and
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blastocysts were obtained by culturing one-cell embryos in 5 µl drops of bicarbonate-buffered
CZB media under oil at 37°C in an atmosphere of 5% CO2 in air.  Postimplantation embryos
were dissected out of the uterine horns at E13.5.
For all isolation procedures, healthy-looking oocytes and preimplantation embryos were
collected in a 35 mm petri dish using a mouth-controlled micropipette and washed free of any
adhering somatic cells by transfer through two dishes of culture medium.  Oocytes and embryos
were either processed immediately for immunofluorescence; or stored at –80oC in lysis buffer for
immunoblotting; or stored at –80oC in culture medium for DNA and RNA isolation.
1.3.1.5. Immunoblot blot analysis
To look for the expression of the Dnmt1s isoform in the oocytes collected from
Dnmt11s/1o, Dnmt1s-TG1 and Dnmt1s-TG2 females, we used the immunoblot technique. The
antibodies used for this technique were the UPT82, UPTC21 and PATH52 antibodies. UPT82
was generated by immunizing a rabbit with a fusion protein that contained the full-length
bacterial GST protein and the amino terminal 118 amino acids of Dnmt1s (Ratnam et al. 2002).
These 118 amino acids are not found in Dnmt1o.  UPT82 was affinity purified on a column
containing a 6-histidine-118 amino acid fusion protein.  UPTC21 was generated by immunizing
a chicken with a fusion protein of 6-histidine plus a segment of Dnmt1 from amino acid 636 to
amino acid 1108.  These amino acids are present in both Dnmt1 and Dnmt1o. PATH52 was a
kind gift from Dr. Tim Bestor (Columbia University, NY) and was generated against epitopes
between amino acids 255 and 753 of Dnmt1 (Carlson et al. 1992).
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Oocytes were collected manually from washings of oviducts or uteri and pooled and lysed
in 5% SDS, 2.5% glycerol, 2.5% β-mercaptoethanol, 0.01% bromophenol blue, 0.025M Tris-
HCl, pH 6.8 (1X sample buffer). All samples were denatured by heating at 95°C for 5 minutes,
and then separated by electrophoresis on SDS-5% polyacrylamide gels. Afterwards they were
transferred to PVDF membranes (Millipore Corporation, Bellerica, MA). The gels were stained
with Coomassie Blue to examine the efficiency of protein transfer.  Membranes were blocked in
5% Carnation dry skim milk in 10 mM Tris-HCl (pH 8.0), 140 mM NaCl, for a least one hour
and probed with UPT82 (diluted 1:3,000 in blocking buffer) or UPTC21 (diluted 1: 1000 in
blocking buffer) or PATH52 (diluted 1:15,000 in blocking buffer) for 3 hours.  Following three
washes of 5 minutes each in 0.1% Tween-20 TBS, the membrane were incubated for one hour at
room temperature in biotinylated donkey anti-rabbit IgG (Amersham, Piscataway, NJ) diluted
1:5,000 in blocking buffer or in rabbit anti-chicken IgG (Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA) diluted 1:50,000 in blocking buffer and washed as above.  Bound
antibody was detected by chemiluminescence (ECL Plus, Amersham, Piscataway, NJ).
1.3.1.6. Immunofluorescence analysis
To study the expression and localization of the Dnmt1s protein in the oocytes and
preimplantation embryos from Dnmt11s/1o, Dnmt1s-TG1 and Dnmt1s-TG2 mice, and Dnmt1s-
TG1/Dnmt1∆1o mice, we used the UPT82 and UPTC21 antibodies that have been described in the
previous paragraph.
Denuded oocytes and preimplantation embryos were freed of the zona pellucida using
acidified (pH 2.5) Tyrode’s medium (Hogan et al. 1986), and fixed for 10 to 15 minutes at room
113
temperature in 3.7% formaldehyde in PBS.  Alternatively, small ovarian follicles were fixed
intact.  All solutions for immunofluorescence of Dnmt1 were prepared in PBS and procedures
carried out at room temperature.  The fixed cells were blocked for at least one hour in blocking
buffer (3% BSA, 0.1% Triton X-100) and then incubated in either 1:100 preimmune serum,
1:100 UPT82, 1:100 UPTC21 or 1:500 PATH52 antibodies diluted in the same blocking buffer
overnight at 4°C in a humidified chamber.  The cells were washed three times for 5 min each in
blocking buffer, and incubated in their corresponding secondary antibodies for one hour. The
secondary antibody used in conjunction with UPT82 and PATH52 was an anti-rabbit IgG
monoclonal antibody coupled with Texas Red (1:250) (Molecular Probes, Eugene, OR) and the
secondary antibody used in conjunction with UPTC21 was an anti-chicken IgG monoclonal
antibody coupled with fluorescein (1:4000) (Aves Labs. Inc.,Tigard, OR).  The cells were then
washed again as before. To mount the cells for viewing, a drop of Vectashield mounting medium
(Vector Laboratories, Burlingame, CA) supplemented with 0.4 µg/ml of the DNA-binding dye
DAPI (Roche Diagnostics, Mannheim, Germany) was used.  Immunofluorescence was
visualized using a Zeiss Axiophot, Zeiss LSM410 laser scanning confocal microscope.
1.3.1.7. PCR genotyping
Dnmt1s-TG1 and Dnmt1s-TG2 mice were genotyped using PCR primers designed to
amplify transgene sequence (Mtase44 5’ ACTGCATGAATTCCTGCAAACAGA 3’ and
(Mtase45 5’ AAAGGGTGTCACTGTCCGACTT 3’) of size 310 bp.   PCR reactions were
performed using approximately 0.1 mg of mouse genomic tail DNA in a 50 ml reaction
containing, 1X PCR buffer (Invitrogen, Carlsbad, CA), 1.5 mM MgCl2, 0.1 mM of each primer,
200 mM dNTPs, and 1.25 Units of Taq Polymerase (Invitrogen, Carlsbad, CA).  The cycling
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conditions were as follows: 5 minutes at 94°C, followed by 30 cycles of 45 seconds at 94°C, 45
seconds at 58°C, and 45 seconds at 72°C, and a final extension of 10 minutes at 72°C.  PCR
reactions were resolved on a 1% agarose gel and visualized by ethidium bromide staining. The
Dnmt11s11o mice were genotyped using the Egg6 (5’AGGAAAACAGTGGAGGAAAC 3’) and
Egg7 (5’TACTTGCACAGGGCTGTCCT 3’) primers.  Cycling conditions were similar as
above.  As shown in figure, presence of a 380 bp band indicated a Dnmt11s/1ο allele while a 480
bp band indicated a wildtype allele.
1.3.1.8. DNA isolation
Most DNA samples were isolated by incubating the required tissues in proteinase K
(Invitrogen, Carlsbad, CA) digestion buffer (10 mM Tris-HCl pH 7.5, 100 mM NaCl, 10mM
EDTA, 0.5% SDS, and 0.2 mg Proteinase K) at 50°C for 3-4 hours, followed by phenol-
chloroform extraction and ethanol precipitation.  DNA samples were resuspended in TE (10 mM
Tris-HCl pH 7.5, 1mM EDTA pH 8).
1.3.1.9. Bisulfite genomic sequencing technique for DNA methylation analysis
To study the methylation patterns of 3 imprinted genes, H19 (paternally methylated),
Snrpn and Peg3 (maternally methylated) in the E13.5 embryos or survivor mice obtained from
the various strains of mutant mice relevant to this study we used the bisulfite genomic
sequencing technique (Clark et al. 1994). These mice had been mated to CAST7 male mice since
the CAST7 strain of mice have single-nucleotide polymorphisms for the H19, Snrpn and Peg3
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genes, thus helping us differentiate between the maternal alleles and the paternal alleles (Mann et
al. 2003)
The DNA to be analyzed for methylation is digested with HindIII and treated with 40.5%
Sodium Bisulfite for 16 hours at 55ºC (Zeschnigk et al.1997). The Sodium Bisulfite converts all
the cytosines without the methyl group attached to them into uracils which on PCR amplification
will result in thymines. The cytosines which are protected by the methyl groups attached to them
will remain as cytosines (Figure 10). Thus, while studying the alleles, presence of CpGs
indicated that they are methylated while presence of CpA's indicated that they are unmethylated.
The treated DNA is PCR amplified using specific primers to the H19, Snrpn and Peg3 genes. For
all three imprinted genes, the regions which were analyzed were part of their DMDs.
DNAs for bisulfite genomic sequencing were isolated from either E13.5 embryos obtained
from the uterine horns of the female mice or the distal end of the tail obtained from the survivor
mice by grinding in liquid nitrogen prior to proteinase K digestion.  DNAs were digested
overnight at 37°C with HindIII, phenol/chloroform extracted, and ethanol precipitated. DNA was
resuspended in TE (10 mM Tris-HCl pH 7.5, 1mM EDTA pH 8) and denatured at a final
concentration of 0.3 M NaOH at 42° C for 30 minutes.  Denatured DNA was treated with sodium
bisulfite (Sigma, St. Louis MO) at a final concentration of 3.06 M and hydroquinone (Sigma, St.
Louis MO) at a final concentration of 0.05 mM in the dark at 55° C for 15 to 18 hours.  DNA
was purified using the Geneclean II kit (Invitrogen, Carlsbad, CA) and resuspended in TE.
Treated DNA was desulphonated for 15 minutes at 37° C at a final concentration of 0.3 M
NaOH, neutralized with 3M NH4OAc at a final concentration of 0.3 M, and ethanol precipitated.
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DNA was resuspended in 100 ml TE and used for PCR analysis.  DNA was stored in the dark at
-20° C for up to two weeks.
The specific regions of the imprinted genes that were analyzed are given below:
H19, GenBank accession number U19616, nucleotides 1301-1732
Snrpn, GenBank accession number AF081460, nucleotides 2151-2562
Peg3, GenBank accession number AF105262, nucleotides 2773-3111
The H19 region includes a G:A (FVB/N:Cast7) polymorphism at nt position 1566. The
Snprn promoter region includes a G:T polymorphism at nt position 2348. The Peg3 region
includes a C:T polymorphism at nt position 3070.
Specific PCR primers used for specific genes are listed below. Nested PCR reactions were
necessary to produce enough product from the genomic DNA.
Genes Outer pair of primers Inner pair of primers
H19
5'GAGTATTTAGGAGGTATAAGAATT3'
5'ATCAAAAACTAACATAAACCC3'
5'GTAAGGAGATTATGTTTATTTTTGG3'
5'CCTCATTAATCCCATAACTAT3'
Snrpn
5'TATGTAATATGATATAGTTTAGAAATTAG3'
5'AATAAACCCAAATCTAAAATATTTTAATC3'
5'AATTTGTGTGATGTTTGTAATTATTTGG3'
5'ATAAAATACACTTTCACTACTAAAATCC3'
Peg3
5'TGATAATAGTAGTTTGATTGGTAGGG3'
TAATTCACACCTAAAACCCTAAAACC3'
5'TTTTGTTAGAGGATTTTGATAAGGAGG3'
5'AAATACCACTTTAAATCCCTATCACC3'
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As mentioned before, two rounds of PCR were performed.  The first reaction contained
1-4 ml of treated DNA in a 25 ml reaction containing, 1X PCR buffer (Invitrogen, Carlsbad,
CA), 1.5 mM MgCl2, 0.4 mM of each primer, 200 mM dNTPs, and 0.50 Units of Taq
Polymerase (Invitrogen, Carlsbad, CA).  Cycling conditions for the first round of PCR were: 2
cycles of 94° C for 4 minutes, 55° C for 2 minutes, and 72° C for 2 minutes, followed by 35
cycles of 94°C for 1 minute, 55° C for 2 minutes, and 72° C for 2 minutes, with a final extension
of 72°C for 10 minutes. The nested round of PCR was performed with the same reaction
conditions and contained 2 - 5 ml of the first reaction product.  Cycling conditions were as
follows:  5 minutes at 94° C followed by 35 cycles of 94° C for 1 minute, 55°C for 2 minutes,
and 72°C for 2 minutes, with a final extension of 72°C for 10 minutes.  PCR products were
electrophoresed on a 1% agarose gel and isolated using the Qiagen fragment isolation kit
(Qiagen, Valencia, CA).  PCR fragments were subcloned into the TOPO-TA pCR2.1 vector
(Invitrogen, Carlsbad, CA) and sequenced using the M13 reverse primer.
Statistical differences in methylation of CpG dinucleotides of imprinted genes among the
various strains of mice analyzed in this study were evaluated using a paired Student T-test (Table
4).
1.3.1.10. DNA sequence analysis
All DNA sequencing was performed on the ABI 3700 DNA Analyzer or the ABI 3100
DNA Analyzer (Applied Biosystems, Foster City, CA). DNA sequence analysis was performed
using MacVector 6.5 software (Oxford Molecular, Atlanta, GA).  AssemblyLIGN Software was
used for DNA sequence alignments (Oxford Molecular, Atlanta, GA).
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1.3.1.11. Analysis of imprinted gene expression
The expression of H19 and Snrpn genes were analyzed to see if there was a correlation
between their observed methylation patterns and their expression.  For the expression assays, the
same embryos and survivor offspring used for methylation analysis were studied.  RNA was
extracted from embryos and tissues using the UltraSpec RNA extraction kit (Biotecx, Houston,
TX) and cDNA was synthesized using the M-MLV kit (Promega, Madison, WI). All the assays
were dependent on the presence of distinguishing polymorphisms between the parental alleles in
the specific imprinted genes studied.
H19 expression
For this assay either ground embryos or skeletal muscle tissue was used as H19 is
expressed during embryonic development and in adult skeletal muscle. The required region of
the H19 gene was PCR amplified using specific H19 primers.  dCTP's were incorporated during
the PCR cycle.  PCR cycling conditions were 29 cycles of 94ºC for 1 minute, 55ºC for 2 minutes
and 72ºC for 2 minutes (Tremblay et al. 1995).  The PCR product, after phenol chloroform
extraction, was digested with CaC8I for 3 hours at 37ºC and run on a polyacrylamide gel. Bands
were visualized using auto-radiography.  The embryos and tissues studied by this method were
obtained from FVB/N X CAST7 matings.  If expression was from the CAST7 allele, PCR
amplified cDNA had a restriction site for Cac8I and so the presence of a 148 bp band indicated
expression from the CAST7 allele.  If expression was from a FVB/N allele, there was no
restriction site for Cac8I, so the presence of a 648 bp band, which is the size of the PCR product,
indicated expression from the FVB/N allele. Thus we could distinguish expression from either
parental allele.
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Snrpn expression using SNuPE assay
In this assay, either ground embryo or ground adult brain tissue was used as there is high
expression of Snrpn in the adult brain. The Snrpn region was PCR amplified from the cDNA
using specific primers.  The PCR conditions were 40 cycles of 94ºC for 30 seconds, 42ºC for 30
seconds and 72ºC for 2 minutes.  The PCR product was extracted from an agarose gel using the
Qiagen fragment isolation kit (Qiagen, Valencia, CA) and 10 ng of the isolated DNA fragment
was mixed with 1uM of the SNuPE primer, the required PCR buffers and 2 uCi of either
32PdGTP or 32PdATP.  The PCR cycling conditions consisted of one cycle of of 94ºC for 30
seconds, 42ºC for 30 seconds and 72ºC for 1 minute (Szabo and Mann 1995).  After
electrophoresis of the samples on a 15% denaturing gel, bands were visualized by
autoradiography.  The incorporation of dGTPs indicated the expression of FVB allele while the
incorporation of dATPs indicated the expression of CAST7 allele (Figures 17 and 18).
The primers used for analyzing the expression of H19 and Snrpn in the various strains of
mice are given below:
Genes Primers Primer sequence
H19 forward 5' CCTCAAGATGAAAGAAATGGT-3'
H19
H19 reverse 5'-AACACTTTATGATGGAACTGC-3'
Snrpn forward 5' -TGCTGCTGTTG CTGCTACTG -3'
Snrpn reverse 5' -GCAGTAAGAGGGGTCAAAAGC-3'.Snrpn
SNuPE primer 5'-CAATTTCACAAGAAGCATT-3'
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1.3.1.12. Methyltransferase activity assay
The assay was adapted from Issa et al. 1993.  The MII stage oocytes were collected from
the various strains of mice being studied in this project and lysed using the lysis buffer (50mM
Tric.HCl pH7.8, 250mM NaCl, 10% Glycerol, 1mM EDTA, 1% Tween80, 0.01% NaN3, 1mM
DTT, 60ug/ml PMSF, 100ug/ml RNase A).  The oocyte protein was then incubated with 5ug of
poly (dIdC) and 3uCi of 3H-S-Adenosyl methyltransferase (SAM) (Sigma, St.Louis, MO) at
37°C for 2 hours.  The reaction was then incubated with the STOP solution  (1% SDS, 2mM
EDTA, 3% 4-aminosalicylate.NaOH pH 7.5  5% Butanol, 125mM  NaCl, 250ug/ml Sheared
herring sperm DNA, 1mg/ml Proteinase K ) for 1 hour at 37°C.  The reaction mix was extracted
with phenol:chloroform by using phase-lock gels . The sample was ethanol- precipitated and
treated with 0.3M NaOH to remove any RNA. The sample was then blotted on a GF/C glass
microfibre filter paper and baked at 80°C. The filter paper was washed with 5% TCA and 70%
ethanol and the radioactivity in the sample was measured using a liquid scintillation counter.
1.3.2. Cloning and methylation
1.3.2.1. Production of cloned embryos
Cloned embryos were produced by Dr. Young Chung and Dr. Keith Latham at Temple
University, Philadelphia, PA, using oocytes from (C57B6/J X DBA2/J) F1 females as recipients
and their cumulus cells as the source of donor nuclei (Wakayama et al. 1998; Chung et al. 2002).
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Preparation of Oocytes and Cumulus Cells
Recipient oocytes for all studies were from obtained from females superovulated by the
injection of 5 IU of PMSG followed 48 h later by 5 IU of hCG. Oocytes were isolated at 13–15 h
post-hCG injection in M2 medium, and cumulus cells were removed with 100 U/ml
hyaluronidase (ICN Pharmaceuticals, Costa Mesa, CA). Oocytes were cultured in CZB medium.
Oocytes were cultured at 37!°C in an atmosphere of 5% CO2 in air. Meiotic spindles were
removed using a blunt, piezo-driven pipette to penetrate the zona pellucida. Spindle removal was
performed in warm (37!°C) Hepes-buffered CZB medium supplemented with 2.5!g/ml
cytochalasin B (Sigma, St.Louis, MO). The spindle-free oocytes were then washed extensively
and returned to culture as above, for 1–2 h before injection. Cumulus cells were removed from
oocytes using hyaluronidase at a concentration of 300 U/ml. Cumulus cells were maintained in
this solution on ice until just before use, when they were collected by centrifugation, resuspended
in a solution of CZB-G supplemented with 2%–3% polyvinyl pyrrolidine (PVP) (Sigma,
St.Louis, MO), and dispersed in small quantities into microdrops on the injection chamber.
Injection of Cumulus Cell Nuclei and Oocyte Activation
Cumulus cells were used as nuclear donor cells. Cumulus cells were isolated from
cumulus-oocyte complexes following superovulation of (C57B6/J X DBA2/J) F1 females.
Cumulus cell nuclei were isolated from individual cells by several rounds of trituration into the
injection pipette.  The pipette was then passed through the zona pellucida and the nuclei were
injected into the spindle-free oocytes.  Injections were performed at room temperature within
5–10 minutes on small groups of spindle-free oocytes in fully equilibrated CZB.  The injected
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oocytes were either activated immediately after injection (immediate activation) or 2-4 hours
after injection (delayed activation). Activation of oocytes was induced by a 6-h incubation in
calcium-free CZB supplemented with 10 mM SrCl2 and 5g/ml cytochalasin B (Sigma, St.Louis,
MO).   Activated oocytes were extensively washed and cultured in CZB at 37!°C in an
atmosphere of 5% CO2 in air.
Procurement of fertilized embryos
To obtain fertilized control embryos, (C57B6/J X DBA2J) F1 females were caged
individually with stud males overnight and examined the next morning for the presence of a
vaginal plug. One-cell fertilized embryos were recovered from the oviducts and cultured in the
same media as the cloned embryos.
1.3.2.2. Production of tetraploid embryos
Tetraploid embryos were constructed by transferring cumulus cell nuclei into unfertilized
MII oocytes obtained from superovulated (C57B6/J X DBA2J) F1females, in which the maternal
chromosome-spindle complex was left in place, followed by 5 !g/ml cytochalasin B treatment to
maintain a diploid complement of maternal chromosomes and of the donor genome.  The
tetraploid embryos were cultured in the same media as the cloned embryos till the 8-cell stage.
1.3.2.3. Production of Parthenogenetic embryos
Parthenogenetic embryos were obtained by immediate activation of intact MII oocytes
obtained from superovulated (C57B6/J X DBA2/J) F1females.  Oocyte activation was by a 6-h
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incubation in calcium-free CZB supplemented with 10 mM SrCl2 and 5g/ml cytochalasin B.  The
embryos were cultured in CZB media at 37!°C in an atmosphere of 5% CO2 in air.
1.3.2.4. Immunofluorescence analysis
Cloned, tetraploid and parthenogenetic embryos were fixed at the 1-cell through
blastocyst stages, permeabilized, and processed for immunofluorescence using the techniques
previously described (Chapter 1.3.1.6 and Ratnam et al. 2002). The fixed cells were incubated in
either 1:100 UPT82, or in 1:100 UPTC21 or 1:500 PATH52. For double staining, simultaneous
staining with both primary antibodies (UPT82 and UPTC21) followed by simultaneous staining
with both their corresponding secondary antibodies was performed.  Immunofluorescence was
visualized using a Zeiss Axiophot, Zeiss LSM410 laser scanning confocal microscope (Carl
Zeiss Microimaging, Thornwood, NY). All images were recorded under identical laser settings.
Statistical differences in staining between embryo classes were evaluated using a !Chi square test.
1.3.2.5. Quantitative analysis of Dnmt1s staining in nuclei of 8-cell embryos
 For each 8-cell embryo stained with either PATH52 or UPT82, confocal images through
the middle of each nucleus were obtained. The intensity of staining of each nucleus was
measured in these confocal sections using the National Institutes of Health Image program
(http://rsb.info.nih.gov/nihimage/). The eight intensity values for each embryo were then
calculated as a fraction of the maximum nuclear intensity value.
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1.4. Discussion
1.4.1. Functional significance of the Dnmt1s and Dnmt1o proteins during mouse
preimplantation development
The predominant DNA (cytosine-5)-methyltransferase in mammals is the Dnmt1 protein
whose main role, or only role, in mammalian organisms is to maintain DNA methylation patterns
on hemimethylated DNA following DNA replication.  Dnmt1 has two isoforms, the Dnmt1s
protein and the Dnmt1o protein.  The Dnmt1o protein, which is only expressed in the oocytes
and preimplantation embryos, maintains methylation patterns on imprinted genes during the 4th
embryonic S-phase when the protein localizes to the 8-cell stage nuclei. Absence of Dnmt1o
protein in the oocyte, leads to a 50% reduction in methylated alleles of imprinted genes which in
turn leads to pre-natal lethality of these embryos.  After implantation of the blastocyst, the
Dnmt1s protein, which only differs from the Dnmt1o protein by a 118 amino acids at the N-
terminus, is expressed in all cells of the post-implantation embryo and takes over the function of
maintaining methylation patterns on hemimethylated DNA.
The reason for the use of two Dnmt1 isoforms is not clear, since they appear to have a
similar function in somatic cells (Ding and Chaillet 2002).  Dnmt1o when expressed in somatic
cells, instead of Dnmt1s, maintained normal patterns of methylation.  It is still to be determined
if Dnmt1s can functionally replace Dnmt1o during oogenesis and preimplantation development.
Also, ES cell lines expressing both isoforms of Dnmt1 revealed that Dnmt1o is much more stable
than Dnmt1s (Ding and Chaillet 2002).  It is probable that there is a difference in stability
between the two isoforms during preimplantation development as well, and therefore one
probable reason for Dnmt1o being used as a maternal effect protein is its increased stability.
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To address these issues, mutant mouse lines were created that expressed Dnmt1s protein
in the oocytes, either by means of a modified allele that encoded for an oocyte-specific Dnmt1s
transcript (Dnmt11s/1o mice) or by means of a transgene that exogenously expressed Dnmt1s
during oogenesis.  By our immunofluoresecence assay, it was determined that the Dnmt1s
protein trafficked to the nuclei in a similar manner to the Dnmt1o protein, that is, it trafficked to
the nuclei only at the 8-cell stage of development where it can thus function to maintain
methylation on imprinted genes specifically at the 4th S-phase of embryonic development.
From the Dnmt1s-TG1, Dnmt1s-TG2 and Dnmt11s/1o lines of mice it was determined that
the presence of Dnmt1s protein during preimplantation development, along with the Dnmt1o
protein, does not cause aberrant DNA methylation in the embryos.   Analysis of offspring from
these mice showed that there was no abnormal methylation on the parental allele of the imprinted
gene that is normally unmethylated nor was there loss of any methylation from the parental allele
that is usually methylated.  Now the question arises to whether Dnmt1s protein could
functionally replace Dnmt1o protein during preimplantation development.  To address this issue
the methylation patterns on a number of imprinted genes (H19, Snrpn and Peg3) in embryos and
adult mice that had developed in the presence of the oocyte-derived Dnmt1s protein, instead of
the Dnmt1o protein, were analyzed.  The mouse lines that were used for this purpose were the
Dnmt1s-TG1/Dnmt1∆1o and Dnmt1s-TG2/Dnmt1∆1o mice.
From our analysis it was clear that the degree to which imprinted gene methylation and
expression was restored in the Dnmt1s-TG1/Dnmt1∆1o mice was variable, ranging from a
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complete restoration of imprinting, as seen in the survivors and some embryos, to a moderate
restoration of imprinting, as seen in a few embryos.  This variability was observed even though
the amount and activity of the transgene-derived Dnmt1s protein in MII oocytes from the
Dnmt1s-TG1/Dnmt1∆1o mice was comparable to the normal amount and activity of the oocyte-
derived Dnmt1o protein in wildtype oocytes. These findings indicate that a range of Dnmt1s
protein levels are available to functionally replace the absent Dnmt1o protein, and we believe
that this replacement takes place at the 4th embryonic S-Phase, as the Dnmt1o protein is normally
found at the nucleus only in the 8-cell stage. It is possible that in the nuclei of certain 8-cell
embryos there are adequate levels of Dnmt1s protein to maintain all the imprinted methylation
patterns and it is these embryos that go on to develop into survivors.  In the other 8-cell embryos
there is probably insufficient levels of Dnmt1s protein to maintain all methylation and therefore
there is incomplete restoration of genomic imprinting in these embryos.   The results obtained
from the Dnmt1s-TG2/Dnmt1∆1o and heterozygous Dnmt1∆1o mice also confirm the above
hypothesis.  Though the amount and activity of the transgene-derived Dnmt1s protein in MII
oocytes from Dnmt1s-TG2/Dnmt1∆1o females was comparable to the amount and activity of the
oocyte-derived Dnmt1o protein in MII oocytes from heterozygous Dnmt1∆1o females, no
survivors were obtained from the Dnmt1s-TG2/Dnmt1∆1o females.  In contrast, the heterozygous
Dnmt1∆1o females gave rise to normal offspring.
The reason for this variability in Dnmt1s levels at the 8-cell stage where it is functionally
required to maintain imprinted methylation patterns, could be its intrinsic instability during early
preimplantation development.  As has been observed from our analysis, there is a distinct decline
in both the Dnmt1s and epitope-tagged Dnmt1s levels from the MII oocyte stage to the 8-cell
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stage while the Dnmt1o protein maintains relatively constant levels.   Since, the proteins
measured during preimplantation development are all derived from oocyte-stores, and not from
embryonic transcripts, the time course of protein levels during preimplantation development
reflects the in vivo decay of the proteins.  It is probable that during preimplantation development,
there is an intrinsically determined decay mechanism at work that makes the Dnmt1s and
epitope-tagged Dnmt1s proteins less stable than the Dnmt1o protein and therefore not available
at the threshold level required to maintain methylation patterns at the 8-cell stage.  Or the
presence of the additional 118 amino acids in the Dnmt1s protein could make it a target of an
extrinsic degradation pathway.  The amino terminal domain of human DNMT1 is known to
interact with the transcriptional repressor protein DMAP1 (Rountree et al. 2000). Presumably the
mouse Dnmt1s also interacts with the mouse Dmap1 which might control the degradation of the
Dnmt1s protein.  The Dnmt1o protein, by virtue of its lacking the 118 amino acids at the N-
terminus, would be excluded from this control and thus able to persist in high concentrations till
the 8-cell stage of development, where it trafficks into the nuclei to maintain methylation
patterns on hemimethylated DNA.
In summary, the Dnmt1s isoform can maintain genomic imprints in the absence of
preimplantation Dnmt1o protein.  However, the ability of Dnmt1s to maintain imprinting is
critically dependant on the level of oocyte and preimplantation Dnmt1s.  Both Dnmt1s and
Dnmt1o have equivalent maintenance methyltransferase functions in oocytes but it appears that
the Dnmt1s is less stable than Dnmt1o and therefore, at the 8-cell stage there is not the required
level of Dnmt1s protein to maintain methylation of imprinted genes. Thus, the stability of the
Dnmt1o protein appears to be a critically important feature in the Dnmt1o-dependent
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maintenance of imprinted gene methylation patterns during preimplantation development,
therefore leading to the evolution of two different isoforms of Dnmt1 protein during different
stages of development.
 The dynamics of Dnmt1s and Dnmt1o proteins in cloned mouse preimplantation embryos
Mammalian cloning by somatic cell nuclear transfer is very inefficient leading to a very low
rate of success in terms of obtaining cloned offspring. In fact, the majority of cloned embryos die
before implantation, thus indicating a defect in essential, early events.  Post-transcriptional gene
regulatory mechanisms comprise some of the most critical mechanisms controlling early
development during normal embryogenesis.  These mechanisms are responsible for a number of
key events, including DNA methylation and other forms of epigenetic information, that affect
long-term viability and developmental potential. These events are probably regulated by the
temporally correct production or activation of ooplasmic proteins, which efficiently interact with
the embryonic genome.
From our previous data, we have seen that in normal embryos, maintenance of a correct
DNA methylation pattern requires the expression of the correct, stage-specific Dnmt1 protein.
Lack of expression of the Dnmt1o protein or misexpression of the Dnmt1s protein during
preimplantation development leads to either embryonic lethality or fewer number of live births
respectively due to lack of or partial maintenance of methylation. During somatic nuclear
transfer, a somatic nucleus introduced into an enucleated oocyte contains the Dnmt1s isoform
which is normally not present in early embryos.  It is possible that the aberrant expression and
localization of the Dnmt1 isoforms during preimplantation development of cloned embryos
could lead to methylation defects such as those that have already been reported and subsequently
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to developmental arrest at later stages of development.  Therefore, to determine if cloned
embryos exhibit a normal pattern of expression and cytoplasmic nuclear trafficking of Dnmt1
proteins we analyzed a number of cloned preimplantation embryos by our immunofluorescence
assay with specific antibodies to Dnmt1 proteins.
The results presented in this study show that diploid cloned mouse embryos produced
using adult cumulus cell nuclei aberrantly regulate the two forms of the Dnmt1 cytosine
methyltransferase. We observe these defects at an early stage of development, when correct
regulation of these proteins is essential to ensure correct DNA methylation patterns and normal
viability at later stages. There was aberrant expression of the Dnmt1s protein in clones at the
eight-cell stage, when this protein is normally not expressed until much later in development.
Also, the Dnmt1s protein showed a mosaic pattern of expression where it was seen only in some
nuclei of the 8-cell embryo.  This aberrant expression of the Dnmt1s protein leads us to believe
that cloned embryos lack the appropriate posttranscriptional gene regulatory mechanisms that
normally prevent Dnmt1s protein expression in preimplantation embryos. Such a defect in
regulating Dnmt1s mRNA translation or protein accumulation could reflect a broader defect in
cloned embryos, affecting multiple maternal mRNAs and their proteins and such a defect would
severely compromise cloned embryo viability.
We also found abundant cytoplasmic Dnmt1o in both normal and cloned eight-cell
embryos but little or no nuclear uptake of Dnmt1o in cloned embryos. Thus, there appears to be a
significant defect in the cytoplasmic-to-nuclear trafficking of Dnmt1o protein in clones. Indeed,
the mosaic pattern of Dnmt1s nuclear localization may indicate defects in the trafficking of both
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Dnmt1o and Dnmt1s into nuclei of eight-cell clones. This defect in cytoplasmic-nuclear protein
trafficking could result from a failure of the somatic nucleus to express essential nuclear import
proteins uniquely required in the early embryo or an incompatibility between somatic
cell–derived chromatin or residual nuclear membrane components and embryonically expressed
proteins. The defect in cytoplasmic-nuclear protein trafficking could affect nuclear
reprogramming and contribute to the mosaic patterns of gene expression reported in cloned
embryos.
One hypothesis about the expression of Dnmt1s in 8-cell cloned embryos is that Dnmt1s
expression in these nuclei may be a consequence of the reduced nuclear abundance of Dnmt1o.
Additional confirmation to this possibility comes from the measurement of Dnmt1s expression in
fertilized embryos that lack the Dnmt1o protein because of their derivation from homozygous
mutant Dnmt1 ∆1o oocytes. Intense UPT82 staining for Dnmt1s was seen in all nuclei of 4-cell, 8-
cell, and 16-cell mutant embryos. This is consistent with the hypothesis that the absence of
Dnmt1o in the nucleus leads to aberrant expression of Dnmt1s. Despite the expression of the
Dnmt1s protein in these embryos, they remain nonviable and show a loss of methylation on
imprinted genes, indicating a lack of functional compensation for the missing Dnmt1o protein.
Based on this observation, the Dnmt1s protein in nuclei of eight-cell cloned embryos may also be
unable to maintain methylation patterns on alleles of imprinted genes.
Thus, the failure of intracellular trafficking of Dnmt1o and the expression of Dnmt1s in
the cloned embryos could contribute to defects in DNA methylation. From earlier data we have
seen that Dnmt1s and Dmt1o have similar maintenance methyltransferase activity. The Dnmt1s
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form is, however, intrinsically less stable than the Dnmt1o form both in somatic cells and during
preimplantation development. The relative instability of Dnmt1s, combined with the near
absence of Dnmt1o from the nucleus, could lead to an overall reduction in Dnmt1 activity within
cloned eight-cell blastomere nuclei and hence a loss of methylation at numerous sites, as occurs
on alleles of imprinted genes in Dnmt1o-deficient embryos.  Moreover, mosaic expression of
Dnmt1s at the eight-cell stage could lead to heterogeneous DNA methylation patterns among
blastomeres and eventually to heterogeneity in methylation patterns among the cells and tissues
of an individual cloned animal or among cloned offspring.
Another interesting observation is that in cloned embryos, the observed nuclear Dnmt1s
protein at the 8-cell stage appears to have been expressed by the embryo itself as opposed to
being derived from the maternal store of the protein.  In wildtype embryos, the Dnmt1o protein
responsible for maintaining methylation of imprinted genes at the 8-cell stage, comes from the
oocyte-store of the protein.  One hypothesis is that the Dnmt1 proteins (both Dnmt1s and
Dnmt1o) probably undergo confirmational changes in the cytoplasm which enable them to
translocate into the nucleus at the 8-cell stage.  The amount of Dnmt1s protein in the cloned
embryo also seems to be much lower than the amount of Dnmt1o protein in the wildtype
embryos. This could probably be explained by the fact that Dnmt1s is intrinsically less stable
than Dnmt1o, as we have shown.
We predict that increased amounts of Dnmt1s protein obtained from the cytoplasm of the
oocyte might lead to an increase in the survival rate of clones.  We therefore intend to introduce
somatic nuclei obtained from the wildtype cumulus cells into the enucleated oocytes of Dnmt1s-
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TG1 mice or homozygous Dnmt11s/1o mice which express high levels of Dnmt1s protein in their
cytoplasm, and study the localization patterns of the Dnmt1 proteins, their effect on the
methylation of the imprinted genes and their contribution to the overall success rate of obtaining
clones.
In summary, our results reveal defects in the regulation of Dnmt1 gene expression and
cytoplasmic-nuclear trafficking that precede any defects thus far reported for cloned embryos of
any species.  None of the cells examined in cloned embryos in this study appeared to express the
correct pattern of nuclear Dnmt1 staining, and thus none of the cells appeared to have been
reprogrammed correctly by this criterion. If defects in posttranscriptional gene regulation,
cytoplasmic-nuclear protein trafficking, and expression of DNA methyltransferases also exist in
clones of other species and are associated with similar blocks in reprogramming, then this would
raise obvious concerns about the use of current cloning technologies for broader purposes such
as therapeutic cloning.
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Figure 29.  Hypothesis to explain the dynamics of Dnmt1 proteins in cloned
preimplantation development
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Figure 29.  Hypothesis to explain the dynamics of Dnmt1 proteins in cloned
preimplantation development
During normal mouse preimplantation development, the Dnmt1o protein which is expressed and
stored in the MII oocyte translocates to the nuclei at the 8-cell stage where it maintains
methylation of imprinted genes at that specific stage.  There is no expression of the Dnmt1s
protein during this period of mouse development. In cloned embryos the somatic nucleus that is
injected into the enucleated oocyte expresses the Dnmt1s protein. From our data, it appears that
the Dnmt1o protein present in the cytoplasm of the oocyte stays constant till the 8-cell stage, but
unlike in the fertilized embryos, there is no uptake of the Dnmt1o protein into the nuclei at the 8-
cell stage. Thus, there appears to be a significant defect in the cytoplasmic-to-nuclear trafficking
of Dnmt1o protein in clones.  This absence of the Dnmt1o protein in the 8-cell nuclei could lead
to the mosaic expression of the embryonic Dnmt1s protein in the 8-cell nuclei. But due to the
relative instability of the Dnmt1s protein, when compared to the Dnmt1o protein, there could be
incomplete maintenance of imprinted gene methylation leading to low number of live births.
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2. Role of Inpp4b and IP3R1 proteins in egg activation and formation of ovarian
teratomas in mice
2.1. Introduction
2.1.1. Oocyte maturation and egg activation
In most animals the development of the immature oocyte into a fertilizable gamete, a
process known as oocyte maturation, involves an arrest in the meiotic cell cycle while awaiting
fertilization (Tunquist and Maller 2003).  In vertebrate oocytes, maturation begins at the G2/M-
phase border of meiosis I, and the arrest at the end of oocyte maturation occurs at metaphase of
meiosis II.  The mechanism of meiotic arrest still remains unclear as well as the molecular signal
transduction pathways that operate during this stage of oogenesis.  Masui and Markert (1971)
described an activity in the cytoplasm of eggs from the leopard frog Rana pipiens that was able
to initiate oocyte maturation when injected into immature G2-arrested oocytes. They termed this
activity the maturation-promoting factor (MPF).  They also discovered that microinjection of the
same cytoplasm into one blastomere of a 2-cell embryo produced a cleavage arrest at metaphase
in the injected blastomere.  This lead to the hypothesis that specific cytoplasmic factors are
responsible for the inhibition of mitosis and cleavage at the metaphase II stage of the maturing
oocyte. This factor was tentatively labeled cytostatic factor (CSF).
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2.1.1.1. Cytostatic factor in oogenesis and egg activation
CSF does not describe a single molecule or protein, but rather an activity found in the egg.
Typically CSF activity occurs in the MII oocyte and metaphase arrest is established and
maintained. CSF activity remains 30-40 minutes after fertilization before declining, but it never
reappears in cleaving embryos. Many researchers have worked to uncover the molecular
composition of CSF activity and candidate proteins which in turn need to fulfill three specific
criteria to fit the definition of a cell cycle inhibitor. It must accumulate during oocyte maturation,
it must be capable of functioning in meiosis II and must be inactivated on fertilization or
parthenogenetic activation (Masui 2000; Kubiak and Ciemerych 2001).  A few candidates have
come to the fore, including the Mos protein where a sharp dose dependence for Mos-induced
cleavage arrest suggested that a threshold amount of Mos protein is required for the arrest
(Sagata et al. 1988; Sheets et al 1994).  The Mos protein activates the MEK/MAPK/p90Rsk
pathway which in turn leads to a Metaphase II arrest (Nebreda and Hunt 1993; Shibuya and
Ruderman 1993). This CSF arrest is also dependent on the inhibition of the APC/C (Anaphase
promoting complex/cyclosome) which is brought about by various pathways including the
Mos/MAPK pathway (Lorka et al. 1998; Peter et al. 2001).  But studies have shown that the Mos
protein and APC/C inactivation is not sufficient for CSF, but is part of a larger pathway
important for establishment of CSF arrest during meiosis II (Peter et al. 2001; Taieb et al. 2001).
There may be other proteins involved which may be part of the Mos/MAPK pathway or acting
independently to maintain CSF arrest. It is important to identify these proteins to have a better
understanding of the molecular processes involved in egg activation.
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2.1.1.2. The role of Ca++ signaling at fertilization
A series of Ca++ oscillations (periodic increase in ooplasmic Ca++ concentration) mediates
many of the molecular events associated with fertilization and the entry into mitosis (Cantrell
2001; Mehlmann and Kline 1994; Carroll 2001). These include the transition of metaphase-
arrested cells into interphase, and the exocytosis of cortical granules. The phosphatidylinositol
(PtdIns) pathway appears to be primarily responsible for this increase in intracellular Ca++. Here,
one or more phospholipases hydrolyze phosphatidylinositol (4,5) biphosphate (PtdIns(4,5)P2) to
diacylglycerol and inositol 1,4,5,-triphosphate(IP3). Soluble IP3 diffuses throughout the
cytoplasm, until it encounters 1,4,5-triphosphate receptor 1 (IP3R1) on the endoplasmic
reticulum. This interaction results in the release of Ca++ and an increase in the concentration of
cytoplasmic free Ca++ (Xu et al. 2002). The opening of IP3R1s is also regulated by the cytosolic
Ca++ concentration, thus allowing the IP3R1s to act as calcium-induced calcium release channels.
Fertilization-induced Ca++ release via phosphatidylinositol metabolism is a process that is
highly regulated from start to finish and many of the key players involved in this regulation are
still unknown.  For instance, the precise composition of the proximal part of this pathway,
phospholipase C hydrolysis of PtdIns (4,5) P2 is not clear (Saunders et al. 2002). It may involve a
sperm surface ligand interacting with a receptor on the egg plasma membrane, in which a ligand-
bound membrane receptor couples with an egg PLC to stimulate IP3 production and Ca
++ release,
analogous to the signaling pathway found ubiquitously in somatic cells. Alternatively there may
be a sperm factor, possibly the recently described phospholipase Cζ that is directly released into
the egg cytosol at the time of fertilization (Saunders et al. 2002).
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There are also other important events occurring that relate to changes in calcium release
during meiotic maturation. During meiotic maturation oocytes become more responsive to
stimuli that release Ca++ (Mehlmann and Kline 1994).  That is, despite similar levels of stored
calcium in all fully grown oocytes (GV and MII stages included) GV-stage oocytes release less
Ca++ than MII oocytes when stimulated with IP3, sperm or Ca
++. A likely explanation is that Ca++
release mechanisms undergo important changes during meiotic maturation. An example of this is
the increase seen in IP3R levels (Fissore et al. 1994). Another observation is that there is not the
expected loss of plasma membrane PtdIns (4,5)P2 in the minutes following fertilization (Halet et
al. 2002). Rather there is a paradoxical net increase that appears to be dependent on exocytosis of
cortical granules. This finding suggests that cortical granule release stimulates an increase in
plasma membrane PtdIns(4,5)P2 synthesis following fertilization, thus ensuring a continuing
supply of IP3 to promote a long series of Ca
++ oscillations.
It is interesting to note that many or all of the cellular events occurring as a consequence
of fertilization-induced Ca++ oscillations can also be seen in unfertilized eggs. Fertilization of
mouse eggs normally occurs during a window of 12-14 hours following the leutinizing hormone
(LH) surge and leads to exit from Metaphase II and entry into interphase. If fertilization does not
occur during this window, and unfertilized mouse eggs remain in the oviduct or are maintained
in a suitable medium, a significant fraction of eggs will undergo spontaneous activation in a
time-dependant manner (Xu et al. 1997). There is a time-dependant reduction in the density of
cortical granules in eggs 13 to 22 hours after the controlled initiation of ovulation by
administered hCG.  Cdc2/cyclin B kinase and MAP kinase activities, events normally associated
with the resumption of the cell cycle in fertilized eggs, steadily decrease from 13 to 22 hours
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after hCG injection. Moreover, during this same time window, there is a marked increase in the
percentage of eggs that can form pronuclei in response to microinjected IP3. Taken together,
these findings are consistent with the notion that with increasing time after ovulation, the
susceptibility of unfertilized eggs to being activated is increased due to the development of a
partially activated state. One expected feature of eggs in this state is that many different stimuli
could elevate intracellular Ca++ and thus enhance the possibility of oocyte activation, leading to
formation of ovarian teratomas (OTs).
2.1.2. Ovarian teratomas
Teratomas are germ cell tumors that are found in men, women and certain susceptible
mouse strains (Peterson et al. 1955, Stevens and Varnum 1974; Eppig et al 1977; Chaillet et al.
1996).  A teratoma is a tumor composed of a bizarre arrangement of differentiated tissues that
normally are found in other parts of the body.  Virtually all teratomas contain a disorganized
mixture of tissues of ectodermal, mesodermal and endodermal origin (Damjanov 1983; Gardner
1983). These structures are found in various proportions and stages of differentiation depending
on the individual teratoma. Immature teratomas contain poorly differentiated carcinoma (EC)
cells in addition to various blends of mature ectodermal, mesodermal and endodermal tissues.
2.1.2.1. Origin of ovarian teratoma
In 1946, Friedman and Moore proposed that an ovarian teratoma develops from an
activated oocyte or its derivatives, such as cells of the blastocyst.  There are a number of
observations in human subjects that support this notion. First, OT’s are usually found in, or
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associated, with the ovary. Secondly, human teratomas are frequently found mixed with germ
cell tumors (Damjanov 1993). Thirdly, the anatomical distribution of many teratomas is along
the line of migration of primordial germ cells from the yolk sac to the genital ridge (Eddy et al.
1981). Lastly, convincing evidence for a germ cell origin of OT’s is derived from their
genotypes. Using chromosomal banding studies and chromosomal polymorphisms at or near the
centromere Linder et al. in 1969 showed that many dermoid cysts are genetically haploid
consistent with a parthenogenetic germ cell origin. This finding has since been confirmed in
more extensive studies in which OT’s were shown to originate from a variety of stages of
oogenesis (Parrington et al. 1984)
2.1.2.2. Genetic analysis of ovarian teratomas
Because oocytes progress through meiosis, a process involving genetic recombination and
segregation of parental homologous chromosomes to different cells, OTs can be analyzed
genetically by comparing the genotype of the tumor to the genotype of the tumor-bearing host.
This approach was used by Linder et al. in 1969 to show parthenogenetic etiology in many
human dermoid-cysts. Such an analysis can identify the latest meiotic stage reached in formation
of an individual teratoma. Because this approach is analogous to identifying cancer-causing
mutations by comparing the genotype of a tumor to the genotype of the tumor-bearing host, the
various meiotic progressions of teratomas have been called types of errors. These errors, as
outlined by Chakravarthy et al. 1989 and Surti et al. 1990, are listed in Table 6 with the expected
genotype of an OT.
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Based on the analysis of five mature teratomas using a limited number of genetic markers,
the original studies by Linder et al. 1969 indicated that mature OTs arose from type 2 errors
(oocytes that completed meiosis 1). In 1990, Surti et al. analyzed 89 mature OTs (mostly
sporadic, non-familial) using only centromere markers and concluded that 65% were from a
Type 2 or a Type 3 error and 35% were from Type 1 or a Type 4 error. The study by Deka et al.
1990 concluded that 21% of the 61 mature OTs analyzed were from a Type 2 error and 39%
were from a Type 3 error. The conclusion from these studies is that human mature OTs can
develop as a consequence of more than one type of meiotic error.
2.1.2.3. Ovarian teratomas in genetically susceptible mouse strains
Although the developmental (meiotic) origin of individual OTs can be determined, little is
known about the genetic predisposition to their formation. In humans, OTs occur spontaneously
with no known genetic or environmental cause, and there are only a few reports suggesting a
familial disposition to their formation. The development of mouse ovarian OTs, however is
clearly genetically restricted. An example of this strong genetic influence is the high incidence of
OTs in certain inbred strains of mice. Greater than 50% of inbred LT/Sv females develop OTs
(Stevens 1983), and all or nearly all of these OTs are from oocytes that have completed meiosis 1
but have failed to complete the second meiotic division (Eppig et al. 1977; Eicher 1978).  This
singular origin of (singular error) for OT formation is not surprising since LT/Sv is an inbred
strain and all the females are genetically identical (LT/Sv is a recombinant inbred strain derived
from progenitor C58B6/J and BALB/c strains).
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Table 6.  Types of errors that lead to formation of ovarian teratomas
The table shows the type of errors that can occur in the progenitor germ cell of an OT and the
expected genotype that would occur in an OT female who is heterozygous for centromeric and
distal markers. It is very rare for a type 5 error to occur as two primordial germ cells must be
present in a single Graafian follicle for them to fuse, and this is not a common occurrence.
Table 6.  Types of errors that lead to formation of ovarian teratomas
Ovarian teratoma genotype
Type of error Error Centromeric
markers
Distal markers
1
Failure to complete
meiosis I or fusion
of first polar body
with oocyte
Heterozygous Heterozygous orhomozygous
2
Failure to complete
meiosis II or fusion
of second polar
body with oocyte
Homozygous Heterozygous orhomozygous
3 Endoreduplication
of mature ovum Homozygous Homozygous
4
Failure of
primordial germ cell
to enter meiosis
Heterozygous Heterozygous
5 Fusion of two ova Heterozygous orhomozygous
Heterozygous or
homozygous
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2.1.2.4. Role of strain-specific modifier genes in ovarian teratoma formation
Strain-specific modifier genes seem to play an important role in the development of LT/Sv
OTs. West et al. in 1993 obtained evidence that a single codominant gene, primary oocyte
population (Poo), was responsible for metaphase arrest in LT/Sv oocytes. Fifty percent of
(C57B6/J x LT/Sv) oocytes underwent spontaneous parthenogenetic activation and development
to the blastocyst stage when cultured in vitro compared to 12% for C57B6/J and 88% LT/Sv
oocytes (Eppig et al. 1996). These data suggest that a single LT/Sv-derived gene (not mapped) is
responsible for the increased level of parthenogenetic development in (LT/Sv x C57B6/J) F1 and
LT/Sv oocytes compared to C57B6/J oocytes.
One study provided the chromosomal location of a single LT/Sv determinant of OTs in
LT/Sv mice (Lee et al. 1997). In this study, 8% of the (C57B6/J x LT/Sv) F2 females analyzed
had an OT. A genome-wide scan identified the ovarian tumorgenesis susceptibility 1(Ots1) gene
on chromosome 6. Of the females analyzed with OTs, 23 females were homozygous for the
LT/Sv-derived allele at both loci, 12 were heterozygous for both loci, one inherited a crossover
between these two loci, and none were homozygous for C57B6/J-derived alleles at either locus.
From these observations Lee and co-workers hypothesized that a single copy of the LT/Sv Ots1
allele is necessary, but not sufficient, for OT formation (i.e., the LT/Sv Ots1 allele is dominant to
the C57B6/J-Ots1 allele and not all individuals homozygous for the LT/Sv-Ots1 allele develop an
OT). Overall these analyses suggest that MI arrest, parthenogenetic activation and the LT/Sv-
Ots1 determinant are all necessary for OT development, but none alone are sufficient for ovarian
teratoma formation.
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Thus, it appears that there may be other genetic determinants involved, in addition to the
Ots1, in the formation of OTs in mice.  But not many candidates or mouse model systems have
come to the fore to explain the other probable pathways that may be involved.  There is also no
direct evidence that changes in the dynamics of proteins involved in egg activation lead to OT
formation in mice.  The Tgkd line of mice produced by Chaillet et al. in 1996, however, seemed
to have the potential to indeed add to our understanding of OT biology and the cell signaling
pathways involved.
2.1.3. Ovarian teratomas in the Tgkd line
In the course of studying the cis-acting requirements for genomic imprinting, Chaillet et al.
produced the Tgkd transgenic line using the RSVIgmyc transgene (Chaillet et al. 1996).  The
RSVIgmyc transgene in the Tgkd line is genomically imprinted.  However, it was also observed
that this line has a high incidence of ovarian teratomas where approximately 20% of hemizygous
FVB-Tgkd (inbred FVB/N mice that are hemizygous for Tgkd  transgene) mice develop
teratomas. The tumors are uni- or bi-lateral, of variable size, and some have evidence of
metastases to the mesenteric lymph nodes and/or lungs. Upon dissection of the tumors, the
central area was composed frequently of haemorrhagic and necrotic material. No other
malignancies or morphological abnormalities were found in adults FVB-Tgkd mice. Interestingly
cultured primary oocytes from FVB-Tgkd mice, like LT/Sv primary oocytes undergo spontaneous
parthenogenetic activation and development to the blastocyst stage.
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Histological examination of FVB-Tgkd teratomas revealed a malignant mixed germ cell
phenotype (teratocarcinoma). The tumors contain areas of mature teratomous structures with
well differentiated, keratinizing squamous epithelium, respiratory epithelium, cartilage,
sebaceous glands, hair follicles, intestine, bone, fat, smooth muscle, and nerves. These structures
are derivatives of all three embryonic germ layers typically represented in teratomas or
teratocarcinomas: ectoderm, mesoderm, and endoderm. Other areas of the tumor are immature,
composed mostly of undifferentiated mesenchymal cells with a high mitotic index, consistent
with embryonal carcinoma cells. The tumors show embryoid bodies, Schiller-Duval bodies
characteristic of endodermal sinus tumors, and malignant trophoblasts characteristic of
choriocarcinoma. The larger tumors contained a significant amount of central necrosis. Tumors
from all mice were histologically similar.
Tgkd allele as an insertional mutation
Three lines of evidence support the idea that the Tgkd allele functions as an insertional
mutation.  First, there is an absolute association between OTs and the presence of a Tgkd allele in
the FVB/N strain. That is, all teratomas from hemizygous FVB-Tgkd females contain the
transgene. Secondly, other transgenic lines produced with the same DNA construct as the Tgkd
mice, but integrated at other chromosomal locations, did not develop tumors. Thirdly,
hemizygous and homozygous Tgkd mice have distinct phenotypes where the hemizygous Tgkd
mice, except for the frequent occurrence of ovarian teratomas, appear phenotypically normal,
whereas homozygous Tgkd mice die around the time of birth. This was demonstrated by
genotyping multiple offspring from various matings between hemizygous males and females at
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different developmental times, using a DNA fragment that immediately flanked the transgene
insertion and that distinguished wildtype from Tgkd alleles on Southern blots. The observed
percentages of the different genotypes at embryonic days 8.5 and 10.5 were roughly equivalent
to the expected percentages. However the observed percentages of homozygous transgenics at
birth were approximately one-half of the expected value. At 3 weeks of age there were no
identifiable homozygous Tgkd mice. These observations lead to the hypothesis that the
expression of a gene neighbouring the insertion is altered in female germ cell, and this alteration
leads to the development of ovarian teratomas.  Under the assumption that indeed the ovarian
teratomas were due to a Tgkd-mediated insertional mutation, Feng Ding and Richard Chaillet
cloned the locus of integration of the transgene and identified the genes in the vicinity of the
insertion.
As a first step in identifying a gene involved in the development of ovarian teratomas,
genomic fragments flanking both sides of the Tgkd  insertion were cloned. This was
accomplished by first identifying single-copy junctional fragments on Southern blots probed
with a variety of transgene fragments. Two junctional fragments, one from each side of the
transgene insertion, were then cloned from sub-genomic libraries of FVB-Tgkd DNA. DNA
sequencing of the junctional fragments and physical mapping of the flanking fragments to the
mouse genome demonstrated that the transgene insertion resulted in small, approximately 1-kb
deletion of genomic DNA. The sequence of DNA flanking the transgene insertion was used to
determine the location of Tgkd within the sequence of the mouse genome. This placed the
transgene insertion between two known chromosome 8 genes, Inpp4b and Il15 (Figure 30), a
location that is consistent with the previous map position determined from a panel of
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recombinant-inbred strains. Because Tgkd inserted into a large, 200 kb interval between Inpp4b
and Il15, there was a possibility that Tgkd disrupted an unidentified gene in this interval. Two
lines of evidence indicate that this was unlikely. First extensive exon trapping of genomic
sequences isolated from 60 kb of the genome surrounding the insertion site was performed, and
no true exons were identified. These failed efforts included screening an ovary c-DNA library
made from 10-day old mice with candidate exon sequences. Secondly no mouse or human ESTs
have been identified in this interval between Inpp4b and Il15. Thus, it was predicted that either
Inpp4b or Il15 expression has been affected by Tgkd, and this effect has lead to the development
of ovarian teratomas.
Of the two genes on either side of Tgkd, alteration of Inpp4b would better account for the
FVB-Tgkd phenotypes. Although little is known about the precise role of Inpp4b, its significant
biological role is probably in modulating phosphotidylinositol signaling. As mentioned before,
phosphotidylinositol signaling via IP3 is known to play a role in egg activation.  It is also known
that the pathway of inositol metabolism that involved the production of PtdIns(3,4)P2 (which, in
turn, is responsible for an increase in IP3 during egg activation) is regulated by phosphatases.  It
is therefore quite feasible that Inpp4b could be indirectly involved in egg activation as well.
Altered Inpp4b activity could lead to an increase in IP3 levels in MII oocytes and consequent
Ca++ release, which in turn, could lead to abnormal egg activation and teratomas. Moreover
phosphotidylinositol signaling is an essential signal transduction system in mammalian cells, and
disruption of a component in this pathway, namely Inpp4b, may well be associated with a
perinatal lethality as seen in homozygous Tgkd mice. In contrast, homozygous null mutations in
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Figure30. Schematics of RSVIgmyc  transgene and its insertion in T g k d mice.
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Figure30. Schematics of RSVIgmyc transgene and its insertion in Tgkd mice.
A. Schematic of insertion of the RSVIgmyc transgene. From previous analysis, it was determined
that RSVIgmyc inserted into a large, 200 kb interval between Inpp4b and Il15 on chromosome 8
B. The RSVIgmyc  transgene DNA construct.  The main portion of the construct is derived from
a Burkitt-like IgA/c-myc translocation (Chaillet et al. 1991).  The 440-bp horizontally hatched
region is a portion of the RSV-LTR.  Cα and Sα are contiguous coding, intronic and switch
regions of IgA. 1, 2, 3 are exons of c-myc. Exon 1 is truncated by Sα. The arrow above the
construct refers to the orientation of a unit copy of the construct in the array of tandem copies
i n s e r t e d  b e t w e e n  I n p p 4 b  a n d  I l 1 5 .
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Il15 are viable and Il15’s primary biological role appears to be in the development of the
immune system, rather than in germ cell development (Ohteki et al. 2001).
2.1.3.1. Strain-specific effects on Tgkd ovarian teratomas
The formation of the ovarian teratomas in the Tgkd females seemed to be dependant on
the strain of the mice in which the transgene was present. As mentioned before, approximately
20% of hemizygous FVB-Tgkd mice develop teratomas while none of the C57B6/J or 129/Sv
mice with the Tgkd transgene developed teratomas.  F1 Tgkd mice produced by mating FVB-
Tgkd mice to 129/Sv, DBA/2J or C57BL/6J(C57B6/J) mice, also do not develop OTs. These
results suggest that, in addition to the gene disrupted by the Tgkd transgene, at least one
additional FVB/N-derived gene is required for OTs to develop in Tgkd females. To test this
hypothesis the following experiment was conducted by Dr. Eicher E (Jackson Laboratories,
BarHarbour, ME). First, backcross generation females were produced by mating (FVB-Tgkd x
C57B6/J)F1 Tgkd or (C57B6/J x FVB-Tgkd)F1 females to FVB/N males. At 120 days of age, the
female were killed and scored for the presence or absence of an OT. 8% of the Tgkd females
analyzed were OT positive whereas the remaining Tgkd females and all the non-Tgkd females
were OT negative. This result suggests that an FVB/N-derived gene, other than the gene
disrupted by the Tgkd transgene is required for OT development in Tgkd females. For simplicity,
this gene was designated Ots2 (ovarian teratoma susceptibility 2).
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To map Ots2, a genome scan was performed using DNA isolated from the 31 Tgkd OT
positive females. The only linkage noted, other than to the region of chromosome 8 containing
the transgene insert, was to markers located on chromosome 6. This would imply that the Ots2
gene is on chromosome 6.  It was hypothesized that the FVB/N-derived Ots2 gene is required for
OT development in Tgkd females and homozygosity for the FVB/N-derived Ots2 gene increases
the probability of OT development. That is, a single copy of an FVB/N-derived Ots2 gene is
necessary but not sufficient, for OT formation in Tgkd females.
There is the possibility that Ots1 and Ots2 is the same gene. There is also the possibility
that they are not the same gene but map to the same region on chromosome 6. To investigate the
possibility that Ots1 and Ots2 are the same gene, FVB-Tgkd females were mated to LT/Sv males
and F1 daughters were analyzed to determine if they developed an OT by 120 days of age.
Females who contained an obvious abdominal growth before 120 days were killed and the
presence of an OT was verified. At 120 days of age, normal appearing females were killed and
checked for an OT. When each female was killed a tail biopsy was taken for later typing for the
presence of Tgkd.  Of the 48 Tgkd females analyzed, 43 were OT positive, whereas 0 of their 64
non-Tgkd female sibs were OT positive. This result suggests that Ots1 and Ots2 are indeed the
same. A direct approach is needed, however to test for identity of Ots1 and Ots2. If these two
genes are the same, this will facilitate the ability to experimentally map the FVB Ots2 and LT/Sv
Ots1 genes.
A strong candidate for the Ots1 and Ots2 genes on chromosome 6 is Itpr1, the gene
encoding the IP3R1 protein.  The level of IP3R1 protein increases almost two-fold during oocyte
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maturation, and as mentioned before, it plays an important role in the release of Ca++ and an
increase in the concentration of cytoplasmic free Ca++ following fertilization.  The IP3R1
dynamics during oocyte maturation and fertilization suggest that strain variation in IP3R1 protein
levels or minor sequence changes in the Itpr1 gene during these periods may influence the
response to IP3 signalling and consequently the tendency to form ovarian teratomas.
2.1.3.2. Type of Meiotic error
One hypothesis for the formation of ovarian teratomas in the FVB-Tgkd females is that
these teratomas arise from oocytes that have undergone meiotic maturation.  To begin to test this
hypothesis, Richard Chaillet used a fragment flanking the Tgkd transgene to genotype a group of
FVB-Tgkd teratomas that developed in the inbred FVB/N background, and compared their
genotypes to those of their hemizygous FVB-Tgkd hosts. On southern blots of BglI-digested
genomic DNA, this fragment distinguishes a wildtype FVB/N allele (7-kb band) from a Tgkd
allele (12-kb band). Approximately one-half of the teratomas examined was hemizygous and the
other half was homozygous. Notably, all teratomas contained at least one Tgkd allele. This
finding effectively eliminates errors of type 3  (endoreduplication of a mature ovum) or type 4
(failure of a primordial germ cell to enter meiosis) as the underlying etiology of FVB-Tgkd
teratomas. However because the genotyping of the teratomas was performed with a single distal
heteromorphic marker located 33 cM from the centromere, the results could not distinguish
among the remaining three possibilities (type 1-failure to complete meiosis; type 2-failure to
complete meiosis II; type 5- fusion of two ova). A type 1 error would be consistent with FVB-
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Tgkd oocytes that are physiologically abnormal early in germ cell development, whereas type 2
or 5 errors would suggest abnormalities during meiotic maturation or soon after its completion.
To distinguish among these possibilities, further genotyping of Tgkd teratomas that had
developed in a mixed strain background was done, using many pericentromeric and distal
heteromorphic markers. This analysis was done by Dr. Eva Eicher.  DNA was isolated from 13
OTs obtained from 12 backcross females obtained by mating (FVB-Tgkd/+ x C57B6/J) Tgkd/+
F1 mice to FVB/N mice. Ten pericentric MIT markers were chosen for analysis such that each
marker tagged a separate chromosome. First the 12 OT positive females were typed to determine
if they were B/F (C57B6/J/FVB/N) or F/F for each marker (only markers that were B/F would be
informative for analysis of their OT). With the exception of 3 MIT markers, the OT from a B/F
female was B/B or F/F. For an OT to be B/B or F/F in a B/F female, MI must have been
completed before the OT developed.   It was thus concluded that the OTs present in Tgkd
females are derived from germ cells that have completed MI and not MII. These results are
similar to results obtained by females of the LT/Sv inbred strain. Taken together the preliminary
observations suggest that the physiologic abnormality in Tgkd female germ cells is in a narrow
window of meiotic maturation, after completion of meiosis I but before completion of meiosis II.
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2.1.4. Specific Aims
2.1.4.1. Specific Aim 1
The FVB-Tgkd line of mice has a high incidence of ovarian teratomas, where approximately
20% of hemizygous FVB-Tgkd mice develop teratomas.  From preliminary studies, there is
strong evidence that Tgkd functions as an insertional mutation where the expression of a gene
neighbouring the insertion is altered in female germ cell, and this alteration leads to the
development of ovarian teratomas.  One of the candidate genes whose expression could have
been altered is the Inpp4b gene.  The Inpp4b phosphatase is known to hydrolyze
phosphatidylinositol lipids and inositol phosphates. We hypothesize that Inpp4b catalyzes the
hydrolysis of IP3, and that disruption of Inpp4b expression could lead to higher IP3 levels in
oocytes, which in turn could lead to parthenogenetic activation of unfertilized eggs and
formation of ovarian teratomas.  There is also the possibility that Inpp4b could act as a cytostatic
factor in MII oocytes to prevent cell division in unfertilized MII oocytes. Decreased Inpp4b
protein levels could reduce the cytostatic activity in MII oocytes, thus leading to teratoma
formation.  To test these possibilities, Inpp4b protein levels will be measured in germinal
vescicle stage oocytes, mature MII oocytes and preimplantation embryos from both FVB
wildtype and FVB-Tgkd females.   Inpp4b mRNA and Inpp4b enzymatic activity will also be
measured in both wildtype and Tgkd females.  The results of these experiments should clarify the
role of Inpp4b in the development of ovarian teratomas in FVB-Tgkd females.
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2.1.4.2. Specific Aim 2
From preliminary studies it has been established that there is a strong FVB/N genetic
determinant (Ots2) needed for OT development in Tgkd females. This determinant has been
placed on chromosome 6, the same chromosome that contains Ots1, an LT/Sv genetic
determinant of OT development.   A good candidate for the Ots2 gene is the Itpr1 gene that
encodes the IP3R1 protein. IP3R1 is responsible for mobilizing intracellular Ca
++ stores upon
binding to IP3 during egg activation. The IP3R1 dynamics during oocyte maturation and
fertilization suggest that strain variation in IP3R1 protein levels or minor sequence changes in the
Itpr1 gene, during these periods may influence the response to IP3 signalling and consequently
the tendency to form ovarian teratomas.  To analyze this hypothesis, the levels of IP3R1 protein
will be analyzed in MII oocytes from 3 different strains, C57B6/J, FVB/N and 129/Sv.  We will
also analyze for sequence differences in the IP3R RNA between the various strains of mice
including the LT/Sv mice.  The outcome of this study will help us have a better understanding of
the role of IP3 and IP3R1 in OT development.
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2.2. Results
2.2.1. Role of Inpp4b in the formation of ovarian teratomas
To confirm the possibility that lower levels of Inpp4b protein is a possible reason for
formation of ovarian teratomas in the FVB/Tgkd females, we compared the levels of Inpp4b
protein, mRNA and Inpp4b activity between the MII oocytes of wildtype FVB/N and FVB-Tgkd
females. We also studied the dynamics of the Inpp4b protein during oogenesis to confirm its
possible association as a cytostatic factor.
2.2.1.1. Measurement of Inpp4b protein levels in wildtype and Tgkd oocytes
In FVB/N strain of mice
The notion that Inpp4b expression is altered in FVB-Tgkd oocytes was tested by
measuring Inpp4b protein levels in MII oocytes from both FVB-Tgkd and FVB/N mice. Oocytes
from both strains were collected at the same time following superovulation with PMS and hCG.
Immunoblots from oocyte extracts were probed with two antibodies to Inpp4b (anti-Inpp4b (N-
20) and anti-Inpp4b (F-13)).  Surprisingly, the levels of Inpp4b were extraordinarly high in
wildtype FVB/N oocytes The 105-kD protein was easily detected in 1/4 of the extract from a
single MII oocyte. The level of Inpp4b protein in FVB-Tgkd oocytes was approximately one half
of that seen in FVB/N oocytes (Figure 31). The likely cause of this reduction in Inpp4b protein is
that the Tgkd insertion in the 3’ region of Inpp4b has generated a hypomorphic Inpp4b allele.
Although the exact mechanism of this effect is unknown, the two likely possibilities are that the
transgene’s imprinting in the later stages of oogenesis has secondarily affected Inpp4b
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transcription, or that a cis-acting regulatory element for Inpp4b transcription has been disrupted
by the Tgkd insertion. Because of the lethal phenotype of Tgkd homozygous mice, the adverse
effect of the Tgkd insertion would appear to apply to both parental alleles favoring the disruption
of a cis-acting regulatory element.
In 129/Sv strain of mice
The levels of Inpp4b protein were also high in the MII oocytes from 129/Sv mice where
the protein could be detected very easily from 1/4-1/2 of an oocyte (Figure 31).  But the
difference in the levels of protein between the wildtype 129/Sv oocyte and the 129/Sv-Tgkd
oocyte was not as dramatic as the difference between the wildtype FVB and FVB-Tgkd oocytes.
This outcome also coincides with the fact that ovarian teratomas develop only in the FVB-Tgkd
mice and not in the 129/Sv-Tgkd mice, thus leading us to two conclusions. One is that the lower
levels of Inpp4b protein could be directly related to the formation of ovarian teratomas.  The
second is that these levels of Innp4b protein could be directly controlled by the Ots2 gene and
therefore differences in either the levels of the Ots2 protein or sequences of the Ots2 gene
between the different strains of mice could lead to differences seen in the levels of Innp4b
protein in the FVB-Tgkd mice and the 129/Sv-Tgkd mice.
2.2.1.2. Measurement of Inpp4b mRNA levels in wildtype and Tgkd oocytes
To further support our results from analyzing the protein levels of Inpp4b, a semi-
quantitative RT-PCR technique was used to compare the levels of Inpp4b mRNA levels in MII
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                                      Figure 31. Inpp4b expression in MII oocytes
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Figure 31. Inpp4b expression in MII oocytes
A.  Expression of Inpp4b protein in MII oocytes. Pools of 10 oocytes were obtained from LT/Sv,
FVB/N, FVB-Tgkd, 129/Sv and 129/Sv-Tgkd strains of mice, lysed and run on a polyacrylamide
gel.  The amount of lysate run on the gel was equivalent to that of 1 oocyte.  The samples were
then transferred to an immunoblot, which was probed with the anti-Inpp4b (N-20) antibody to
determine the levels of Inpp4b protein among the various strains of mice.  A significant decrease
in Inpp4b levels is seen between the wildtype FVB/N and FVB-Tgkd oocytes. But the difference
in levels of protein between the wildtype 129/Sv oocyte and the 129/Sv-Tgkd oocyte is not as
dramatic as the difference between the wildtype FVB and FVB-Tgkd oocytes.  The level of
Inpp4b protein in the LT/SV oocytes is comparable to the levels in the 129/Sv oocytes. B.
Expression of Inpp4b mRNA in MII oocytes.  RNA was collected from 50 wildtype FVB/N and
FVB-Tgkd oocytes and cDNA was obtained using reverse transcriptase.  PCR for different
number of cycles (32, 34 and 36) was performed on equal amounts of cDNA from FVB and
FVB-Tgkd oocytes, using radiolabeled nucleoside triphosphates to detect by autoradiograms
small amounts of PCR product during a linear phase of product accumulation. As seen in figure
there is a slight decrease in the levels of Inpp4b mRNA in the MII oocytes from FVB-Tgkd mice
when compared to oocytes from wildtype FVB/N females. But this difference is not as dramatic
as the difference seen in the Innp4b protein levels between the two strains of mice.
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oocytes from FVB/N and FVB-Tgkd females.  PCR for different numbers of cycles was
performed on equal amounts of cDNA from FVB/N and FVB-Tgkd oocytes.  Radiolabeled
nucleoside triphosphates were used to detect small amounts of PCR product during a linear phase
of product accumulation by autoradiograms. The mRNA for the Innp4b-α  form is the
predominant form in adult mouse ovaries (data not shown) and therefore the mRNA measured in
the MII oocytes was also the Inpp4b-α form.  As shown in Figure 31, there was a slight decrease
in the levels of Inpp4b mRNA in the MII oocytes from FVB-Tgkd mice when compared to
oocytes from wildtype FVB/N females.  But this difference was not as dramatic as the difference
seen in the Innp4b protein levels between the two strains of mice.  There could be various
reasons for this including the fact that the difference in Inpp4b protein levels seen between the
FVB-Tgkd mice and FVB/N mice could be due to a difference in post-transcriptional regulation
of the protein. Or there could be a qualitative difference betweens FVB-Tgkd and FVB/N Inpp4b
transcripts that is not evident in the RT-PCR assay.
2.2.1.3. Measurement of Inpp4b activity in wildtype and Tgkd oocytes
Inpp4b activity was measured in ovaries from FVB-Tgkd and FVB/N females to confirm
that there is a direct consequence of lower Inpp4b protein levels on phosphatidylinositol
metabolism and egg activation. This was analyzed using radiolabeled [3H] 1,3,4 inositol
triphosphate (gift from Norris A, Iowa State University, IA) as the substrate and the activity level
was determined by the extent of conversion of the radiolabeled substrate to [3H] 1,3 inositol
biphosphate. Ideally the Inpp4b activity should have been measured in MII oocytes. However
attempts to use oocytes were not successful, inspite of using 100 MII oocytes and allowing the
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reaction to proceed for a wide range of time points.  The reason for the lack of success could be
that the number of oocytes was low or that the substrate used in this assay was not the right
substrate for the activity of Inpp4b protein in the MII oocyte. To determine if a difference in
Inpp4b activity could be seen in ovaries from FVB-Tgkd and FVB/N females, Inpp4b activity
was measured in equal amount of ovary protein from the two strains.  As seen in Table 7, there
was a 10% decrease in the amount of Innp4b activity in the ovaries from FVB-Tgkd females
when compared to the ovaries from the FVB/N females.   This decrease is not as significant as
the difference seen in protein levels in the MII oocytes from FVB-Tgkd and FVB/N females.  But
the reason for this could be that the ovary is a more heterogenous mixture than the MII oocyte
and there could be other phosphatases involved whose activity coincide with that of the Inpp4b
protein and thus distort the results obtained from this assay.  To obtain a much cleaner assay, it
would be worthwhile to try measuring Inpp4b activity in pools of larger number of MII oocytes
or using a different substrate other than the 1,3,4 inositol triphosphate.
2.2.1.4. Inpp4b as a cytostatic factor
As mentioned before, there was a possibility that Inpp4b might be involved as a cytostatic
factor to prevent egg-activation before fertilization or parthenogenetic activation.  To prove this
hypothesis, we decided to check if Inpp4b fit into some of the criteria required to be a cytostatic
factor, i.e. it accumulates during oocyte maturation, it is capable of functioning in meiosis II and
its level decreases on fertilization or parthenogenetic activation. GV stage oocytes and MII
oocytes were collected from wildtype FVB/N females and FVB-Tgkd females following
superovulation with PMSG and hCG. Immunoblots from oocyte extracts were probed with the
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Table 7.  Measurement of Inpp4b activity in mouse ovary
The assay used for the determination of Inpp4b in ovary extracts was modified from Majerus et
al. 1990.  The ovaries lysate collected from the mice were incubated with radiolabeled [3H] 1,3,4
inositol triphosphate as the substrate for 60 minutes at 37°C.  The reaction product, [3H] 1,3
inositol biphosphate, which is presumably obtained due to the activity of Inpp4b in the ovaries,
was eluted with 8 ml of 0.4M Ammonium formate, 0.1Formic acid, and radioactivity was
measured by liquid scintillation spectroscopy as counts per minute (cpm).
cpm per 5 ug of ovary protein
Assay number
FVB/N FVB/Tgkd
Assay 1 73 62
Assay 2 72.5 48
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anti-Inpp4b antibody.  Surprisingly, the levels of Inpp4b were significantly low in wildtype GV
oocytes with the protein level being 1/10 of the level found in wildtype MII oocytes (Figure 32).
Seemingly there was a 10-fold increase in the Innp4b protein level during oocyte maturation
leading to high amounts of the protein in the MII oocyte.   This rise in Inpp4b concentration
associated with meiotic maturation is greatly diminished in oocytes from hemizygous Tgkd
females, such that the concentration in MII oocytes is, on average, less than one-half of that in
wildtype oocytes.
To determine if there is also a fall in the protein level after oocyte fertilization, 1-cell and
2-cell embryos were collected from wildtype FVB/N females after mating them to wildtype
males. MII oocytes were collected as previously described.  Immunoblots with these oocyte and
embryo extracts were probed with the anti-Inpp4b (N-20) antibody.  There was a distinct
decrease in the level of Inpp4b protein after fertilization and in the 2-cell stage embryos the
protein was barely visible on the immunoblot (Figure 32).  Thus, these findings are consistent
with the notion that Inpp4b is a cytostatic factor that prevents spontaneous activation or cell
division of unfertilized MII oocytes.  Therefore, the low levels of Inpp4b proteins seen in the MII
oocytes from FVB-Tgkd females would not be sufficient to prevent spontaneous activation and
thus lead to ovarian teratoma formation.
2.2.1.5. Localization of Inpp4b protein in the MII oocyte
Using the Inpp4b (N-20) antibody we analyzed the localization of the Inpp4b protein in the
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Figure 32. Expression of Inpp4b protein during oogenesis and fertilization
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Figure 32. Expression of Inpp4b protein during oogenesis and fertilization
A. Immunoblot of wildtype FVB/N embryos and wildtype FVB/N or FVB-Tgkd oocytes probed
with the anti-Inpp4b antibody (N-20).  10 oocytes were used for the GV-stage (germinal vescicle
stage) lanes and 1 oocyte or 1 embryo for each of the other lanes. 10 MII stage oocytes were
pooled and 1/10th of this extract was loaded per lane. Similarly, 3 embryos were pooled and 1/3rd
of this extract was loaded per lane.  A significant increase in Inpp4b levels is seen from the GV
stage to the MII stage of oogenesis. In contrast, a definite decrease is observed in the level of
Inpp4b after fertilization.  Also, a significant difference is observed between the FVB/N and
FVB-Tgkd GV-stage oocytes just like in the MII stage oocytes.  B. Graph depicting Inpp4b
dynamics during oogenesis.  The graph is a summary of the approximate changes in Inpp4b
protein concentration per oocyte from GV stage oocytes to 2-cell stage embryos.
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MII oocyte by immunofluorescence techniques.  As seen in Figure 33 the Inpp4b protein seemed
to localize to the cortical region of the oocyte.  Considering our hypothesis that Inpp4b might
have a role to play in the Ca++ transients, its localization to the oocyte cortex appears promising
since the calcium channels involved in egg activation are present along the oocyte plasma
membrane.  This leads us to believe that there might be a physical interaction between the
calcium channels and Inpp4b protein.
Taken together, the results from the studies so far seem to suggest that Inpp4b plays an
important role in the formation, or rather, in the prevention of formation of ovarian teratomas
from MII oocytes.  Lower levels of Inpp4b protein coincide with the higher incidence of ovarian
teratomas and the dynamics of Inpp4b protein during oogenesis correspond to the requirements
for a cytostatic factor. Thus, it appears that Inpp4b could be part of a cytostatic factor that
prevents spontaneous egg activation.
2.2.2. Role of IP3R1 in the formation of ovarian teratomas
From preliminary data it was observed that the Itpr1 gene was a good candidate for the
Ots2 gene (the FVB/N genetic determinant needed for OT development in Tgkd females). As
mentioned before, the IP3R1 dynamics during oocyte maturation and fertilization suggest that
strain variation in IP3R1 protein levels, or minor sequence changes in the Itpr1 gene during these
periods, may influence the response to IP3 signalling and consequently the tendency to form
ovarian teratomas.  To analyze both aspects of this hypothesis two separate experiments were
done. The level of IP3R1 protein was analyzed in MII oocytes from 3 different strains, C57B6/J,
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   Figure 33. Localization of Inpp4b protein in MII oocyte
MII oocyte stained with anti-Inpp4b antibody
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Figure 33. Localization of Inpp4b protein in MII oocyte
Using the anti-Inpp4b (N-20) antibody the localization of the Inpp4b protein in the MII oocyte
was analyzed by immunofluorescence techniques. Three confocal sections through the MII
oocyte are shown.  The arrow indicates the localization of the Inpp4b protein to the cortical
region of the MII oocyte.
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FVB/N and 129/Sv.  We also analyzed for sequence differences in the IP3R1 mRNA between the
various strains of mice including the LT/Sv mice.
2.2.2.1. Measurement of IP3R1 protein levels in the MII oocytes
To analyze the probability that there were differences in the levels of IP3R1 protein in
oocytes from different strains of mice, MII oocytes from 3 different strains of mice, C57B6/J,
FVB and 129/Sv, were collected at the same time following superovulation with PMSG and
hCG.  Immunoblots from these oocyte extracts were probed with the anti-IP3R1 antibody that
could easily detect the 206 kD protein from an extract of 20 oocytes.  As shown in Figure 34,
there was no significant difference in the levels of IP3R1 protein between the MII oocytes from
the three different strains.  This result leads us to rule out the possibility that differences in the
level of IP3R1 protein between the various strains of mice affect their individual susceptibility to
formation of ovarian teratomas via their response to IP3 signalling or their regulation by the
Inpp4b protein.  Therefore, it was important to consider the second possibility that differences in
the sequence of the Itpr1 gene between the various strains could lead to differences in their
tendency to form ovarian teratoma.
2.2.2.2. Analysis of sequence differences in the Itpr1 gene among various strains of mice.
From the results described in the previous paragraph, it seemed that differences in the
Itpr1 sequence could be a probable reason for the differences in the incidence of ovarian
171
Figure 34. Measurement of IP3R1 protein levels in MII oocytes
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Figure 34. Measurement of IP3R1 protein levels in MII oocytes
Pools of 25 oocytes were obtained from C57B6/J, FVB/N and 129/Sv strains of mice, lysed and
run on a polyacrylamide gel.  The samples were then transferred to an immunoblot, which was
probed with the anti-IP3R1 antibody to determine the levels of the 260 kD IP3R1 protein among
the various strains of mice.  No significant difference in IP3R1 levels is seen between the
different strains.
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teratomas in the different strains.  mRNA was collected from the ovaries of C57B6/J, FVB/N
and LT/Sv mice and c-DNA was obtained using reverse transcriptase.  21 sets of primers were
designed (Table 9) which covered the entire IP3R1 c-DNA.  Using these primer sets, the IP3R1 c-
DNA was PCR-amplified and the PCR products obtained were sequenced.  Thus the sequence
for the entire IP3R1 cDNA from the FVB/N ovary was obtained.  This sequence was compared
to the genomic sequence of the C57B6/J Itpr1 gene obtained from PubMed (GenBank Accession
# NT_039353).  11 single nucleotide polymorphisms (SNPs) were observed in various regions of
the IP3R1 cDNA between FVB/N and C57B6/J (Table 8).  Out of the 11 SNPs, 10 gave rise to
silent mutations (no change in the amino acid sequence). But one of them (nucleotide #1323,
GenBank Accession number NM_010585) lead to a change in an amino acid (Table 8).  Amino
acid residue # 331 (GenBank Accession number NM_010585) which was a serine in FVB/N
strain was converted to a proline in the C57B6/J strain. The occurrence of these SNP’s was
confirmed by obtaining IP3R1 cDNA from C57B6/J and LT/Sv ovaries and the specific regions
with the above mentioned SNP’s were sequenced.   It was observed that most of the SNP’s
obtained from the genomic sequence of the C57B6/J Itpr1 gene were true SNP’s between the
FVB/N and C57B6/J IP3R1 cDNA.  But the SNP of interest, nucleotide #1323, was not a true
SNP.   Nucleotide #1323 was a thymine in all three strains of mice.
Thus, further analysis need to be done to determine if there are other changes in the
IP3R1 protein among the oocytes from FVB/N, C57B6/J and LT/Sv strains of mice which might
be responsible for the differences in their response to IP3 signalling and consequently the
tendency to form ovarian teratomas.
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Table 8.  Single Nucleotide polymorphisms (SNPs) in Itpr1 cDNA between different strains
of mice
To look for sequence differences in the IP3R1 mRNA between various strains of mice, cDNA
was obtained from the ovaries of C57B6/J, FVB and LT/Sv. 21 sets of primers were designed
(Table 8) which covered the entire IP3R1 c-DNA (Reference sequence number: NM_010585
from NCBI).  Using these primer sets the IP3R1 c-DNA was PCR-amplified and the PCR
products obtained were sequenced.  Thus, the sequence for the entire IP3R1 cDNA from FVB/N
was compared to the genomic sequence of C57B6/J (Reference sequence number: NT_039353
from NCBI) and a total of 11 different single nucleotide polymorphisms (SNP’s) were obtained.
In the table, the nucleotides in red are the nucleotide differences seen among the different strains.
The single amino acid change observed occurred at amino acid # 331, where the serine residue in
FVB/N and LT/Sv was converted to a proline residue in C57B6/J.   But on confirmation by our
cDNA analysis, this SNP of interest, nucleotide #1323, was not a true SNP.   This nucleotide was
a thymine in all three strains of mice.
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Table 8.  Single Nucleotide polymorphisms (SNPs) in Itpr1 cDNA between different
strains of mice
Codons
FVB/N C57BL/6J LT/Sv
Nucleotide number Amino acid change
AAT AAC AAT 762 No change
TTT TTC TTT 825 No change
GAC GAT GAC 1023 No change
TGT TGC TGT 1087 No change
ACG ACA ACG 1147 No change
TCT TCC TCT 1162 No change
TCA CCA TCA 1323
S →  P
(amino acid # 331)
ACC ACA ACC 1719 No change
GAT GAC GAC 4348 No change
GTG GTA GTG 7225 No change
CTC CTT CTT 7261 No change
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2.3. Materials and Methods
2.3.1. Collection of oocytes and preimplantation embryos
Germinal vescicle (GV) stage oocytes were obtained by puncture of ovarian follicles of 7-
12 week-old-females in MII medium (Sigma, St.Louis, MO), as previously described (Clarke et
al. 1992). Metaphase II (MII) oocytes were collected from 7-week-old females that were
superovulated by injection of 7.5 IU of pregnant mares’ serum gonadotropin, PMSG
(CalBioChem, LaJolla, CA), followed 44 to 48 hours later by 5 IU of human chorionic
gonadotropin, hCG (CalBioChem, LaJolla, CA).  These oocytes were recovered from the
oviducts 20 hours post-hCG and the cumulus cells were dispersed with 1 mg/ml hyaluronidase
(Roche Diagnostics, Mannheim, Germany), as described (Hogan et al. 1986).
Preimplantation embryos were obtained as previously described (Clarke et al. 1992).
Superovulated females were caged individually with stud males overnight, and examined for the
presence of a vaginal plug the next morning.  One-cell embryos were recovered from the
oviducts at E0.5 and 2-cell embryos at E1.5 in Hepes-buffered CZB medium (Erbach et al.,
1994) and the cumulus mass dispersed as described above.
For all isolation procedures, healthy-looking oocytes and preimplantation embryos were
collected in a 35 mm Petri dish using a mouth-controlled micropipette and washed free of any
adhering somatic cells by transfer through two dishes of culture medium.  Oocytes and embryos
were either processed immediately for immunofluorescence or stored at –80oC in lysis buffer for
immunoblotting; or stored at –80oC in culture medium for RNA isolation.
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2.3.2. Role of Inpp4b in ovarian teratoma formation
2.3.2.1. Immunoblot analysis
To study the levels of Inpp4b protein in the oocytes and preimplantation embryos collected
from FVB/N, FVB-Tgkd, 129/Sv and 129/Sv-Tgkd females, we used the immunoblot technique.
The antibodies used for this technique were the Inpp4b (N-20) or the Inpp4b (F13) antibodies
(Santa Cruz Biotechnology, SantaCruz, CA).  These antibodies were generated to different
epitope regions of the Inpp4b protein.  Both antibodies gave similar results when used to analyze
the Inpp4b protein in the FVB/N and FVB-Tgkd oocytes.
Oocytes or preimplantation embryos were collected manually from washings of oviducts or
uteri and pooled and lysed in 5% SDS, 2.5% glycerol, 2.5% β-mercaptoethanol, 0.01%
bromophenol blue, 0.025M Tris-HCl, pH 6.8 (1X sample buffer). All samples were denatured by
heating at 95°C for 5 minutes, and then separated by electrophoresis on SDS-5% polyacrylamide
gels at 4°C. Afterwards they were transferred to PVDF membranes (Millipore Corporation,
Bellerica, MA). Membranes were blocked in 5% Carnation dry skim milk in 10 mM Tris-HCl
(pH 8.0), 140 mM NaCl, for a least one hour and probed with either Inpp4b (N-20) or Inpp4b (F-
13) diluted 1:10,000 in blocking buffer for 3 hours.  Following three washes of 5 minutes each in
0.1% Tween-20 TBS, the membrane were incubated for one hour at room temperature in
biotinylated rabbit anti-goat IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA)
diluted 1:30,000 in blocking buffer and washed as above.  Bound antibody was detected by
chemiluminescence (ECL Plus, Amersham, Piscataway, NJ).
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2.3.2.2. Immunofluorescence analysis
To study the localization of the Inpp4b protein in the oocytes from wildtype FVB/N
females we used the Inpp4b (N-20) antibody that has been described in the previous paragraph.
Denuded oocytes were freed of the zona pellucida using acidified (pH 2.5) Tyrode’s
medium (Hogan et al. 1986), and fixed for 10 to 15 minutes at room temperature in 3.7%
formaldehyde in PBS. All solutions for immunofluorescence of Inpp4b were prepared in PBS
and procedures carried out at room temperature.  The fixed cells were blocked for at least one
hour in blocking buffer (3% BSA, 0.1% Triton X-100) and then incubated in either 1:100
preimmune serum or 1:100 Inpp4b (N-20) antibody diluted in the same blocking buffer
overnight at 4°C in a humidified chamber.  The oocytes were washed three times for 5 min each
in blocking buffer, and incubated in an anti-goat IgG monoclonal antibody coupled with Alexa
Fluor (1:250) (Molecular Probes, Eugene, OR) for an hour at room temperature.  The cells were
then washed again as before. To mount the cells for viewing, a drop of Vectashield mounting
medium (Vector Laboratories, Burlingame, CA) supplemented with 0.4 µg/ml of the DNA-
binding dye DAPI (Roche Diagnostics, Mannheim, Germany) was used.  Immunofluorescence
was visualized using a Zeiss Axiophot, Zeiss LSM410 laser scanning confocal microscope.
2.3.2.3. RT-PCR assay
To study the RNA levels of Inpp4b in the FVB/N and FVB-Tgkd females, a semi-
quantitative RT-PCR technique was used (Ding and Chaillet 2001).  RNA was collected from 50
MII oocytes using the Rneasy mini kit (Qiagen, Valencia, CA) and cDNA was obtained from
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this mRNA using the M-MLV Reverse Transcriptase kit (Promega, Madison, WI).  PCR for
different number of cycles (32, 34 and 36 cycles) was performed on equal amounts of cDNA
from FVB and FVB-Tgkd oocytes, using radiolabeled oligonucleotides (32P dCTPs).   PCR
reactions were performed using approximately cDNA from 50 MII oocytes in a 10 ml reaction
containing, 1X PCR buffer (Invitrogen, Carlsbad, CA), 1.5 mM MgCl2, 10uM of the Inpp4b
(Forward) and Inpp4b (Reverse) primers, 200 mM dNTPs, 32P dCTPs and 1.25 Units of Taq
Polymerase (Invitrogen, Carlsbad, CA).  The cycling conditions were as follows: 5 minutes at
94°C, followed by 32, 34 or 36 cycles of 45 seconds at 94°C, 45 seconds at 58°C, and 45
seconds at 72°C, and a final extension of 10 minutes at 72°C.  The Innp4b–α form, with a
hydrophilic C-terminus is the form predominantly expressed in adult mouse ovaries (data not
shown).  The RT-PCR assay measured just the α form under the assumption that this is very
likely the predominant form in the MII oocytes as well.  4ul of the PCR product obtained was
run on a polyacrylamide gel and bands were visualized using autoradiography. Thus, a series of
PCR products from a range of amplification cycles was obtained and the results of an FVB/N
series were compared to that of an FVB-Tgkd series.
The PCR primers used for the RT-PCR assay were as follows:
Innp4b(forward)  5’ACACCGACCACATCACAACA 3’
Inpp4b (reverse) 5’ TACGAAGACCACCGTTCTTG 3’
2.3.2.4. Inpp4b activity assay
The assay used for the determination of Inpp4b in ovary extracts from FVB/N and FVB-
Tgkd females, was modified from Majerus et al. 1990.  The ovaries collected from the mice were
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ground in liquid nitrogen and lysed in 0.5 ml of 2% Triton X-100, 20mM Hepes, 10mM EDTA,
10ug of Leupeptin/ml, and 1mM of Protease inhibitor (Roche Diagnostics, Mannheim,
Germany).  The lysate was incubated with radiolabeled [3H] 1,3,4 inositol triphosphate (gift from
Norris A, Iowa State University, IA) as the substrate in 25ul or 50ul containing 50mM MES (pH
6.5) and 5mM EDTA for 60 minutes at 37°C.  Reactions were stopped by dilution to 1ml with
cold water and poured onto a 0.4ml Dowex formate column (BioRad Laboratories, Hercules,
CA).  The reaction product, [3H] 1,3 inositol biphosphate was eluted with 8 ml of 0.4M
Ammonium formate, 0.1M Formic acid, and radioactivity was measured by liquid scintillation
spectroscopy.
2.3.3. Role of IP3R1 in ovarian teratoma formation
2.3.3.1. Immunoblot analysis
To look for differences in the levels of IP3R1 protein in MII oocytes from 3 different
strains of mice, MII oocytes were collected from the oviducts of C57B6/J, FVB/N and 129/Sv
strains of mice and lysed in 1X sample buffer as has been described before. The immunoblot
assay is very similar to what has already been described for studying the Inpp4b protein levels in
section. The antibody used in this assay was the anti-IP3R1 antibody (Affinity BioReagents,
Golden, CO) diluted 1:1000 in blocking buffer and the PVDF membrane with the oocyte extracts
was probed with this antibody for 3 hours.  The secondary antibody used was the biotinylated
donkey anti-rabbit IgG (Amersham, Piscataway, NJ) diluted 1:3,000 in blocking buffer.  Bound
antibody was detected by chemiluminescence as described earlier.
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2.3.3.2. Analysis of c-DNA for sequence differences in Itpr1 gene
To look for sequence differences in the IP3R1 mRNA between various strains of mice,
mRNA was collected from the ovaries of C57B6/J, FVB/N and LT/Sv mice using the RNA
UltraSpec kit (Biotecx, Houston, TX) and c-DNA was obtained using the M-MLV reverse
transcriptase kit (Promega, Madison, WI).  21 sets of primers were designed (Table 9) which
covered the entire IP3R1 c-DNA.  These primers were designed on the basis of the IP3R1 cDNA
obtained for the ICR strain of mice (GenBank Accession number NM_01085).  Using these
primer sets the IP3R1 c-DNA was PCR-amplified using the Pfu-Turbo Polymerase and the PCR
products obtained were sequenced.  Thus the sequence for the entire IP3R1 cDNA from the
FVB/N ovary was obtained.  This sequence was compared to the genomic sequence of the
C57B6/J Itpr1 gene obtained from PubMed (GenBank Accession # NT_039353). A total of 11
different single nucleotide polymorphisms (SNP’s) were obtained along the entire cDNA.
The comparison of the IP3R1 cDNA sequence from the different strains of mice was
performed using AssemblyLIGN Software (Oxford Molecular, Atlanta, GA).  The translation of
the cDNA sequence into its corresponding IP3R1 amino acid sequence was done using
MacVector 6.5 software (Oxford Molecular, Atlanta, GA).
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Table 9.  Primers to analyze Itpr1 c-DNA for SNPs
21 sets of primers were designed which covered the entire IP3R1 cDNA.  These primers were
designed on the basis of the IP3R1 cDNA sequence from the ICR strain of mice (GenBank
Accession number: NM_010585).
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Table 9.  Primers to analyze Itpr1 c-DNA for SNPs
Forward primers Reverse primers
Region
amplified
atcctaacggaacgagctcc gctgtacaacacaacggtca region 21
nt:129-449
ggatttatcagcaccttagg tggccagcattgacaggatt region 20
nt:401-900
ttacaagcttcgctccatcg ccaggcattcttcctcaaag region 19
nt:826-1310
tggctacagggcattacttg tttccaacttcccagcgatg region18
nt:1251-1712
ctttgccaatgatgccagca tttccggttgttgtggagca region17
nt:1660- 2140
ttggcttcatgcagaagcag gacacatccttgcaaagagg region16
nt:2061- 2561
gacatcctcagctactacag ggttaatcggagaaggtcag region15
nt:2510- 2992
gaggttgtgaacttagccag cacattacttggcccttcct region 14
nt:2921- 3400
ataggatctcctgcctcctgt tcatcgggaccttggccttt region13
nt:3291-3750
cattgtggagaagtctgagc tgaagatgtgctgcatcgtc region 12
nt:3700- 3719
tgtttctcaagccagggatc tgagtgaccacacgaacgat region 11
nt:4110-4560
atccatctggtggagctctt tcttggctacgtcagagagca region 10
nt:4451-4961
gctgatgccgagccaaaaag ttctctccatagcctctgtc region 9
nt:4897-5400
ataccaagcaactgctggag tggaatactcggtcactgga region 8
nt:5301-5790
caacctggtcatcgatctca taggctgcatgatggtgatg region 7
nt:5740-6230
cctgatgaccattaccagtc ctttccatgatggccagtagca region 6
nt:6131-6630
tggacctggtgttagaactg gagcgcaggaagaagtcattga region 5
nt:6570-7065
attacaccacagagcgggaa gaactccacatccagaacca region 4
nt:7008-7502
ctgctgggagctttcaatgtct ctcacacgtgtgttcgttatcc region 3
nt:7391-7912
atgtgtgcagggtagagacg tccttcactttcaccagcac region 2
nt:7809-8280
gtgctggtgaaagtgaagga cacatgtacccttagtgggcaa region 1
nt:8197-8218
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2.4. Discussion
An ovarian teratoma (OT) is a benign tumor originating in the ovary from a female germ
cell. The incidence of ovarian teratomas in women is high.  Early studies suggest that an OT is
derived from outgrowths of activated, mature oocytes. Although the developmental (meiotic)
origin of individual OTs can be determined in humans, little is known about the genetic
predisposition to their formation.   The two mouse OT models are the LT/Sv strain and the Tgkd
transgene in the inbred FVB/N strain (FVB-Tgkd strain) and the analysis of these two strains of
mice may lead us to the identification of genes that are related to the formation of ovarian
teratomas.
One hypothesis for the formation of ovarian teratomas in the FVB-Tgkd females is that
these teratomas arose from oocytes that have undergone meiotic maturation.  This hypothesis
was confirmed by Dr. Eva Eiker (The Jackson Laboratory, Bar Harbor, ME), who genotyped the
Tgkd teratomas that had developed in a mixed strain background using many heteromorphic
markers.  From her analysis, it was concluded that the OTs present in Tgkd females are indeed
derived from germ cells that have completed MI and not MII. These results are similar to results
obtained from females of the LT/Sv inbred strain.
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2.4.1. Role of Inpp4b disruption on the formation of Tgkd ovarian teratomas
From earlier analyses, it was concluded that the Tgkd allele functioned as an insertional
mutation.  The hypothesis was that the expression of a gene neighbouring the insertion is altered
in female germ cell, and this alteration lead to the development of ovarian teratomas.  From work
done by Feng Ding and Richard Chaillet, it was concluded that the transgene inserted between
two known chromosome 8 genes, Inpp4b and Il15.  Of the two genes on either side of Tgkd,
alteration of Inpp4b would better account for the FVB-Tgkd phenotypes as its significant
biological role is probably in modulating phosphotidylinositol signaling which is known to play
a role in egg activation. Here, one or more phospholipases hydrolyze phosphatidylinositol (4,5)
biphosphate (PtdIns(4,5)P2) to diacylglycerol and inositol 1,4,5,-triphosphate (IP3). Soluble IP3
diffuses throughout the cytoplasm, where it associates with 1,4,5-triphosphate receptor (IP3R1).
This interaction results in an increase in the concentration of cytoplasmic free Ca++ and thus
leads to egg activation. It is possible that Innp4b could be one of the components of the pathway
involved in the production of PtdIns(4,5)P2 and therefore, altered Inpp4b activity would lead to
abnormal egg activation and teratomas.
From our analyses it was determined that indeed the Inpp4b protein levels in the FVB-
Tgkd females was lowered in comparison to the wildtype FVB/N oocytes.  It is possible that this
reduction is due to the Tgkd transgene insertion in the 3’ region of Inpp4b, which in turn, might
have generated a hypomorphic Inpp4b allele.  Although the exact mechanism of this effect is not
known, one likely possibility is that a cis-acting regulatory element for Inpp4b transcription has
been disrupted by the Tgkd insertion.  Also, the lethal phenotype of Tgkd/Tgkd homozygous
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mice, leads us to believe that the adverse effect of the Tgkd insertion would apply to both
parental alleles thus favoring the disruption of a cis-acting regulatory element. Surprisingly, there
was no significant difference in the level of Inpp4b protein between the 129/Sv and 129/Sv-Tgkd
oocytes. This result will be discussed in detail in later paragraphs.
To confirm our results from analyzing the protein levels of Inpp4b, a semi-quantitative
RT-PCR technique was used to compare the levels of Inpp4b mRNA levels in MII oocytes from
FVB/N and FVB-Tgkd females. There was a slight decrease in the levels of Inpp4b mRNA in the
MII oocytes from FVB-Tgkd mice when compared to oocytes from wildtype FVB/N females.
But this difference was not as dramatic as the difference seen in the Innp4b protein levels
between the two strains of mice.  There could be various reasons for this including the fact that
the difference in Inpp4b protein levels seen between the FVB-Tgkd mice and FVB/N mice could
be due to a difference in post-transcriptional regulation of the protein. Or there could be a
qualitative difference betweens FVB-Tgkd and FVB/N Inpp4b transcripts that is not evident in
the RT-PCR assay.  Also, Inpp4b activity was measured in ovaries from FVB-Tgkd and FVB/N
females to confirm that there is a direct consequence of lower protein levels on
phosphatidylinositol metabolism.  A 10% decrease in the amount of Innp4b activity was
recorded in the ovaries from FVB-Tgkd females when compared to the ovaries from the FVB/N
females.   This decrease is not as significant as the difference seen in protein levels in the MII
oocytes from FVB-Tgkd and FVB/N females.  But the reason for this could be that the ovary is a
more heterogenous mixture than the MII oocyte and there could be other active phosphatases
involved that distort the results obtained from this assay or the substrate used was not the right
substrate for the activity of Inpp4b protein in the MII oocyte or ovary. Further analysis will be
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necessary, to measure Inpp4b activity in pools of large number of MII oocytes or using a
different substrate other than the 1,3,4 inositol triphosphate.
There is also the possibility that Inpp4b could act as a cytostatic factor in MII oocytes to
prevent cell division in unfertilized MII oocytes.  Few candidates have been discovered so far
that could be involved in CSF activity, including the Mos protein, but it is clear that there are
other proteins involved which may be part of the Mos/MAPK pathway or could be acting
independently to maintain CSF arrest.  If Inpp4b is indeed a candidate involved as a cytostatic
arrest of MII oocytes, it needs to fulfill three specific criteria to fit the definition of a cell cycle
inhibitor. It must accumulate during oocyte maturation, it must be capable of functioning in
meiosis II and must be inactivated on fertilization or parthenogenetic activation. To test this
hypothesis, the dynamics of Inpp4b protein was analyzed during oogenesis and preimplantation
development.  The levels of Inpp4b were significantly low in wildtype GV oocytes with the
protein level being 1/10th of the level found in wildtype MII oocytes.  Seemingly there was a 10-
fold increase in the Inpp4b protein level during oocyte maturation leading to high amounts of the
protein in the MII oocyte.   This rise in Inpp4b concentration associated with meiotic maturation
is diminished in oocytes from FVB-Tgkd females, and so the concentration in MII oocytes is
lower than that in wildtype oocytes.  Also, there was a dramatic decrease in the level of Inpp4b
protein after fertilization and in the 2-cell stage embryos.  Thus, these findings are consistent
with the notion that Inpp4b is a cytostatic factor that prevents spontaneous activation or cell
division of unfertilized MII oocytes.  Therefore the low levels of Inpp4b proteins seen in the MII
oocytes from FVB-Tgkd females would not be sufficient to prevent spontaneous activation, and
thus lead to ovarian teratoma formation.
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Taken together, the results from the studies so far seem to suggest that Inpp4b seems to
play an important role in the prevention of ovarian teratoma formation from MII oocytes.  Lower
levels of Inpp4b protein coincide with the higher incidence of ovarian teratomas and the
dynamics of Inpp4b protein during oogenesis correspond to the requirements for a cytostatic
factor. Thus, it appears that Inpp4b could be part of a cytostatic factor that prevents spontaneous
egg activation and therefore lower levels of this protein could lead to ovarian teratoma formation
To confirm the results from our analyses that reduction in Innp4b levels is indeed
responsible for teratoma formation in FVB-Tgkd females, an independent transgenic experiment
will be undertaken to phenocopy the Tgkd teratoma phenotype.  Interfering, double stranded
Inpp4b RNA will be expressed specifically in MII oocytes using the zona pellucida 3(ZP3)
promoter (Stein et al. 2003). These transgenic lines will then be analyzed for the formation of
ovarian teratomas.
Another experiment to test the role of Inpp4b reduction in the formation of teratomas in
FVB-Tgkd females is the re-establishment of Inpp4b protein levels in the FVB-Tgkd oocytes.
This will be done by expressing wildtype Inpp4b protein levels in maturing FVB-Tgkd oocytes,
from a ZP3-Inpp4b transgene (Lira et al. 1990).  The expected outcome is that the forced
expression of Inpp4b in FVB-Tgkd oocytes will preclude the development of ovarian teratomas.
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2.4.2. IP3R1 as a probable candidate for control of spontaneous egg activation
The formation of the ovarian teratomas in the Tgkd females seemed to be dependant on the
strain of the mice in which the transgene was present. As mentioned before, only the hemizygous
FVB-Tgkd mice develop teratomas while none of the C57B6/J or 129/Sv mice with the Tgkd
transgene developed teratomas.  F1 Tgkd mice produced by mating FVB-Tgkd mice to 129/Sv,
DBA/2J or C57B6/J mice, also do not develop OTs. These results suggest that, in addition to the
gene disrupted by the Tgkd transgene, at least one additional FVB/N-derived gene (Ots2) is
needed for OT development in Tgkd females and this determinant has been placed on
chromosome 6, the same chromosome that contains Ots1, an LT/Sv genetic determinant of OT
development.   A good candidate for the Ots2 gene is the Itpr1 gene that encodes for the IP3R1
protein that, in turn, is responsible for mobilizing intracellular Ca++ stores upon binding to IP3
during egg activation. The IP3R1 dynamics during oocyte maturation and fertilization suggest
that strain variation in IP3R protein levels or minor sequence changes in the Itpr1 gene, during
these periods may influence the response to IP3 signalling and consequently the tendency to form
ovarian teratomas.
To analyze this hypothesis, the levels of IP3R1 protein were analyzed in MII oocytes
from 3 different strains, C57B6/J, FVB/N and 129/Sv. There was no significant difference in the
levels of IP3R1 protein between the MII oocytes from the three different strains.  This result lead
us to rule out the possibility that differences in the level of IP3R1 protein between the various
strains of mice affect their individual susceptibility to formation of ovarian teratomas via their
response to IP3 signalling or their regulation of the Inpp4b protein.  Therefore, we considered the
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second possibility, that differences in the sequence of the Itpr1 gene between the various strains
could lead to differences in their tendency to form ovarian teratoma.
When we analyzed for sequence differences in the IP3R1 mRNA among the three strains
of mice, C57B6/J, FVB/N and LT/Sv, it was observed that there were 10 different SNPS but none
of them gave rise to an amino acid change.  It is therefore necessary to further analyze the IP3R1
protein for other possible differences that might lead to strain specificity for OT formation.
Preliminary data (data not shown) indicate that there are two different forms of the IP3R1 cDNA
in the ovary.  The only difference between the two isoforms seems to be the lack of a single exon
in one of them.  It would be worthwhile to determine which isoform is present in the oocyte and
if there is a difference in this isoform among the different strains.
 Thus, from our results, it is possible to build a hypothesis to explain the role of Inpp4b
and IP3R1 proteins during egg activation.  In most vertebrates the development of the immature
oocyte into a fertilizable gamete, a process known as oocyte maturation involves an arrest at
metaphase of meiosis II.  This arrest is brought about by the cytostatic factor (CSF) present in
high levels in the MII oocyte.  From our studies it appears that the Inpp4b could be one of the
cytostatic factors as it shows a 10-fold increase in concentration from the GV stage of oogenesis
to the MII stage, that stage of oogenesis where the specific function of the CSF is called upon
(i.e., maintenance of Metaphase II arrest).   At this stage, the high levels of Innp4b, probably act
on the PtdIns(4,5)P2’s, either directly or indirectly, converting them to monophosphates and thus
keeping the concentration of the PtdIns(4,5)P2’s under the minimum  levels required for egg
activation. On fertilization by sperm or parthenogenetic activation, the levels of Inpp4b fall
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dramatically, leading to a net increase in the PtdIns(4,5)P2’s, as has been observed by Halet et al.
2002.  One or more phospholipases hydrolyze the PtdIns(4,5)P2’s to diacylglycerol and IP3.
Soluble IP3 interacts with IP3R1, and this interaction results in a series of Ca
++ oscillations which
in turn mediates many of the molecular events associated with fertilization and the entry into
mitosis and cell division. The Inpp4b could also act directly on the IP3 at the MII stage, keeping
their levels under the minimum level required for activation or it could associate with the IP3R1
and thus prevent the IP3-IP3R1 interaction that would otherwise lead to egg activation (Figure
35).
In the FVB-Tgkd mice, the low levels of Inpp4b in the MII oocytes probably lead to an
increase in the PtdIns(4,5)P2’s during maturation and these in turn are acted upon by the
phospholipases leading to the release of IP3. IP3 associates with IP3R1 resulting in the Ca
++
oscillations which ultimately lead to oocyte activation and ovarian teratomas.  It is also possible
that low levels of Inpp4b could lead to an increase in IP3 levels or IP3-IP3R1 interaction, thus
leading to oocyte activation.
To confirm that Inpp4b levels are indeed associated with egg activation, it would be
necessary to analyze the activation state of GV-stage and MII oocytes from FVB/N and FVB-
Tgkd mice.  These will include a number of measures like change in cortical granule content,
time of pronucleus appearance and the number and amplitude of Ca++ transients.  The activation
state of the oocytes will be induced by incubation in SrCl2 and IP3 injections.  These experiments
will be done by Dr. Norris A., Iowa State University, IA.  If the oocytes from FVB-Tgkd mice
indeed show a higher activation state than those from the wildtype mice, then it would confirm
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our hypothesis that decreased levels of Inpp4b protein are indeed associated with physiological
abnormalities of FVB-Tgkd germ cells.
Another factor to consider is the strain specificity that is seen in the occurrence of ovarian
teratomas due to the transgene. Surprisingly, there is no dramatic decrease in the levels of Inpp4b
protein in the MII oocytes from 129/Sv-Tgkd mice when compared to the wildtype 129/Sv mice,
inspite of the insertion of the transgene.  One hypothesis is that the FVB-derived Ots2 gene,
which is required for the formation of the FVB-Tgkd ovarian teratomas, is also responsible for
the maintenance of Inpp4b levels.  If it is confirmed that Itpr1 is indeed the Ots2 gene, then it is
possible that a variant form of the IP3R1 protein seen in the C57B6/J-Tgkd and probably in the
129/Sv-Tgkd strains of mice, is able to bring back the level of Inpp4b protein back to the level
seen in the wildtype mice and thus able to keep oocyte activation in check.  In contrast, the IP3R1
protein variant seen in the FVB-Tgkd and LT/Sv mice is unable to maintain the Inpp4b levels and
thus leads to ovarian teratoma formation.
Thus from our experiments, we have been able to shed some light on the role of Inpp4b
and IP3R1 as potential genetic determinants for controlling spontaneous activation of unfertilized
oocytes. These studies have brought our attention to new signaling pathways that could be
involved in ovarian teratoma formation and further studies are necessary to elucidate the exact
mechanism involved.
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Figure 35. Hypothetical role of Inpp4b during MII stage of oogenesis
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Figure 35. Hypothetical role of Inpp4b during MII stage of oogenesis
A. Initiation of egg activation after fertilization. A series of Ca++ oscillations mediates many of
the molecular events associated with fertilization and the entry into mitosis (Cantrell 2001;
Mehlmann and Kline 1994; Carroll 2001). The phosphatidylinositol (PtdIns) pathway appears to
be primarily responsible for this increase in intracellular Ca++. Here, one or more phospholipases
(including phospholipase Cζ) hydrolyze PtdIns(4,5)P2 to DAG and IP3. Soluble IP3 diffuses
throughout the cytoplasm, until it encounters IP3R1 on endoplasmic reticulum. This interaction
results in the release of Ca++ and an increase in the concentration of cytoplasmic free Ca++ (Xu et
al. 2002).  B. Hypothetical role of Inpp4b to prevent egg activation before fertilization. At the
MII stage, the high levels of Innp4b, probably act on the PtdIns(4,5)P2, either directly or
indirectly, converting them to monophosphates and thus keeping the concentration of the
PtdIns(4,5)P2’s under the minimum  levels required for egg activation. The Inpp4b could also act
directly on the IP3 at the MII stage, keeping their levels under the minimum level required for
activation or it could associate with the IP3R1 and thus prevent the IP3-IP3R1 interaction which
would otherwise lead to egg activation.  Thus, through any of these pathways, Inpp4b could
prevent the series of Ca++ oscillations which is responsible for the resumption of Meiosis II and
cell division and thus prevent abnormal egg activation before fertilization
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